
<html lang="en"     class="pb-page"  data-request-id="646a03ae-aa2a-4a68-bec0-50236e27b392"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00425"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo" /></meta><meta name="dc.Creator" content="Edwige  Lorthiois" /></meta><meta name="dc.Creator" content="Karen  Anderson" /></meta><meta name="dc.Creator" content="Anna  Vulpetti" /></meta><meta name="dc.Creator" content="Olivier  Rogel" /></meta><meta name="dc.Creator" content="Frederic  Cumin" /></meta><meta name="dc.Creator" content="Nils  Ostermann" /></meta><meta name="dc.Creator" content="Stefan  Steinbacher" /></meta><meta name="dc.Creator" content="Aengus  Mac Sweeney" /></meta><meta name="dc.Creator" content="Omar  Delgado" /></meta><meta name="dc.Creator" content="Sha-Mei  Liao" /></meta><meta name="dc.Creator" content="Stefan  Randl" /></meta><meta name="dc.Creator" content="Simon  Rüdisser" /></meta><meta name="dc.Creator" content="Solene  Dussauge" /></meta><meta name="dc.Creator" content="Kamal  Fettis" /></meta><meta name="dc.Creator" content="Laurence  Kieffer" /></meta><meta name="dc.Creator" content="Andrea  de Erkenez" /></meta><meta name="dc.Creator" content="Louis  Yang" /></meta><meta name="dc.Creator" content="Constanze  Hartwieg" /></meta><meta name="dc.Creator" content="Upendra A.  Argikar" /></meta><meta name="dc.Creator" content="Laura R.  La Bonte" /></meta><meta name="dc.Creator" content="Ronald  Newton" /></meta><meta name="dc.Creator" content="Viral  Kansara" /></meta><meta name="dc.Creator" content="Stefanie  Flohr" /></meta><meta name="dc.Creator" content="Ulrich  Hommel" /></meta><meta name="dc.Creator" content="Bruce  Jaffee" /></meta><meta name="dc.Creator" content="Jürgen  Maibaum" /></meta><meta name="dc.Description" content="The highly specific S1 serine protease factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system. Genetic associations in humans..." /></meta><meta name="Description" content="The highly specific S1 serine protease factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system. Genetic associations in humans..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 30, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00425" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00425" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00425" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00425" /></link>
        
    
    

<title>Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00425" /></meta><meta property="og:title" content="Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0016.jpeg" /></meta><meta property="og:description" content="The highly specific S1 serine protease factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system. Genetic associations in humans have implicated AP activation in age-related macular degeneration (AMD), and AP dysfunction predisposes individuals to disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The combination of structure-based hit identification and subsequent optimization of the center (S)-proline-based lead 7 has led to the discovery of noncovalent reversible and selective human factor D (FD) inhibitors with drug-like properties. The orally bioavailable compound 2 exerted excellent potency in 50% human whole blood in vitro and blocked AP activity ex vivo after oral administration to monkeys as demonstrated by inhibition of membrane attack complex (MAC) formation. Inhibitor 2 demonstrated sustained oral and ocular efficacy in a model of lipopolysaccharide (LPS)-induced systemic AP activation in mice expressing human FD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00425"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00425">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00425&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00425&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00425&amp;href=/doi/10.1021/acs.jmedchem.7b00425" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5717-5735</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00426" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00433" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition <i>in Vivo</i></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edwige++Lorthiois">Edwige Lorthiois</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6147-9321" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Anderson">Karen Anderson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Vulpetti">Anna Vulpetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3114-8679" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Rogel">Olivier Rogel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++Cumin">Frederic Cumin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nils++Ostermann">Nils Ostermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Steinbacher">Stefan Steinbacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aengus++Mac+Sweeney">Aengus Mac Sweeney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Omar++Delgado">Omar Delgado</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sha-Mei++Liao">Sha-Mei Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Randl">Stefan Randl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++R%C3%BCdisser">Simon Rüdisser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Solene++Dussauge">Solene Dussauge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kamal++Fettis">Kamal Fettis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Kieffer">Laurence Kieffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++de+Erkenez">Andrea de Erkenez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis++Yang">Louis Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Constanze++Hartwieg">Constanze Hartwieg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Upendra+A.++Argikar">Upendra A. Argikar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0939-0813" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+R.++La+Bonte">Laura R. La Bonte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald++Newton">Ronald Newton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Viral++Kansara">Viral Kansara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefanie++Flohr">Stefanie Flohr</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulrich++Hommel">Ulrich Hommel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Jaffee">Bruce Jaffee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Maibaum">Jürgen Maibaum</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Proteros Biostructures GmbH, D-82152 Planegg-Martinsried, Germany</span></div><div class="corresp-info"><strong>*</strong>E.L. Tel: +41-61-6961955. E-mail: <a href="/cdn-cgi/l/email-protection#492c2d3e202e2c6725263b3d212026203a0927263f283b3d203a672a2624"><span class="__cf_email__" data-cfemail="abcecfdcc2ccce85c7c4d9dfc3c2c4c2d8ebc5c4ddcad9dfc2d885c8c4c6">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>J.M. Tel:+41-61-6965560. E-mail: <a href="/cdn-cgi/l/email-protection#f59f80908792909baa9e99948086db98949c97948098b59b9a839487819c86db969a98"><span class="__cf_email__" data-cfemail="69031c0c1b0e0c07360205081c1a470408000b081c042907061f081b1d001a470a0604">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00425&amp;href=/doi/10.1021%2Facs.jmedchem.7b00425" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5717–5735</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 16, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 March 2017</li><li><span class="item_label"><b>Published</b> online</span>30 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00425" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00425</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5717%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEdwige%2BLorthiois%252C%2BKaren%2BAnderson%252C%2BAnna%2BVulpetti%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00425%26title%3DDiscovery%2Bof%2BHighly%2BPotent%2Band%2BSelective%2BSmall-Molecule%2BReversible%2BFactor%2BD%2BInhibitors%2BDemonstrating%2BAlternative%2BComplement%2BPathway%2BInhibition%2Bin%2BVivo%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5735%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00425"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2778</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00425" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Edwige&quot;,&quot;last_name&quot;:&quot;Lorthiois&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Anderson&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Vulpetti&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Rogel&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;Cumin&quot;},{&quot;first_name&quot;:&quot;Nils&quot;,&quot;last_name&quot;:&quot;Ostermann&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Steinbacher&quot;},{&quot;first_name&quot;:&quot;Aengus&quot;,&quot;last_name&quot;:&quot;Mac Sweeney&quot;},{&quot;first_name&quot;:&quot;Omar&quot;,&quot;last_name&quot;:&quot;Delgado&quot;},{&quot;first_name&quot;:&quot;Sha-Mei&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Randl&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Rüdisser&quot;},{&quot;first_name&quot;:&quot;Solene&quot;,&quot;last_name&quot;:&quot;Dussauge&quot;},{&quot;first_name&quot;:&quot;Kamal&quot;,&quot;last_name&quot;:&quot;Fettis&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Kieffer&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;de Erkenez&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Constanze&quot;,&quot;last_name&quot;:&quot;Hartwieg&quot;},{&quot;first_name&quot;:&quot;Upendra&quot;,&quot;last_name&quot;:&quot;A. Argikar&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;R. La Bonte&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;Newton&quot;},{&quot;first_name&quot;:&quot;Viral&quot;,&quot;last_name&quot;:&quot;Kansara&quot;},{&quot;first_name&quot;:&quot;Stefanie&quot;,&quot;last_name&quot;:&quot;Flohr&quot;},{&quot;first_name&quot;:&quot;Ulrich&quot;,&quot;last_name&quot;:&quot;Hommel&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Jaffee&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Maibaum&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5717-5735&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00425&quot;},&quot;abstract&quot;:&quot;The highly specific S1 serine protease factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system. Genetic associations in humans have implicated AP activation in age-related macular degeneration (AMD), and AP dysfunction predisposes individuals to disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The combination of structure-based hit identification and subsequent optimization of the center (S)-proline-based lead 7 has led to the discovery of noncovalent reversible and selective human factor D (FD) inhibitors with drug-like properties. The orally bioavailable compound 2 exerted excellent potency in 50% human whole blood in vitro and blocked AP activity ex vivo after oral administration to monkeys as demonstrated by inhibition of membrane attack complex (MAC) formation. Inhibitor 2 demonstrated sustained oral and ocular efficacy in a model of lipopolysaccharide (LPS)-induced systemic AP&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00425" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00425&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00425" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00425&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00425" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00425&amp;href=/doi/10.1021/acs.jmedchem.7b00425" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00425" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00425" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00425%26sid%3Dliteratum%253Aachs%26pmid%3D28621538%26genre%3Darticle%26aulast%3DLorthiois%26date%3D2017%26atitle%3DDiscovery%2Bof%2BHighly%2BPotent%2Band%2BSelective%2BSmall-Molecule%2BReversible%2BFactor%2BD%2BInhibitors%2BDemonstrating%2BAlternative%2BComplement%2BPathway%2BInhibition%2Bin%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5717%26epage%3D5735%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290838" title="Carbonyls">Carbonyls</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The highly specific S1 serine protease factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system. Genetic associations in humans have implicated AP activation in age-related macular degeneration (AMD), and AP dysfunction predisposes individuals to disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The combination of structure-based hit identification and subsequent optimization of the center (<i>S</i>)-proline-based lead <b>7</b> has led to the discovery of noncovalent reversible and selective human factor D (FD) inhibitors with drug-like properties. The orally bioavailable compound <b>2</b> exerted excellent potency in 50% human whole blood <i>in vitro</i> and blocked AP activity <i>ex vivo</i> after oral administration to monkeys as demonstrated by inhibition of membrane attack complex (MAC) formation. Inhibitor <b>2</b> demonstrated sustained oral and ocular efficacy in a model of lipopolysaccharide (LPS)-induced systemic AP activation in mice expressing human FD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The alternative pathway (AP) of the complement system, when triggered by pathogen- or damage-associated molecular patterns on nonhost and injured host cells, provides an innate immune defense mechanism in all vertebrates.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The AP also functions as an amplification mechanism for both the classical and the lectin pathways. A low level of steady complement activation by AP “tick-over” results in the generation of a small fraction of soluble C3-convertase in plasma (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Upon activation, the initial C3-convertase cleaves complement C3 into the anaphylatoxin C3a and the larger fragment C3b, which binds to cell surfaces (opsonization) and recruits factor B (FB), a pro-enzyme of the S1 serine protease family. FD cleaves FB in its complex with C3b thereby generating the active surface-bound C3-convertase (C3bBb). C3bBb stabilized by properdin (P) cleaves additional molecules of C3, thus triggering a local amplification of AP activation, and moreover by recruitment of additional C3b generates the C5-convertase (C3bC3bBb). C3- and C5-convertases are key players in the alternative complement pathway ultimately leading to the formation of the membrane attack complex (MAC) and cell lysis. Dysregulation of AP and activation against the host has been connected to a variety of diseases such as age-related macular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), membranoproliferative glomerulonephritis type II (MPGNII), and paroxysmal nocturnal hemoglobinuria (PNH).<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a> The S1 protease FD plays a central function in AP amplification by catalyzing the first and rate-limiting proteolytic step. FD is highly substrate specific due to a unique active site architecture that requires an induced-fit conformational transition to acquire full proteolytic activity. The extremely high specificity of FD is essential as it circulates in the blood as a mature enzyme, albeit adopting a latent active site conformation, and is not regulated by any known endogenous inhibitor.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic drawing of the classical, the lectin, and the alternative complement pathways, highlighting the pivotal role of the S1 serine protease factor D. An inhibitor of factor D has the potential to block the initiating step of the alternative pathway (AP) and the amplification loop that augments the other two pathways and prevent the formation of the AP C3 and C5 convertases. The key effector mechanisms of innate immunity contributed by complement are opsonization by C3 fragments and lysis by deposition of the membrane attack complex (MAC) on cell surfaces.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a consequence, FD inhibition appears to be an attractive mechanism to block the complement AP with high specificity and efficiency. For this reason, we had embarked in 2006 on an extensive drug discovery effort in the quest to develop orally effective, reversible noncovalent FD inhibitors useful for clinical therapy.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> When we initiated our project, the only reported FD inhibitors were nonselective and covalent-irreversible, such as 2-carbamimidoylbenzo[b]thiophen-6-yl thiophene-2-carboxylate (BCX-1470),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> properties that were considered as incompatible with selective and sustained AP inhibition required for disease therapy, in particular in view of the short plasma half-life of FD.<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> Furthermore, no small molecule AP inhibitor has become available to date for clinical use.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Our multiple parallel approaches for initial hit identification included structure-based S1 target family scaffold hopping and tailored library design, focused fragment-based screening (FBS), screening of diverse Novartis corporate fragment libraries and function-based high-throughput screening using assays for FD thioesterolysis and for AP-mediated MAC deposition. Subsequent merging of newly discovered structural motifs essential for binding to the unique conformation of the latent FD active site together with further structure–activity relationship (SAR) optimization eventually culminated in the center (<i>S</i>)-proline-based FD inhibitors <b>1</b> and <b>2</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These compounds were shown to efficiently block alternative pathway (AP) activation and to prevent lysis of PNH erythrocytes <i>in vitro</i>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We describe herein a more detailed account of our work leading to the novel inhibitor <b>2</b> with promising <i>in vitro</i> selectivity and safety profiles, distribution into ocular tissues, and demonstrated <i>in vivo</i> and <i>ex vivo</i> efficacy after oral administration in animal models of complement activation. Small-molecule potent and selective FD inhibitors were very recently reported by researchers at Achilion, however, without disclosing the origin and chemical structure of these compounds. ACH-4471, which has entered into early clinical investigation, was shown to block <i>ex vivo</i> induced AP activity in cynomolgus monkeys after oral dosing, to reduce complement-mediated hemolysis of PNH erythrocytes, and to block dysregulated AP activity <i>in vitro</i> in aHUS patient serum.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Compounds <b>1</b>–<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As previously reported,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> the center (<i>S</i>)-proline-based FD inhibitor <b>3</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) was identified from a structure-based library design approach inspired by a structurally related analog binding to kallikrein 7, a member of the S1 protease family, and demonstrated moderate potency in blocking the thioesterolytic activity of latent human FD. Inhibitor <b>3</b> was shown by X-ray crystallography to bind in a bent conformation to the S1, S1′, and S2′ pockets of FD, in which the salt bridge between Asp<sub>182</sub> and Arg<sub>218</sub> at the bottom of the S1 pocket is present (closed conformation). Initial broad SAR exploration of the various portions of molecule <b>3</b>, in part by iterative small library design, failed to deliver any analogs with significantly improved <i>in vitro</i> potencies in the FD thioesterolysis assay (data not shown). Gratifyingly, the <i>N</i>-urea (<i>S</i>)-proline analog <b>4</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) was uncovered by structure-similarity searches in the corporate compound collection and found to be a modest inhibitor of FD in the thioesterolysis assay. Computational modeling predicted the <i>N</i>-methyl-1<i>H</i>-indol-3-yl pharmacophore to bind into the S1 pocket.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, the generation of an X-ray crystal structure of <b>4</b> in complex with recombinant human FD by both crystal soaking and cocrystallization remained unsuccessful in our hands, despite significant efforts. We therefore prepared its close analog <b>5</b>, in which the bulky diphenylmethane-amido residue is replaced by the less hydrophobic <i>meta</i>-OCF<sub>3</sub>-anilide motif of <b>3</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). Although compound <b>5</b> was ∼4-fold less potent toward FD, as compared to <b>4</b>, the X-ray crystal structure of <b>5</b> bound to the active site of FD could be eventually resolved (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). The electron density map was consistent with a single binding conformation of <b>5</b>, revealing the indole scaffold to be positioned in the S1 pocket and the <i>N</i>-methyl group pointing toward the side chain of Arg<sub>218</sub> at the bottom of this binding site. The (<i>S</i>)-proline and the <i>meta</i>-OCF<sub>3</sub>-anilide portion of <b>5</b> occupied the S1′–S2′ specificity pockets in a very similar manner as observed for the parent inhibitor <b>3</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE">5FBE</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Crystal structure of the complex between human FD and <b>5</b> (in pink) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT">5NAT</a>) overlaid with FD-bound <b>6</b> (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBI">5FBI</a>). Hydrogen-bond interactions of the urea carbonyl to the Gly<sub>193</sub> NH (oxyanion hole) and the amide NH of compound <b>5</b> to the backbone carbonyl of Leu<sub>41</sub> are highlighted, as well as the H-bonds of the terminal carboxamide of <b>6</b> to Thr<sub>214</sub> of the self-inhibitory loop and to Arg<sub>218</sub> at the bottom of the S1 pocket, and the H-bond of the indole-NH with the Arg<sub>218</sub> backbone carbonyl. Note that the benzoic acid portion of <b>6</b> is positioned in solvent space and hence is not resolved in the crystal structure. (B) Crystal structure of the complex between human FD and <b>7</b> (in orange) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR">5NAR</a>). The imidazole side chain of the catalytic His<sub>57</sub> is in an “out” conformation. The network of H-bonds between the <i>N</i>-carbamoyl residue of <b>7</b> and Thr<sub>214</sub>, Arg<sub>218</sub>, and a water molecule bound deeply in the S1 pocket is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The indole-carboxamide fragment <b>6</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), which had previously been identified through screening of a focused set of fragments, was shown by <sup>1</sup>H–<sup>15</sup>N HSQC-NMR to bind with very weak affinity to FD and by X-ray crystallography to be accommodated by the S1 pocket of latent FD in its closed conformation.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Remarkably, the indole moiety of both <b>6</b> and <b>4</b> adopted a very similar planar orientation within the S1 pocket and sandwiched between the Lys<sub>192</sub> side chain on one side and the self-inhibitory loop on the other side (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Moreover, the closely overlapping positions of the indole nitrogen atom of <b>4</b> and the C2 atom of <b>6</b>, as well as the respective bond vectors, suggested combining these structural motifs (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). As a consequence, compound <b>7</b> bearing an <i>N</i>-carbamoyl substituted indole was synthesized and demonstrated a remarkable 40-fold increase in inhibitory activity in the FD thioesterolysis assay, as compared to <b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The binding efficiency index (BEI)<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> and the lipophilic ligand efficiency (LLE)<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> for <b>7</b> (BEI 13.3; LLE 3.54) were improved compared to those calculated for compounds <b>3</b>–<b>6</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). Importantly, compound <b>7</b> revealed similar potency with an IC<sub>50</sub> value of 0.8 μM in the FD proteolysis assay using human FB in complex with cobra venom factor (CVF–FB), which is an ortholog of the activated human C3, as the endogenous surrogate substrate.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The (2<i>R</i>)-configured enantiomer <b>8</b> was 60-fold less active in the FD thioesterolytic assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The X-ray crystal complex of <b>7</b> bound to FD (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) was determined at 1.55 Å resolution using the soaking method. The <i>N</i>-carbamoyl group of <b>7</b>, being key for strong binding affinity, is positioned deeply in the S1 pocket, as expected, and is engaged in direct H-bond interactions with the terminal guanidine nitrogen of the Arg<sub>218</sub> side chain and the backbone carbonyl of Thr<sub>214</sub> in a similar manner as was previously observed in the crystal structure of fragment <b>6</b> bound to FD (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). In addition, one of the amide NH is in H-bond distance to an enzyme-bound water molecule positioned in a polar environment comprising the Ile<sub>227</sub> amide backbone and the hydroxyl of the Thr<sub>214</sub> side chain. An additional interaction between the NH of the urea S1–S1′ spacer in <b>7</b> and the Ser<sub>215</sub> backbone carbonyl is also observed. The corresponding (<i>S</i>)-proline scaffold and the OCF<sub>3</sub>-anilide moiety of both <b>7</b> and <b>3</b> are closely superpositioned in the S1′–S2′ prime sites (not shown).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Potency Data for Compounds <b>7</b>–<b>18</b>, using a FD Thioesterolytic Fluorescent Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Half-maximal inhibition of recombinant human complement FD catalytic domain, as determined in a thioesterolysis-based assay using Z-Lys-thiobenzylester as the substrate.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Data represent mean values of duplicate measurements.</p></div></div><div></div></div><div class="NLM_p">Compound <b>7</b> showed excellent selectivity against a panel of 10 human S1 proteases including kallikrein 7, chymotrypsin, trypsin, coagulation factor Xa, thrombin, plasmakallikrein, and neutrophil elastase (all IC<sub>50</sub> values >30 μM), and furthermore against a standard safety panel of 26 enzymes, receptors, ion channels, and transporters (IC<sub>50</sub> values >30 μM; weak affinities for adenosine 3 receptor (Ad3, 8.8 μM), adenosine transporter (AdT, 4.2 μM), and cyclo-oxygenase 1 (COX-1, 6.4 μM)). Also, <b>7</b> did not inhibit the hERG channel (IC<sub>50</sub> > 30 μM; dofetilide binding assay) and showed no signs for <i>in vitro</i> genotoxicity (mini-AMES<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and Micronucleus test<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>). No inhibition of the cytochrome P450 enzymes CYP3A4 and CYP2D6 (IC<sub>50</sub> > 30 μM) and only weak inhibitory activity against CYP2C9 (IC<sub>50</sub> = 3.4 μM) were observed. Inhibitor <b>7</b> displayed modest solubility, medium permeability in the Caco-2 assay (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) and moderate <i>in vitro</i> clearance in rat and human liver microsomes (not shown). Importantly, the compound displayed a promising <i>in vivo</i> pharmacokinetic profile in Sprague–Dawley (SD) rats (dosed at 1 mg/kg intravenously (iv) and at 10 mg/kg orally (po)), characterized by moderate clearance (CL = 21 mL/min/kg), a terminal half-life (<i>T</i><sub>1/2</sub>) of 1.4 h, sustained micromolar exposure levels in plasma (AUC<sub>0–8h</sub> = 4990 nM h; <i>C</i><sub>max</sub> = 1167 nM), and 25% oral bioavailability. Based on its overall properties, we considered compound <b>7</b> as a reasonable starting point for further SAR exploration.</div><div class="NLM_p">Our initial efforts were aimed at optimizing the binding interactions to the S1, S1′, and S2′ pockets considered as hot spots in the active site of latent FD,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> rather than expanding into the S1β region, with the objective to improve potency not at the expense of BEI<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> and LLE.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> We reasoned that additional contacts to the S1′ site, in particular to the small indentation defined by the His<sub>57</sub> backbone, the Cys<sub>42</sub>–Cys<sub>58</sub> disulfide bridge, and the Ser<sub>215</sub> side chain (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), would improve FD binding. Accordingly, alterations of the (<i>S</i>)-proline scaffold were envisaged by introducing small hydrophobic substituents to C4, C5, or both of the center ring with appropriate absolute configuration (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Introduction of a methyl group to the 4-position of the proline, either with absolute (<i>R</i>)- or with absolute (<i>S</i>)-configuration (compounds <b>9</b> and <b>10</b>, respectively), and likewise the incorporation of a fused <i>trans</i>-3,4-cyclopropyl-proline (<b>11</b>) did not significantly influence the <i>in vitro</i> potency, as compared to <b>7</b>, when tested in the biochemical FD assay. Replacing the pyrrolidine by a piperidine center ring resulted in a dramatic loss in potency (<b>12</b>). In contrast, and very gratifyingly, attaching a fused <i>trans-</i>4,5-cyclopropyl ring to the proline scaffold gave a 10-fold improvement in potency with <b>13</b> displaying an IC<sub>50</sub> value of 50 nM. The potency of <b>13</b> was retained when measured in the CVF:FB proteolytic ELISA assay (IC<sub>50</sub> = 0.21 μM), and moreover <b>13</b> inhibited AP activation <i>in vitro</i> in a functional membrane attack complex (MAC) deposition assay using 50% human whole blood,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> albeit with a 20-fold decrease in activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Potency Data for Compounds <b>13</b> and <b>19</b>–<b>26</b>, Using a FD Thioesterolytic Fluorescent Assay and a MAC Deposition Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char=".">FD IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MAC IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">hPPB (%)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.045</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.250</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.587</td><td class="colsep0 rowsep0" align="char" char=".">>99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">95.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Half-maximal inhibition of recombinant human complement FD catalytic domain, as determined in a thioesterolysis-based assay using Z-Lys-thiobenzylester as the substrate.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Half-maximal inhibition of soluble MAC complex formation, as determined in an ELISA assay using alkaline-phosphatase-conjugated-anti-C9-neoepitope in normal human whole blood diluted with an equal amount of gelatin veronal buffer.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Data represent mean values of duplicate measurements.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Compound fraction in % bound to human plasma protein.</p></div></div></div><div class="NLM_p">To inform further medicinal chemistry design, we determined the crystal structure of <b>13</b> in complex with FD (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). The overall binding pose of <b>13</b> emulating the U-shaped active site conformation of latent FD extending from S1 to S2′ was confirmed, with the His<sub>57</sub> again adopting a “noncanonical” catalytic-triad conformation. The (<i>S</i>)-proline ring portion of the bicyclic aza-bicyclo[3.1.0]hexane scaffold adopted a very similar bound conformation as observed for the unsubstituted analog <b>7</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). The axial methylene group of the cyclopropyl ring is oriented toward the back surface of the S1′ site and forms close van der Waals contacts by nicely filling the small hydrophobic indentation that is formed as a consequence of the flipped conformation of the His<sub>57</sub> side chain.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Superpositions of compounds <b>7</b> (in orange color), <b>13</b> (magenta) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW">5NAW</a>), <b>14</b> (cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA">5NBA</a>), and <b>18</b> (yellow) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6">5NB6</a>) observed in their X-ray crystal structures in complex to human FD. The conformational flexibility of the His<sub>57</sub> and Ser<sub>215</sub> side chains are highlighted, while the Cys<sub>42</sub>–Cys<sub>58</sub> disulfide bridge conformation is largely conserved. (B) Close-up view highlighting the antiparallel dipole–dipole interaction observed between the C–F dipole in <b>14</b> and the FD His<sub>57</sub> carbonyl dipole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore the impact of the C4-substitution and stereochemistry by introducing a fluorine atom to the center pyrrolidine, the (<i>R</i>)- and (<i>S</i>)-configured monofluoro analogs <b>14</b> and <b>15</b>, as well as the 4,4-difluoro derivative <b>16</b>, were synthesized. A 10-fold improvement in potency was accomplished for (4<i>R</i>)-<b>14</b>, whereas both the (4<i>S</i>)-diastereomer <b>15</b> and the difluoro analog <b>16</b> were found to be equipotent to the parent compound <b>7</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The stereodependent effects of a fluorine and other heteroatoms substituting the C3 and C4 positions of N-acylated proline-carboxamides on ring puckering is well documented.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> A fluorine at position C4 of the proline alters the relative energies of the ring puckers, which can lead to the nearly exclusive population of a single conformer. The C<sub>4</sub>-<i>endo</i> conformation is preferred for 4(<i>S</i>)-fluoro-proline monosubstituted derivatives, whereas 4(<i>R</i>)-fluoro-prolines adopt the C<sub>4</sub>-<i>exo</i> conformation which in case of (4<i>R</i>)-<b>14</b> is expected to direct the fluorine atom toward the S1′ back surface, thereby enhancing the van der Waals interactions to the protein. Moreover, the presence of the (4<i>R</i>)-fluorine results in a preference for the <i>trans</i>-peptidic bond of the <i>N</i>-acyl proline resembling the FD bound conformation observed for inhibitors <b>7</b> and <b>13</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The X-ray crystal structure of <b>14</b> bound to FD (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) indeed revealed the proline ring in a C<sub>4</sub>-<i>exo</i> pucker, thereby positioning the F atom close to the Cys<sub>48</sub>–Cys<sub>52</sub> disulfide bridge and the His<sub>57</sub> backbone carbonyl. The antiparallel dipole–dipole interaction observed between the large C–F dipole and the His<sub>57</sub> carbonyl dipole may further contribute to the improved binding affinity of <b>14</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). In contrast, the fluorine of (4<i>S</i>)-<b>15</b> in its anticipated C<sub>4</sub>-<i>endo</i> conformation is directed toward solvent space without being involved in direct binding interactions.</div><div class="NLM_p">Next, we introduced polar substituents to C4 of the proline ring with the aim to improve aqueous solubility while retaining <i>in vitro</i> potency. Proline amides bearing a (4<i>S</i>)-hydroxy or (4<i>S</i>)-amino group have been shown to preferentially adopt a C<sub>4</sub>-<i>endo</i> ring pucker,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> in line with our design concept to place a solubilizing group close to solvent space. Compound <b>17</b> bearing a (4<i>S</i>)-OH showed a ∼3-fold drop in biochemical potency, whereas the more soluble (4<i>S</i>)-NH<sub>2</sub> analog <b>18</b> exhibited similar affinity for FD compared to <b>7</b>, despite the slightly reduced van der Waals contacts of the proline <i>endo</i>-pucker to the S1′ hydrophobic surface observed in the FD/<b>18</b>-complex X-ray structure (depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A).</div><div class="NLM_p">We next focused our efforts on exploring the S2′ region identified as hydrophobic hotspot defined by Gly<sub>142</sub> and the side chains of Ile<sub>143</sub> and Arg<sub>151</sub>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The trifluoromethoxy-phenyl residue in its energetically favored perpendicular conformation<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> positions the highly lipophilic CF<sub>3</sub> moiety deeply into the S2′ pocket, thereby tightly filling the small hydrophobic indentation of the enzyme (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Replacement of the OCF<sub>3</sub> group in <b>13</b> by an OCHF<sub>2</sub> (<b>19</b>) decreased potency by 3-fold, whereas the OCH<sub>3</sub> analog <b>20</b> showed a more pronounced 6-fold potency drop likely due to the favored in-plane conformation of the methoxy-anilide portion<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Halogen replacements were tolerated with a preference for bromine over a chlorine atom (<b>22</b> vs <b>21</b>), reflecting the increase in strength of the halogen bond to the backbone carbonyl of Trp<sub>141</sub> as a result of the increase in halogen size (<i>vide infra</i> for a more detailed discussion).<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structures of human FD in complex with <b>2</b> (the protein is shown in gray color and the ligand in cyan color; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7">5NB7</a>) overlaid with the crystal structure of the complex with compound <b>13</b> (only the ligand is shown, magenta color). The network of H-bonds (black dashed lines) in the S1 pocket, to the backbone of Gly<sub>193</sub> and the H-bond between the amide spacer and Leu<sub>41</sub> backbone carbonyl are conserved. (B) Close up view of the S2′ region, the halogen bond (green dashed lines) between the bromine atom in compound <b>2</b> and the Trp<sub>141</sub> backbone carbonyl is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The concept of introducing an additional fluorine atom at the 2-position of the P2′ anilide moiety of <b>13</b> derived from SAR data for structurally related proline-based FD inhibitors, such as <b>1</b>, bearing <i>ortho</i>-F substituted benzylamides at P2′.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>23</b> was found to be 4-times more potent than the des-fluoro analog <b>13</b> in both the thioesterolysis assay and the MAC deposition assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The gain in potency could be explained by the conformational preference of the anilide moiety induced by the presence of the <i>ortho</i>-F adjacent to the amidocarbonyl spacer, properly directing the <i>meta</i>-OCF<sub>3</sub> into the S2′ pocket.<a onclick="showRef(event, 'ref23 ref31'); return false;" href="javascript:void(0);" class="ref ref23 ref31">(23, 31)</a> The conformation with the fluorine <i>cis</i> to the amide carbonyl is destabilized by electrostatic repulsion, while the preferred <i>trans</i> conformation is favored by the formation of the NH/CF 1,3-antiperiplanar dipolar interaction. In addition, the improvement in potency observed upon introduction of the <i>ortho</i>-F might also be the result of the increased aniline N–H acidity, thereby strengthening the H-bond with the Leu<sub>41</sub> backbone carbonyl.</div><div class="NLM_p">Replacement of the 2-fluoro-aniline by a 2-aminopyridine residue was designed to have a similar effect on the ligand conformation due to a repulsion between the nitrogen atom of the pyridine and the carbonyl of the amide P1′–P2′ linker. Compounds <b>24</b> bearing a 2-F,3-CF<sub>3</sub>-aniline P2′ motif and <b>25</b> bearing a 6-CF<sub>3</sub>-pyridine were found to be equipotent in the biochemical assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Notably, in the MAC deposition assay performed using 50% human whole blood, a lower “IC<sub>50</sub> shift” was observed for <b>25</b> compared to <b>24</b>, which could be attributed to the lower % fraction of compound <b>25</b> bound to human plasma protein (hPPB) as compared to <b>24</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Most strikingly, the 6-bromo-pyridine analog <b>26</b> exhibited single-digit nanomolar potency in both assays in line with the moderate hPPB of <b>26</b> and consistent with our more general observation that pyridyl P2′-residues resulted in reduced “IC<sub>50</sub> shifts” between the biochemical and MAC deposition assays. We reasoned that the pyridyl nitrogen further increases the size of the σ-hole of the bromine atom<a onclick="showRef(event, 'ref29 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref32">(29, 32)</a> leading to an increase in the strength of the halogen bond with the carbonyl of Trp<sub>141</sub> (<i>vide infra</i>).</div><div class="NLM_p">With the attractive P1′ cyclopropyl proline and the 2-amino-6-bromo-pyridine S2′-binding motif in hand, we next turned our attention to the optimization of the P1 indole carboxamide portion. The contact between the NH of the urea P1–P1′ spacer in <b>7</b> and the Ser<sub>215</sub> backbone carbonyl in the crystal structure complex with FD (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) was recognized to be suboptimal. In addition, the dihedral angle between the indole plane and that of the urea group has to be almost perpendicular in order to allow for the accommodation of the indole scaffold in the S1 pocket. As such a conformation is likely less favored energetically in solution, we sought to properly modify the spacer. Compound <b>27</b> harboring a potentially more beneficial amide spacer, however, was found to be 30-fold less potent than <b>23</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In contrast, the inverted-indole analog <b>28</b> demonstrated improved potency with only a 10-fold loss compared to <b>26</b> in the biochemical assay. In the case of <b>28</b>, the slightly more acidic protons of the amide linker may weakly contribute to a favorable contact with the Ser<sub>215</sub> backbone carbonyl. Surprisingly, a dramatic loss in potency was observed in the MAC deposition assay for <b>28</b>. In this case, % hPPB would not entirely explain the larger “IC<sub>50</sub> shift” observed for <b>28</b> as compared to compound <b>26</b> with slightly lower %PPB (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Most gratifyingly, a 10-fold boost in potency in both the biochemical and the MAC deposition assays was observed when the indole in <b>28</b> was replaced by an indazole moiety leading to compound <b>2</b>, which is equipotent to <b>26</b> in the thioesterolysis assay and 5-fold less potent in the MAC deposition assay despite similar % hPPB. Notably, replacing the <i>N</i>-carbamoyl group (<b>2</b>) by an <i>N</i>-acetyl group (<b>29</b>) had only a marginal impact on potency, which was unexpected in view of the observed H-bonding interactions between both hydrogen atoms of the terminal NH<sub>2</sub> deep in the S1 pocket<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a>B, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) but which could possibly result from differences in desolvatation energies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Potency Data for Compounds <b>2</b>, <b>23</b>, and <b>26</b>–<b>30</b>, Using a FD Thioesterolytic Fluorescent Assay and a MAC Deposition Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0015.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">P1-motif</th><th class="colsep0 rowsep0" align="center" char=".">FD IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">MAC IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">hPPB (%)<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.066</td><td class="colsep0 rowsep0" align="char" char=".">1.86</td><td class="colsep0 rowsep0" align="char" char=".">86.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Half-maximal inhibition of recombinant human complement FD catalytic domain, as determined in a thioesterolysis-based assay using Z-Lys-thiobenzylester as the substrate.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Half-maximal inhibition of soluble MAC complex formation, as determined in an ELISA assay using alkaline-phosphatase-conjugated-anti-C9-neoepitope in normal human whole blood diluted with an equal amount of gelatin veronal buffer.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Data represent mean values of duplicate measurements.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Compound fraction in % bound to human plasma protein.</p></div></div></div><div class="NLM_p">We determined the X-ray crystal structure of <b>2</b> in complex with FD at high 1.33 Å resolution (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The overall binding mode of the proline scaffold and the indazole moiety to the S1 and S1′ pockets, respectively, is very similar to the binding mode observed for <b>13</b>. The network of H-bonds in the S1 pocket and the H-bond between the amide spacer and the Leu<sub>41</sub> backbone carbonyl are conserved for <b>2</b>. In contrast, the S2′ binding modes are strikingly distinct for the two compounds with the 6-Br-pyridine motif (<b>27</b>) located in the lower part of the pocket, thereby positioning the bromine atom into the region that is occupied by the CF<sub>3</sub> moiety of the trifluoromethoxy-phenyl residue present in <b>13</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Notably, the bromine atom forms a σ-hole halogen bond interaction with the backbone carbonyl of Trp<sub>141</sub>.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref33'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref33">(27-30, 33)</a> The C<sub>pyr</sub>–Br···O angle is 164.6°, thus fulfilling the typical angular preference with a measured bromine–oxygen distance (3.09 Å) significantly lower than the sum of the van der Waals radii (<i>R</i><sub>vdW</sub>(Br–O) = 3.37 Å).<a onclick="showRef(event, 'ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref29">(27, 29)</a> The pyridyl nitrogen in <b>2</b> further increases the size of the σ-hole of the bromine atom, thereby leading to an increase in the strength of the halogen bond with the carbonyl of Trp<sub>141</sub>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Similarly, the presence of an <i>ortho</i>-F atom in the 3-Br-anilide P2′ moiety, as in <b>30</b>, is expected to strengthen the halogen σ-hole interaction<a onclick="showRef(event, 'ref29 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref32">(29, 32)</a> with the Trp<sub>141</sub> carbonyl (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_p">To this point of our work, we had been quite successful in improving the <i>in vitro</i> potency by >2000-fold, starting from our initial hit <b>3</b> and by iteratively optimizing the interactions of the inhibitors to each single key hot spot of the FD S1–S1′–S2′ pockets, without any significant increase in ligand molecular size. This accomplishment is reflected in a remarkable increase in the BEI and LLE, respectively, for <b>2</b> (MW 482; BEI 17.1; LLE 6.9, cLogP 1.3), one of the most potent FD inhibitors discovered in this series, as compared to <b>3</b> (MW 465; BEI 10.4; LLE 1.4; cLogP 3.5). The ability to effectively manage MW and cLogP proved to be very important as increase in those parameters has been associated with deterioration of the ADMET profile.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">The initial lead compound <b>7</b> was shown to have modest aqueous solubility, moderate Caco-2 cell permeability, and low-micromolar CYP2C9 inhibitory activity (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The presence of a fused 4,5-cyclopropyl ring (<b>13</b>), while slightly improving solubility, appeared to further increase CYP2C9 inhibition. Introduction of a polar OH or NH<sub>2</sub> substituent to the proline ring ameliorated CYP2C9 affinity (<b>17</b> and <b>18</b>), and in case of <b>18</b> improved solubility, albeit at the cost of permeability. Notably, both <b>14</b> and <b>17</b> demonstrated strong efflux in the Caco-2 permeability assay.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. High Throughput Equilibrium Solubility, Permeability, and CYP2C9 Inhibition for (<i>S</i>)-Proline-based FD Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="​" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">HT-eq solubility, pH 6.8 (mM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="​">Caco-2 <i>P</i><sub>app</sub>(AB)/(BA) × 10<sup>–6</sup>(cm/s), ratio(BA)/(AB)</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C9 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char="​">6.1, 6.3/1</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.077</td><td class="colsep0 rowsep0" align="char" char="​">4.5, 5.7/1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char="​">0.75, 8.0/10</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char="​">0.77, 17/22</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char="​">2.1, 5.1/2.5</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char="​">5.1, 6.5/1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">0.046</td><td class="colsep0 rowsep0" align="char" char="​">10, 7.0/0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char="​">11.3, 14.2/1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="char" char="​">9.6, 10.3/1.1</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char="​">15.3, 18.1/1.2</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Equilibrium high-throughput solubility in aqueous buffer (pH 6.8).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Diclofenac was used as CYP2C9 substrate.</p></div></div></div><div class="NLM_p">Introduction of an <i>ortho</i>-F atom to the P2′ aniline moiety, substituted by either OCF<sub>3</sub> or CF<sub>3</sub> (<b>23</b>, <b>24</b>), reduced solubility and led to sub-micromolar affinities for CYP2C9. In contrast, switching from an aniline to a 2-aminopyridyl P2′ motif led to a superior CYP2C9 profile by increasing the IC<sub>50</sub> value ∼30-fold for <b>25</b> and <b>26</b>, as compared to <b>24</b>, accompanied by a marginal improvement in solubility. Introduction of the 3-carboxamide indazole S1 motif (<b>2</b>) resulted in a slight improvement in aqueous solubility, in cell permeability without efflux potential in Caco-2 cells, and in the P450 inhibition profile (IC<sub>50</sub> > 20 and 17 μM for CYP2D6 and 3A4, respectively). The excellent overall selectivity of inhibitor <b>2</b> in a broad panel of proteases, kinases, receptors, and ion-channels has been previously reported.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Furthermore, <b>2</b> did not inhibit the hERG channel (IC<sub>50</sub> > 30 μM; dofetilide binding and Qpatch assays) and showed no evidence for mutagenic, clastogenic, or aneugenic potential when assessed in a miniaturized version of the Ames-test and in the standard <i>in vitro</i> micronucleus test, respectively.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">Efficient synthetic routes to access <i>N</i>-urea (compounds <b>5</b>, <b>7</b>–<b>26</b>) and N-acylated (<b>2</b>, <b>27</b>–<b>30</b>) substituted proline-carboxamides are outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, <i>N</i>-Boc protected (<i>S</i>)- and (<i>R</i>)-proline, as well as mono- and disubstituted proline analogs, all available as single stereoisomers from commercial sources, were coupled with substituted anilines or amino-pyridines, respectively, to afford the corresponding amide intermediates A. Removal of the <i>N</i>-Boc protecting group to intermediates B and subsequent reaction with 1-methyl-1<i>H</i>-indol-3-yl-isocyanate (<b>31</b>) or the 1-carbamoyl analog <b>32</b> furnished the <i>N</i>-urea linker derivatives <b>5</b> and <b>7</b>–<b>26</b>. Similarly, the HBTU-mediated coupling reaction of intermediates B with carboxylic acids <b>33</b>–<b>36</b> afforded target compounds <b>2</b>, <b>27</b>–<b>30</b> containing an amide linker. For the preparation of the 4(<i>S</i>)-amino-proline analog <b>18</b> from the commercially available (4<i>S</i>)-4-<i>N</i>-Fmoc-amino-1-Boc-<span class="smallcaps smallerCapital">l</span>-proline, the deprotection of the Fmoc protecting group was performed using piperidine 20% in DMF (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, step d).</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Inhibitors <b>2</b>, <b>5</b>, and <b>7</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> or DMF, RT or DMF, 70 °C (for X = CF and R<sup>1</sup> = OCF<sub>3</sub>); (b) 1-chloro-<i>N</i>,<i>N</i>,2-trimethylpropenylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C (for X = N and R<sup>1</sup> = CF<sub>3</sub>, Br); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) R<sup>2</sup>NCO (<b>31</b> or <b>32</b>), Et<sub>3</sub>N, THF; (e) piperidine 20% in DMF, RT for the Fmoc deprotection leading to <b>18</b>; (f) R<sup>5</sup>CO<sub>2</sub>H (<b>33</b>, <b>34</b>, <b>35</b>, or <b>36</b>), HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, RT (cf. <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for structures).</p></p></figure><div class="NLM_p">The 4(<i>R</i>)- and 4(<i>S</i>)-methyl-proline analogs <b>9</b> and <b>10</b> were prepared from the commercially available <i>N</i>-Boc-4-methylene-proline (<b>37</b>) by HBTU-coupling with 3-OCF<sub>3</sub>-aniline to afford <b>38</b>, followed by hydrogenation reaction in the presence of Pd on charcoal to produce a mixture of diastereoisomers, which were separated by reversed-phase prep-HPLC to afford (2<i>S</i>,4<i>R</i>)-<b>39</b> and (2<i>S</i>,4<i>S</i>)-<b>40</b>, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The absolute configuration was assigned based on ROESY-NMR experiments showing a NOE-effect between proton-H2 and the 4-methyl group for the <i>trans</i>-configured <b>39</b> and on the other hand a NOE-effect between protons H2 and H4 for <i>cis</i>-<b>40</b>.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Intermediates <b>39</b> and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, RT, 100%; (b) H<sub>2</sub>, Pd/C, MeOH, <b>39</b> (7%) and <b>40</b> (53%).</p></p></figure><div class="NLM_p">Isocyanate <b>32</b> was prepared in four steps by starting from indole-3-carboxylic acid (<b>41</b>) by formation of benzylester <b>42</b>, N-carboxamidation using sodium hydride and chlorosulfonylisocyanate to produce <b>43</b>. This was followed by saponification to yield the carboxylic acid <b>45</b>, and finally by thermal Curtius rearrangement of the acyl azide intermediate formed from <b>45</b> in the presence of DPPA and Et<sub>3</sub>N in toluene<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). It is important to note that the acyl azide intermediate prepared from acid <b>45</b> precipitates in the reaction mixture and must be purified by filtration before being added portion-wise<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> to hot toluene in order to ensure a smooth Curtius rearrangement. All attempts to perform this reaction in one pot from acid <b>45</b> failed to give the desired isocyanate <b>32</b>. The <i>N</i>-methylindole isocyanate <b>31</b> was prepared accordingly from commercially available 1-methylindole-3-carboxylic acid (<b>44</b>) following a similar synthetic protocol.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes for Intermediates <b>31</b>–<b>33</b> and <b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions:(a) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF (83%); (b) NaH, THF, ClSO<sub>2</sub>NCO (<b>43</b>, 29%; <b>47</b>, 75%); (c) H<sub>2</sub>, Pd/C 10%, THF/DMF, (100%); (d) (i) Et<sub>3</sub>N, DPPA, CH<sub>2</sub>Cl<sub>2</sub>, −15 to 15 °C, (ii) toluene, reflux (<b>31</b>, 89%; <b>32</b>, 52%); (e) NaOH, MeOH/H<sub>2</sub>O (95%); (f) BrCH<sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub> (100% for 2 steps).</p></p></figure><div class="NLM_p last">Carboxylic acid <b>34</b> is commercially available and the synthesis of <b>35</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) has been reported previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The (1-carbamoyl-1<i>H</i>-indol-3-yl)-acetic acid (<b>33</b>) was prepared by <i>N</i>-carboxamidation of ethyl 2-(indol-3-yl)acetate (<b>46</b>) with chlorosulfonylisocyanate subsequent to deprotonation with NaH in THF followed by saponification, and acid <b>36</b> was obtained in two steps from 1-(1<i>H</i>-indazol-3-yl)ethan-1-one (<b>48</b>) by alkylation with <i>tert</i>-butylbromoacetate and final ester-deprotection under acidic conditions (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vivo</i> Pharmacology</h3><div class="NLM_p">Since inhibitor <b>2</b> demonstrated an excellent <i>in vitro</i> profile, including high potency and selectivity, we further evaluated the potential of <b>2</b> for <i>in vivo</i> use and for its ability to achieve exposure in the eye, given the evidence for the role of the AP in AMD.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Compound <b>2</b> displayed an excellent oral PK profile in Sprague–Dawley rats<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and, following an oral dose (10 mg/kg) in Brown Norway rats, demonstrated a good distribution and sustained exposure in ocular tissues including the neural retina and the posterior eye cup (PEC), which comprises the sclera, retinal pigmented epithelium, and choroid. Mean exposure levels in plasma, the PEC, and the retina at 6 h after dosing were 0.36, 0.43, and 0.09 μM, respectively (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). For context, these values exceeded significantly the IC<sub>50</sub> for <b>2</b> in the <i>in vitro</i> MAC deposition assay (0.05 μM, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma and ocular pharmacokinetics profiles of inhibitor <b>2</b> in Brown Norway rats after oral administration (10 mg/kg). The compound was formulated as a suspension in 0.5% HPMC and 0.1% Tween 80 and was administered by oral gavage to male 250 g Brown Norway rats (<i>n</i> = 2 per time point). Tissues from 2 animals were collected at 0.25, 0.5, 1, 3, 6, and 24 h, respectively, for analysis (4 eyes/time point; each eye dissected into neural retina and posterior eye cup). Two plasma samples per time point were collected. Points represent the mean, and error bars represent the standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In other studies, we have shown that the significant difference in active site conformation of murine vs human FD precludes the binding of our compounds.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To enable <i>in vivo</i> efficacy assessment, we generated mice that express only the human enzyme (human FD knock-in mice) at blood levels that are in the reported range for humans.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We developed a pharmacodynamic model of complement AP activation in these mice using lipopolysaccharide (LPS). Intraperitoneal administration of LPS induces activation of the AP, as detected by increased levels of AP breakdown products Ba and iC3b + C3d in the circulation and in the ocular tissues, respectively.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We administered <b>2</b> by oral gavage at 30 mg/kg to groups of human FD knock-in mice at different time points up to 24 h prior to the end of the experiment. LPS was administered to all groups at 7.5 h prior to the end of the experiment, so that all mice experienced the same window of complement activation. At study termination, plasma and eye tissue were collected for measurement of complement breakdown products. Compound <b>2</b> caused a sustained inhibition of Ba generation in the plasma, with suppression to or below baseline levels for up to 8 h (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). In the eye, complete suppression of complement activation was seen for at least 12 h (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibitor <b>2</b> tested at 30 mg/kg in the human factor D knock-in mouse pharmacodynamic model: (A) inhibition of Ba generation in plasma and (B) inhibition of iC3b and C3d generation in ocular tissues. Groups of mice (<i>n</i> = 4, female human FD knock-in) were treated either with <b>2</b> or dosing vehicle by oral gavage at 24, 16, 12, 8, 6, and 4 h, respectively, prior to the termination of the study. All animals were given intraperitoneal LPS to activate complement 7.5 h prior to study termination. Baseline complement levels were obtained from mice that received oral dosing vehicle and intraperitoneal saline (indicated by PBS line on graph). The positive control group received oral dosing vehicle and intraperitoneal LPS (LPS line on graph). Data shown represent mean ± sem for the group. Statistical analysis was by ANOVA with Tukeys multiple comparison test, where ***<i>P</i> < 0.001 and **<i>P</i> < 0.01 compared to the positive control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitor <b>2</b> was further investigated in cynomolgus monkeys to characterize the PK–PD relationship. <i>In vitro</i> potency of <b>2</b> was shown to be very similar against human and monkey FD (IC<sub>50</sub> values in FD thioesterolytic assays of 0.005 μM and in 50% serum MAC deposition assays of 0.011 μM for both human and monkey). A predose serum sample was collected from each animal to establish individual baseline complement activity. After a single oral dose of <b>2</b> at 10 or 50 mg/kg, serum samples were obtained at 4, 7, and 24 h postadministration. <i>Ex vivo</i> assessment for complement activity in serum was performed using zymosan to induce AP activation (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). All monkeys showed complete suppression of complement activity in serum collected 4 h after dosing. Individual blood levels of <b>2</b> were determined using liquid chromatography coupled to mass spectrometry (LC-MS). The <i>ex vivo</i> half-maximal efficacious concentration (EC<sub>50</sub>) was determined to be 0.038 μM, with complete inhibition observed at exposures >0.5 μM (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition of <i>ex vivo</i> MAC deposition after oral dosing of <b>2</b> to male cynomolgus monkeys. A single dose of <b>2</b> was administered by oral gavage at 10 (<i>n</i> = 3) and 50 mg/kg (<i>n</i> = 3), respectively. Serum samples were obtained predosing and at 4, 7, and 24 h after dosing, and complement activity was assessed with an <i>ex vivo</i> serum MAC deposition assay (A). The concentration of <b>2</b> in each sample relative to complement inhibition achieved was plotted in panel B. The dotted lines indicate the 95% confidence band for the curve.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Merging the key pharmacophoric elements of two hits identified from SBDD and FBS approaches<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> led to the first sub-micromolar noncovalent FD inhibitor <b>7</b>, which was selected as a lead compound. Subsequent structure-based optimization efforts focused on improving binding interactions to the S1, S1′, and S2′ key hot-spots of the FD active site in combination with optimizing the ADMET profile. Modifications of the P1′ center proline were extensively explored and resulted in the bicyclic (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-aza-bicyclo[3.1.0]hexane scaffold, exemplified by <b>13</b>, as a preferred S1′ binding motif for this class of FD inhibitors. Replacing the P2′ anilide portion of the initial lead <b>7</b> by the 2-amino-6-bromo-pyridine motif provided inhibitors with markedly improved potencies in the 50% human whole blood MAC deposition functional assay. Finally, SAR tuning of the P1 indole-carboxamide portion in <b>26</b> identified the indazole-carboxamide motif, and switching concomitantly to the <i>N</i>-acetyl spacer, as in <b>2</b>, turned out to be beneficial for reducing CYP2D6 affinity. Compound <b>2</b> combines excellent <i>in vitro</i> potency and distribution into ocular tissue with a clean <i>in vitro</i> selectivity and safety profile. Compound <b>2</b> demonstrated <i>in vivo</i> efficacy in a FD-knock in mouse model of complement activation and blocked systemic AP activity <i>ex vivo</i> after oral administration to cynomolgus monkeys. Compound <b>2</b> warranted further preclinical evaluation including <i>in vivo</i> efficacy, tolerability, and safety.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Experimental Procedures and Compound Characterization for Novel Compounds</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Chemistry Information</h4><div class="NLM_p">Unless otherwise specified, all solvents and reagents were obtained from commercial suppliers and used without further drying or purification. (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-<i>tert</i>-butyl ester [CAS 197142-34-0] was purchased from Neptune Technotrade (USA). Phase separator was obtained from Biotage, Isolute Phase separator (part no. 120-1908-F for 70 mL and part no. 120-1909-J for 150 mL). Normal-phase flash chromatography was performed using Merck silica gel 60 (230–400 mesh), Merck Darmstadt, Germany. <i>R</i><sub><i>f</i></sub> values for thin layer chromatography (TLC) were determined using 5 cm × 10 cm TLC plates, silica gel F254, Merck, Darmstadt, Germany. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance DPX 400 BBO spectrometer. High-resolution mass spectra (HRMS) measurements were performed by using electrospray ionization in positive ion modus after separation by liquid chromatography. The elemental composition was derived from the mass spectra acquired at the high resolution of about 30000 on a Q Exactive Plus mass spectrometer (Thermo Scientific) coupled to an Ultimate 3000 UHPLC. High mass accuracy of <1.5 ppm was obtained by using a lock mass. Mass spectra (MS) and liquid chromatography mass spectra (LC–MS) were determined by using electrospray ionization in positive and negative ion modus using an Agilent 1100 series instrument. Purity was determined by analytical HPLC using an Agilent 1100 or 1200 series instrument and by integration of the area under the UV absorption curve at λ = 254 or 214 nm wavelenght; all final compounds reported were at least 95% pure; <i>t</i><sub>R</sub> refers to retention time.</div><div class="NLM_p last">The following conditions (a–e) were used for analytical HPLC, if not indicated otherwise. Conditions a: Waters Symmetry C18; particle size 3.5 μm; column size 2.1 mm × 50 mm; eluent/gradient 20–95% CH<sub>3</sub>CN/H<sub>2</sub>O, 3.5 min, 95% CH<sub>3</sub>CN, 2 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA); flow rate 0.6 mL/min, column temperature 25 °C. Conditions b: Agilent Eclipse XDB-C18; particle size 1.8 μm; column size 4.6 mm × 50 mm; eluent/gradient 20–100% CH<sub>3</sub>CN/H<sub>2</sub>O, 6 min, 100% CH<sub>3</sub>CN, 1.5 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% of TFA); flow rate 1 mL/min. Conditions c: Waters X-Bridge C18; particle size 2.5 μm; column size 3 mm × 50 mm; eluent/gradient 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O, 8.6 min; 98% CH<sub>3</sub>CN, 1.4 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA); flow rate 1.4 mL/min; column temperature 40 °C. Conditions d: Waters Sunfire C18: particle size 2.5 μm; column size 3 mm × 30 mm; eluent/gradient 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O, 2.5 min; 98% CH<sub>3</sub>CN, 0.8 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA); flow rate 1.4 mL/min. Conditions e: Agilent Eclipse XDB-C18; particle size 1.8 μm; column size 4.6 mm × 50 mm; eluent/gradient 5–100% CH<sub>3</sub>CN/H<sub>2</sub>O, 6 min, 100% CH<sub>3</sub>CN, 1.5 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% of TFA); flow rate 1 mL/min.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure 1: Preparation of (<i>S</i>)-Pyrrolidine-2-carboxylic Acid (3-Trifluoromethoxyphenyl)amide, Trifluoroacetate Salt (Intermediate B (R = H), <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h4><div class="NLM_p">Step A, to a mixture of <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (5.00 g, 23.2 mmol), 3-(trifluoromethoxy)aniline (3.73 mL, 27.9 mmol), and <i>N</i>,<i>N</i>,<i>N′</i>,<i>N′</i>-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU; 13.2 g, 34.8 mmol) in <i>N</i>,<i>N</i>-dimethyl-formamide (DMF, 60 mL) was added diisopropylethylamine (DIPEA; 7.95 mL, 46.5 mmol), and the resulting yellow solution was stirred at RT under a nitrogen atmosphere for 16 h. The solvent was evaporated under reduced pressure, the residue thus obtained was dissolved in EtOAc, and the organics were washed with 1 N HCl. An aqueous saturated NaHCO<sub>3</sub> solution was added, the layers were separated, and the aqueous phase was back-extracted twice with dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude residue was purified by flash column chromatography on silica gel (c-hexane/EtOAc 3:1 to 2:1) to give (<i>S</i>)-2-(3-trifluoromethoxy-phenylcarbamoyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (intermediate <b>A</b> (R = H), <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) as a solid (8.52 g, yield 98%). TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:1) 0.6. LC–MS (ESI, <i>m</i>/<i>z</i>) 397.1 [M + Na]<sup>+</sup>, 275.2 [MH – Boc]<sup>+</sup>, 373.3 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC, conditions a) 3.81 min (purity 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 9.80 (br s, 1H), 7.59 (s, 1H), 7.28 (m, 2H), 6.89 (m, 1H), 4.47 (m, 1H), 3.42 (m, 2H), 2.26 (m, 1H), 1.94 (m, 3H), 1.50 (s, 9H).</div><div class="NLM_p">Step B: To a solution of (<i>S</i>)-2-(3-trifluoromethoxy-phenylcarbamoyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (5.91 g, 15.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added trifluoroacetic acid (TFA, 4.48 mL, 63.1 mmol), and the solution was stirred at RT for 24 h. The reaction mixture was concentrated under reduced pressure, diethyl ether (Et<sub>2</sub>O) was added, and the precipitate was filtered off to give crude (<i>S</i>)-pyrrolidine-2-carboxylic acid (3-trifluoromethoxy-phenyl)-amide trifluoroacetate salt as a brownish solid (5.04 g, yield 82%). LC–MS (ESI, <i>m</i>/<i>z</i>) 275.2 [M + H]<sup>+</sup>, 273.3 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC, conditions a) 2.47 min (purity >95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.8 (s, 1H), 9.27 (br s, 1H), 8.73 (br s, 1H), 7.79 (s, 1H), 7.50 (m, 2H), 7.13 (d, <i>J</i> = 6.8 Hz, 1H), 4.34 (m, 1H), 3.30 (m, 2H), 2.36 (m, 1H), 2.02 (m, 1H), 1.94 (m, 2H).</div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 1-(2-((1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-((6-Bromopyridin-2-yl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1<i>H</i>-indazole-3-carboxamide (<b>2</b>)</h5><div class="NLM_p last">The synthesis of compound <b>2</b> has been reported previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> (<i>S</i>)-Pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Methyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] (<b>5</b>)</h5><div class="NLM_p last">To a solution of (<i>S</i>)-pyrrolidine-2-carboxylic acid (3-trifluoromethoxy-phenyl)-amide trifluoro acetate salt (200 mg, 0.515 mmol; preparation described in General Procedure 1) and Et<sub>3</sub>N (143 μL, 1.03 mmol) in THF (5 mL) was added a solution of 3-isocyanato-1-methyl-1<i>H</i>-indole <b>31</b> (133 mg, 0.77 mmol) in THF (5 mL), and stirring was continued for 5 h at RT under a nitrogen atmosphere. A solution of <b>31</b> (44 mg, 0.26 mmol) in THF (1 mL) was added again, and the reaction mixture was stirred for another 16 h at RT. The mixture was poured into 1 N HCl and was extracted twice with EtOAc. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by flash column chromatography (SiO<sub>2</sub>, solvent <i>c</i>-hexane/EtOAc 2:3) and subsequent prep HPLC (Waters SunFire C18-ODB; particle size 5 μm; column size 19 mm × 50 mm; eluent/gradient 20% CH<sub>3</sub>CN/H<sub>2</sub>O 2.5 min, 20–100% CH<sub>3</sub>CN in H<sub>2</sub>O for 10 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH); flow rate 20 mL/min). The combined pure fractions were freeze-dried to afford <b>5</b> as a white solid (92 mg, yield 40%). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 2:3) 0.35. <i>t</i><sub>R</sub> (HPLC conditions a) 3.67 min (purity 95%). LC–MS (ESI, <i>m</i>/<i>z</i>) 447.3 [M + H]<sup>+</sup>, 469.1 [M + Na]<sup>+</sup>, 915.3 [2M + Na]<sup>+</sup>, 445.3 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 10.2 (s, 1H), 7.67 (br s, 1H), 7.45 (d, <i>J</i> = 7.8 Hz, 1H), 7.34–7.27 (m, 5H), 7.12 (t, <i>J</i> = 7.5 Hz, 1H), 6.91 (m, 1H), 6.23 (s, 1H), 4.78 (d, <i>J</i> = 7.6 Hz, 1H), 3.80 (s, 3H), 3.62 (m, 1H), 3.48 (m, 1H), 2.70 (dd, <i>J</i> = 12.5, 6.2 Hz, 1H), 2.32–2.13 (m, 2H), 1.93 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 447.16385; found, 447.16386.</div></div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure 2: Preparation of (<i>S</i>)-Pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>7</b>)</h4><div class="NLM_p">To a solution of (<i>S</i>)-pyrrolidine-2-carboxylic acid (3-trifluoromethoxy-phenyl)-amide trifluoro acetate salt (328 mg, 0.845 mmol; preparation described in General Procedure 1) and Et<sub>3</sub>N (353 μL, 2.53 mmol) in THF (7.5 mL) was added a suspension of <b>32</b> (170 mg, 0.845 mmol) in THF (7.5 mL). Stirring was continued at RT for 1 h under a nitrogen atmosphere. The reaction mixture was then poured into water and extracted twice with EtOAc. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by prep HPLC (Waters SunFire C18-ODB; particle size 5 μm; column size 19 mm × 50 mm; eluent/gradient 20% CH<sub>3</sub>CN/H<sub>2</sub>O 2.5 min, 20–100% CH<sub>3</sub>CN in H<sub>2</sub>O for 10 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH); flow rate 20 mL/min) to give, after lyophilization of the pure fractions, the title compound <b>7</b> as a white powder (173 mg, yield 43%). The enantiomeric excess (ee) > 99% was determined by chiral HPLC and in comparison with <b>8</b>: <i>t</i><sub>R</sub> (Chiral Pack IC; particle size 5 μm; column size 4.6 mm × 250 mm; eluent heptane/isopropanol (85:15) containing 0.03% diethylamine; flow rate 1 mL/min; UV detection at 240 nm) 11.0 min (99.7% <b>7</b>), 14.04 min (0.3% <b>8</b>). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:2) 0.10. <i>t</i><sub>R</sub> (HPLC conditions c) 4.15 min (purity 99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 476.2 [M + H]<sup>+</sup>, 973.2 [2M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.3 (s, 1H), 8.25 (d, <i>J</i> = 8.6 Hz, 1H), 8.19 (s, 1H), 7.96 (s, 1H), 7.83 (s, 1H), 7.75 (d, <i>J</i> = 7.85 Hz, 1H), 7.51 (br d, <i>J</i> = 8.1 Hz, 1H), 7.42 (t, <i>J</i> = 8.2 Hz, 1H), 7.36 (br s, 2H), 7.23 (t, <i>J</i> = 7.5 Hz, 1H), 7.15 (t, <i>J</i> = 7.5 Hz, 1H), 7.02 (d, <i>J</i> = 7.85 Hz, 1H), 4.46 (m, 1H), 3.73 (m, 1H), 3.62 (m, 1H), 2.22 (m, 1H), 2.06 (m, 1H), 1.96 (m, 2H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 476.1540; found, 476.1539; calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 498.1360; found, 498.1358; calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>NH<sub>4</sub> [M + NH<sub>4</sub>]<sup>+</sup> 493.1806; found, 493.1805.</div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (<i>R</i>)-Pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>8</b>)</h5><div class="NLM_p last">White solid (133 mg, yield 59%) obtained according to General Procedure 2 from (<i>R</i>)-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic acid). <i>t</i><sub>R</sub> (HPLC conditions c) 4.08 min (>99% purity). Enantiomeric excess ee >99% (by chiral HPLC, as described for <b>7</b>). LC–MS (ESI, <i>m</i>/<i>z</i>) 476.4 [M + H]<sup>+</sup>, 951.7 [2M + H]<sup>+</sup>, 474.3 [M – H]<sup>−</sup>, 949.7 [2M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 10.3 (s, 1H), 8.27 (d, <i>J</i> = 8.3 Hz, 1H), 8.20 (s, 1H) 7.98 (s, 1H), 7.85 (s, 1H), 7.78 (d, <i>J</i> = 7.85 Hz, 1H), 7.55 (br d, <i>J</i> = 8.7 Hz, 1H), 7.45 (t, <i>J</i> = 8.2 Hz, 1H), 7.38 (br s, 2H), 7.26 (t, <i>J</i> = 7.7 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 7.04 (br d, <i>J</i> = 8.2 Hz, 1H), 4.49 (dd, <i>J</i> = 8.2, 3.9 Hz, 1H), 3.79–3.61 (m, 2H, overlapping with H<sub>2</sub>O signal), 2.24 (m, 1H), 2.07 (m, 1H), 1.99 (m, 2H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 476.15402; found, 476.15364.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (2<i>S</i>,4<i>R</i>)-4-Methyl-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>9</b>)</h5><div class="NLM_p last">White solid (38 mg, yield 78%) obtained according to General Procedure 2 from (2<i>S</i>,4<i>R</i>)-4-methyl-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared from (2<i>S</i>,4<i>R</i>)-2-(3-trifluoromethoxy-phenylcarbamoyl)-4-methyl-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>39</b>) prepared as described below). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:3) 0.45. <i>t</i><sub>R</sub> (HPLC conditions c) 4.51 min (purity 99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 489.1 [M – H]<sup>−</sup>, 445.0 [M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.3 (s, 1H), 8.27 (d, <i>J</i> = 8.1 Hz, 1H), 8.17 (s, 1H), 7.98 (s, 1H), 7.85 (s, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.53 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (t, <i>J</i> = 8.5 Hz, 1H), 7.38 (br s, 2H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 7.04 (d, <i>J</i> = 8.1 Hz, 1H), 4.54 (d, <i>J</i> = 8.1 Hz, 1H), 3.94 (t, <i>J</i> = 8.2 Hz, 1H), 3.19 (t, <i>J</i> = 8.4 Hz, 1H), 2.56 (m, 1H), 2.07 (m, 1H), 1.90 (m, 1H), 1.09 (t, <i>J</i> = 6.4 Hz, 3H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 490.16967; found, 490.16924.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (2<i>S</i>,4<i>S</i>)-4-Methyl-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>10</b>)</h5><div class="NLM_p last">White solid (29 mg, yield 59%) obtained according to General Procedure 2 from (2<i>S</i>,4<i>S</i>)-4-methyl-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared from (2<i>S</i>,4<i>S</i>)-2-(3-trifluoromethoxy-phenylcarbamoyl)-4-methyl-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>40</b>), prepared as described below). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:3) 0.45. <i>t</i><sub>R</sub> (HPLC conditions c) 4.39 min (purity 99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 490.3 [M + H]<sup>+</sup>, 976.6 [2M + H]<sup>+</sup>, 488.3 [M – H]<sup>−</sup>, 977.7 [2M – H]<sup>−</sup>, 1023.8 [2M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.4 (s, 1H), 8.27 (d, <i>J</i> = 8.3 Hz, 1H), 8.24 (s, 1H), 7.98 (s, 1H), 7.86 (s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (t, <i>J</i> = 8.2 Hz, 1H), 7.37 (br s, 2H), 7.25 (t, <i>J</i> = 7.7 Hz, 1H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 7.04 (d, <i>J</i> = 8.2 Hz, 1H), 4.45 (t, <i>J</i> = 7.8 Hz, 1H), 3.92 (t, <i>J</i> = 8.2 Hz, 1H), 3.22 (t, <i>J</i> = 9.4 Hz, 1H), 2.42 (m, 2H), 1.53 (m, 1H), 1.12 (t, <i>J</i> = 5.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 490.16967; found, 490.16929.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (1<i>S</i>,2<i>S</i>,5<i>R</i>)-3-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 3-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>11</b>)</h5><div class="NLM_p last">Pale yellowish solid (64 mg, yield 53%) obtained according to General Procedure 2 from (1<i>S</i>,2<i>S</i>,5<i>R</i>)-<i>N</i>-(3-(trifluoromethoxy)phenyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (1<i>S</i>,2<i>S</i>,5<i>R</i>)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid). <i>t</i><sub>R</sub> (HPLC conditions c) 4.27 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 488.2 [M + H]<sup>+</sup>, 510.1 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.6 (s, 1H), 8.26 (d, <i>J</i> = 8.3 Hz, 1H), 8.17 (s, 1H), 7.95 (s, 1H), 7.88 (br s, 1H), 7.74 (d, <i>J</i> = 7.85 Hz, 1H), 7.51 (m, 1H), 7.46 (t, <i>J</i> = 8.2 Hz, 1H), 7.37 (br s, 2H), 7.25 (t, <i>J</i> = 7.7 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 7.05 (d, <i>J</i> = 8.1 Hz, 1H), 4.58 (s, 1H), 3.88 (d, <i>J</i> = 9.25 Hz, 1H), 3.79 (dd, <i>J</i> = 9.25, 4.0 Hz, 1H), 1.78 (m, 1H), 1.72 (m, 1H), 0.84 (m, 1H), 0.37 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 488.1540; found, 488.1539; calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>F<sub>3</sub>Na [M + Na]<sup>+</sup> 510.1360; found, 510.1358.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (<i>S</i>)-Piperidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>12</b>)</h5><div class="NLM_p last">White solid (16 mg, yield 16%) obtained according to General Procedure 2 from (<i>S</i>)-<i>N</i>-(3-(trifluoromethoxy)phenyl)piperidine-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)piperidine-2-carboxylic acid). TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:2) 0.21. <i>t</i><sub>R</sub> (HPLC conditions c) 4.68 min (purity 98%). LC–MS (ESI, <i>m</i>/<i>z</i>) 490.1 [M + H]<sup>+</sup>, 1001.2 [2M + Na]<sup>+</sup>, 488.1 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.3 (s, 1H), 8.51 (s, 1H), 8.25 (d, <i>J</i> = 8.10 Hz, 1H), 7.98 (s, 1H), 7.82 (s, 1H), 7.76 (d, <i>J</i> = 8.10 Hz, 1H), 7.54 (d, <i>J</i> = 8.35 Hz, 1H), 7.42 (t, <i>J</i> = 8.3 Hz, 1H), 7.37 (br s, 2H), 7.23 (t, <i>J</i> = 7.6 Hz, 1H), 7.15 (t, <i>J</i> = 7.5 Hz, 1H), 7.02 (d, <i>J</i> = 8.1 Hz, 1H), 4.89 (m, 1H), 4.06 (d, <i>J</i> = 12.1 Hz, 1H), 3.47 (t, <i>J</i> = 11.9 Hz, 1H), 2.15 (d, <i>J</i> = 13.7 Hz, 1H), 1.75 (m, 2H), 1.34 (m, 1H), 1.50 (m, 1H), 1.38 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 490.16967; found, 490.16959.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(3-Trifluoromethoxy-phenyl)-amide] (<b>13</b>)</h5><div class="NLM_p last">White solid (640 mg, yield 89%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-(trifluoromethoxy)phenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoro acetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid [CAS 197142-34-0; Neptune Technotrade, USA]). TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:2) 0.40. LC–MS (ESI, <i>m</i>/<i>z</i>) 488 [M + H]<sup>+</sup>, 997.2 [2M + Na]<sup>+</sup>, 486.1 [M – H]<sup>−</sup>, 443.2 [M – CONH<sub>2</sub>]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions c) 4.29 min (purity >99%). <i>t</i><sub>R</sub> (HPLC conditions d) 2.1 min (purity >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 10.2 (s, 1H), 8.66 (s, 1H), 8.27 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.84 (s, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.56 (d, <i>J</i> = 8.3 Hz, 1H), 7.44 (t, <i>J</i> = 8.2 Hz, 1H), 7.39 (br s, 2H), 7.27 (t, <i>J</i> = 7.6 Hz, 1H), 7.20 (t, <i>J</i> = 7.5 Hz, 1H), 7.04 (d, <i>J</i> = 8.3 Hz, 1H), 4.21 (t, <i>J</i> = 8.1 Hz, 1H), 3.94 (m, 1H), 2.37 (dd, <i>J</i> = 13.0, 8.8 Hz, 1H), 2.19 (m, 1H), 1.83 (m, 1H), 0.83 (m, 1H), 0.59 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 170.7, 156.0, 152.9, 148.4, 140.8, 133.6, 130.4, 124.3, 124.0, 121.0, 120.0 (q, <i>J</i> = 255 Hz, CF<sub>3</sub>), 119.2, 118.6, 117.7, 115.2, 115.15, 114.5, 111.1, 61.5, 36.3, 31.5, 16.4, 13.9. HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 488.1540; found, 488.1539; calcd for C<sub>23</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 510.1360; found, 510.1358.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (2<i>S</i>,4<i>R</i>)-4-Fluoro-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>14</b>)</h5><div class="NLM_p last">White solid (67 mg, yield 68%) obtained according to General Procedure 2 from (2<i>S</i>,4<i>R</i>)-4-fluoro-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:2) 0.35. LC–MS (ESI, <i>m</i>/<i>z</i>) 494.0 [M + H]<sup>+</sup>, 492.1 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions c) 4.00 min (purity >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.5 (s, 1H), 8.44 (s, 1H), 8.27 (d, <i>J</i> = 10.1 Hz, 1H), 7.99 (s, 1H), 7.85 (s, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.46 (t, <i>J</i> = 8.2 Hz, 1H), 7.38 (br s, 2H), 7.26 (t, <i>J</i> = 7.7 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 7.05 (br d, <i>J</i> = 8.1 Hz, 1H), 5.51 (br d, <i>J</i> = 53 Hz, 1H), 4.64 (dd, <i>J</i> = 9.0, 7.6 Hz, 1H), 4.07–3.85 (m, 2H), 2.56 (m, 1H), 2.18 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>19</sub>F<sub>4</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 494.14459; found, 494.14423.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (2<i>S</i>,4<i>S</i>)-4-Fluoro-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>15</b>)</h5><div class="NLM_p last">White solid (42 mg, yield 69%) obtained according to General Procedure 2 from (2<i>S</i>,4<i>S</i>)-4-fluoro-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (2<i>S</i>,4<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid using CH<sub>2</sub>Cl<sub>2</sub> instead of DMF in step A). <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:3) 0.2. <i>t</i><sub>R</sub> (HPLC conditions c) 3.97 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 494 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.2 (s, 1H), 8.30 (s, 1H), 8.28 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.83 (s, 1H), 7.81 (br d, <i>J</i> = 8.3 Hz, 1H), 7.58 (m, 1H), 7.45 (t, <i>J</i> = 8.3 Hz, 1H), 7.41 (br s, 2H), 7.26 (t, <i>J</i> = 7.7 Hz, 1H), 7.18 (t, <i>J</i> = 7.5 Hz, 1H), 7.05 (m, 1H), 5.45 (br d, <i>J</i> = 54 Hz, 1H), 4.6 (m, 1H), 4.09–3.87 (m, 2H), 2.62–2.35 (m, 2H; overlapping with DMSO signal). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>19</sub>F<sub>4</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 494.14459; found, 494.14396.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>S</i>)-4,4-Difluoro-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>16</b>)</h5><div class="NLM_p last">Pale brownish solid (66 mg, yield 52%) obtained according to General Procedure 2 from (<i>S</i>)-4,4-difluoro-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared according to the General Procedure 1 by starting from (<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid). LC–MS (ESI, <i>m</i>/<i>z</i>) 512.2 [M + H]<sup>+</sup>, 510.1 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions c) 4.37 min (purity >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.5 (s, 1H), 8.48 (s, 1H), 8.28 (d, <i>J</i> = 8.2 Hz, 1H), 8.00 (s, 1H), 7.83 (br s, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.47 (t, <i>J</i> = 8.2 Hz, 1H), 7.43 (br s, 2H), 7.27 (t, <i>J</i> = 7.7 Hz, 1H), 7.19 (t, <i>J</i> = 7.2 Hz, 1H), 7.07 (br d, <i>J</i> = 8.1 Hz, 1H), 4.75 (dd, <i>J</i> = 9.0, 5.6 Hz, 1H), 4.21 (m, 2H), 2.93 (m, 1H), 2.58 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>18</sub>F<sub>5</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 512.1352; found, 512.1350; calcd for C<sub>22</sub>H<sub>18</sub>F<sub>5</sub>N<sub>5</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 534.1171; found, 534.1169; calcd for C<sub>22</sub>H<sub>18</sub>F<sub>5</sub>N<sub>5</sub>O<sub>4</sub>NH<sub>4</sub> [M + NH<sub>4</sub>]<sup>+</sup> 529.1617; found, 529.1617.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (2<i>S</i>,4<i>S</i>)-4-Hydroxy-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide] (<b>17</b>)</h5><div class="NLM_p last">White solid (50 mg, yield 36%) obtained according to General Procedure 2 from (2<i>S</i>,4<i>S</i>)-4-hydroxy-<i>N</i>-(3-(trifluoromethoxy)phenyl)pyrrolidine-2-carboxamide trifluoro acetate salt (prepared according to General Procedure 1 by starting from (2<i>S</i>,4<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid). <i>t</i><sub>R</sub> (HPLC conditions c) 3.65 min (purity 98%). LC–MS (ESI, <i>m</i>/<i>z</i>) 492.1 [M + H]<sup>+</sup>, 514.2 [M + H]<sup>+</sup>, 490.1 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.3 (s, 1H), 8.27 (m, 2H), 7.99 (s, 1H), 7.85 (br s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.56 (br d, <i>J</i> = 8.3 Hz, 1H), 7.46 (t, <i>J</i> = 8.2 Hz, 1H), 7.39 (br, 2H), 7.26 (t, <i>J</i> = 7.6 Hz, 1H), 7.18 (t, <i>J</i> = 7.5 Hz, 1H), 7.06 (br d, <i>J</i> = 8.10 Hz, 1H), 5.30 (m, 1H), 4.49 (dd, <i>J</i> = 8.4, 5.9 Hz, 1H), 4.40 (m, 1H), 3.86 (dd, <i>J</i> = 10.0, 5.7 Hz, 1H), 3.56 (dd, <i>J</i> = 9.85, 4.8 Hz, 1H), 2.46 (m, 1H), 1.91 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 492.14893; found, 492.14880.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (2<i>S</i>,4<i>S</i>)-4-Amino-pyrrolidine-1,2-dicarboxylic Acid 1-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-Trifluoromethoxy-phenyl)-amide], Formate Salt (<b>18</b>)</h5><div class="NLM_p">(2<i>S</i>,4<i>S</i>)-4-<i>N</i>-Fmoc-amino-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] was prepared according to General Procedure 2 from (9<i>H</i>-fluoren-9-yl)methyl ((3<i>S</i>,5<i>S</i>)-5-((3-(trifluoromethoxy)phenyl)carbamoyl)pyrrolidin-3-yl)carbamate trifluoro acetate salt (prepared according to General Procedure 1 by starting from (4<i>S</i>)-4-<i>N</i>-Fmoc-amino-1-Boc-<span class="smallcaps smallerCapital">l</span>-proline), White solid (472 mg, yield 59%). TLC, <i>R</i><sub><i>f</i></sub> (AcOEt) 0.55. <i>t</i><sub>R</sub> (HPLC conditions a) 4.17 min (purity >95%). MS (LC/MS): 713.2 [M + H]<sup>+</sup>, 735.1 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">(2<i>S</i>,4<i>S</i>)-4-<i>N</i>-Fmoc-amino-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1<i>H</i>-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] (380 mg, 0.533 mmol) was dissolved in a 20% solution of piperidine in DMF (2 mL). The mixture was stirred for 1 h at RT and then directly purified by prep HPLC (Interchrom C18-ODB; particle size 10 μm; column size 28 mm × 250 mm; eluent/gradient 5% CH<sub>3</sub>CN in H<sub>2</sub>O 2.5 min, then 5% to 100% CH<sub>3</sub>CN in H<sub>2</sub>O in 32.5 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH); flow rate 40 mL/min). To the combined fractions containing the title compound was added 1 N NaOH, and the aqueous layer was extracted with EtOAc three times. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue thus obtained was then purified by prep HPLC (Water SunFire C18-ODB; particle size 5 μm; column size 19 mm × 50 mm; eluent/gradient 5% to 60% CH<sub>3</sub>CN in H<sub>2</sub>O for 18 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH); flow rate 20 mL/min), and the combined pure fractions were freeze-dried to give <b>18</b> as a white solid (138 mg, 48%). <i>t</i><sub>R</sub> (HPLC conditions a) 2.73 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 491.2 [M + H]<sup>+</sup>, 489.1 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.28 (s, 1H), 8.25 (d, <i>J</i> = 7.8 Hz, 1H), 8.21 (s, 1H), 7.97 (s, 1H), 7.82 (s, 1H), 7.75 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 1H), 7.43 (t, <i>J</i> = 8.1 Hz, 1H), 7.37 (br s, 2H), 7.23 (t, <i>J</i> = 7.6 Hz, 1H), 7.15 (t, <i>J</i> = 7.0 Hz, 1H), 7.04 (d, <i>J</i> = 7.6 Hz, 1H), 4.42 (m, 1H), 3.80 (m, 1H), 3.63 (m, 1H), 3.45 (m, 1H; overlapping with H<sub>2</sub>O signal), 2.24 (m, 1H; overlapping with DMSO signal), 1.81 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 491.1649; found, 491.1648.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(3-Difluoromethoxy-phenyl)-amide] (<b>19</b>)</h5><div class="NLM_p last">White solid (39 mg, yield 61%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-(difluoromethoxy)phenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 3-(difluoromethoxy)aniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A). <i>t</i><sub>R</sub> (HPLC conditions c) 3.80 min (purity 98%). LC–MS (ESI, <i>m</i>/<i>z</i>) 470.0 [M + H]<sup>+</sup>, 468.9 [M – H]<sup>−</sup>, 425.0 [M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.1 (s, 1H), 8.65 (s, 1H), 8.28 (d, <i>J</i> = 8.2 Hz, 1H), 8.01 (s, 1H), 7.81 (d, <i>J</i> = 7.7 Hz, 1H), 7.63 (s, 1H), 7.44 (m, 1H), 7.37 (br s, 2H), 7.35 (t, <i>J</i> = 8.2 Hz, 1H), 7.27 (m, 2H), 7.20 (m, 1H), 7.20 (t, <i>J</i> = 74 Hz, 1H), 6.87 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 4.21 (t, <i>J</i> = 8.0 Hz, 1H), 3.94 (m, 1H), 2.36 (dd, <i>J</i> = 13.0, 8.9 Hz, 1H), 2.17 (m, 1H), 1.83 (m, 1H), 0.85 (m, 1H), 0.59 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>21</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 470.16344; found, 470.16403.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(3-Methoxy-phenyl)-amide] (<b>20</b>)</h5><div class="NLM_p last">White solid (55 mg, yield 66%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-methoxyphenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 3-methoxyaniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A). <i>t</i><sub>R</sub> (HPLC conditions c) 3.33 min (purity 97%). LC–MS (ESI, <i>m</i>/<i>z</i>) 434.0 [M + H]<sup>+</sup>, 388.9 [M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.89 (s, 1H), 8.64 (s, 1H), 8.28 (d, <i>J</i> = 8.2 Hz, 1H), 8.02 (s, 1H), 7.81 (d, <i>J</i> = 7.7 Hz, 1H), 7.39 (br s, 2H), 7.35 (m, 1H), 7.27 (m, 1H), 7.23–7.16 (m, 3H), 6.63 (m, 1H), 4.21 (t, <i>J</i> = 8.0 Hz, 1H), 3.93 (m, 1H), 3.73 (s, 3H), 2.35 (dd, <i>J</i> = 12.9, 8.9 Hz, 1H), 2.18 (m, 1H), 1.81 (m, 1H), 0.85 (m, 1H), 0.58 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 434.18228; found, 434.18243.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(3-Chlorophenyl)-amide] (<b>21</b>)</h5><div class="NLM_p last">White solid (47 mg, 61%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-chlorophenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 3-chloroaniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A). <i>t</i><sub>R</sub> (HPLC conditions b) 4.12 min (purity >95%). LC–MS (ESI, <i>m</i>/<i>z</i>) 438.0/440.0 [M + H]<sup>+</sup>, 437.8 [M – H]<sup>−</sup>, 393/395 [M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.1 (s, 1H), 8.66 (s, 1H), 8.29 (d, <i>J</i> = 8.2 Hz, 1H), 8.01 (s, 1H), 7.86 (t, <i>J</i> = 1.9 Hz, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.51 (m, 1H), 7.39 (br s, 2H), 7.34 (t, <i>J</i> = 8.1 Hz, 1H), 7.27 (m, 1H), 7.20 (m, 1H), 7.11 (m, 1H), 4.20 (t, <i>J</i> = 8.0 Hz, 1H), 3.94 (m, 1H), 2.37 (dd, <i>J</i> = 12.9, 8.8 Hz, 1H), 2.17 (m, 1H), 1.82 (m, 1H), 0.85 (m, 1H), 0.60 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub>N<sub>5</sub><sup>35</sup>Cl [M + H]<sup>+</sup> 438.13274; found, 438.13272.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 3-[(3-Bromophenyl)amide] 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)amide] (<b>22</b>)</h5><div class="NLM_p last">White solid (45 mg, yield 59%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-bromophenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 3-bromoaniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A). <i>t</i><sub>R</sub> (HPLC conditions b) 4.20 min (purity >95%), LC–MS (ESI, <i>m</i>/<i>z</i>) 481.9/483.0 [M + H]<sup>+</sup>, 481.9/482.8 [M – H]<sup>−</sup>, 436.9/438.9 [M – CONH<sub>2</sub>]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.1 (s, 1H), 8.65 (s, 1H), 8.29 (d, <i>J</i> = 8.2 Hz, 1H), 8.01 (m, 2H), 7.81 (d, <i>J</i> = 7.7 Hz, 1H), 7.55 (m, 1H), 7.39 (br s, 2H), 7.30–7.23 (m, 3H), 7.20 (m, 1H), 4.19 (t, <i>J</i> = 8.1 Hz, 1H), 3.94 (m, 1H), 2.36 (dd, <i>J</i> = 13.0, 9.0 Hz, 1H), 2.18 (m, 1H), 1.82 (m, 1H), 0.85 (m, 1H), 0.60 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub>N<sub>5</sub><sup>79</sup>Br [M + H]<sup>+</sup> 482.08223; found, 482.08221.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(2-Fluoro-3-trifluoromethoxy-phenyl)-amide] (<b>23</b>)</h5><div class="NLM_p last">White solid (270 mg, yield 63%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(2-fluoro-3-(trifluoromethoxy)phenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 2-fluoro-3-(trifluoromethoxy)aniline [CAS 1159512-64-7] and heating the reaction mixture at 70 °C in step A). <i>t</i><sub>R</sub> (HPLC conditions b) 4.46 min (purity 99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 506 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.98 (s, 1H), 8.68 (s, 1H), 8.29 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.95 (m, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.42 (br s, 2H), 7.33–7.26 (m, 3H), 7.20 (t, <i>J</i> = 7.1 Hz, 1H), 4.40 (dd, <i>J</i> = 8.5, 7.3 Hz, 1H), 3.91 (m, 1H), 2.38 (dd, <i>J</i> = 12.8, 8.9 Hz, 1H), 2.23 (m, 1H), 1.83 (m, 1H), 0.86 (m, 1H), 0.59 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>20</sub>O<sub>4</sub>N<sub>5</sub>F<sub>4</sub> [M + H]<sup>+</sup> 506.14459; found, 506.14471.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(2-Fluoro-3-trifluoromethyl-phenyl)-amide] (<b>24</b>)</h5><div class="NLM_p last">White solid (45 mg, yield 72%) obtained according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(2-fluoro-3-(trifluoromethyl)phenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to the General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 2-fluoro-3-(trifluoromethyl)aniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A). <i>t</i><sub>R</sub> (HPLC conditions b) 4.39 min (purity 97%). LC–MS (ESI, <i>m</i>/<i>z</i>) 490 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.0 (s, 1H), 8.68 (s, 1H), 8.29 (d, <i>J</i> = 8.3 Hz, 1H), 8.21 (t, <i>J</i> = 7.5 Hz, 1H), 8.05 (s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.53 (t, <i>J</i> = 6.9 Hz, 1H), 7.43 (br s, 2H), 7.40 (t, <i>J</i> = 8.0 Hz, 1H), 7.28 (t, <i>J</i> = 7.7 Hz, 1H), 7.20 (t, <i>J</i> = 7.5 Hz, 1H), 4.40 (dd, <i>J</i> = 8.6, 7.3 Hz, 1H), 3.90 (m, 1H), 2.39 (dd, <i>J</i> = 12.9, 8.9 Hz, 1H), 1.83 (m, 1H), 0.87 (m, 1H), 0.61 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>23</sub>H<sub>20</sub>O<sub>3</sub>N<sub>5</sub>F<sub>3</sub> [M + H]<sup>+</sup> 490.14968; found, 490.14981.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(6-Trifluoromethyl-pyridin-2-yl)-amide] (<b>25</b>)</h5><div class="NLM_p">To a solution of (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-<i>tert</i>-butyl ester ([CAS 197142-34-0; Neptune Technotrade, USA; 400 mg, 1.76 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (9.6 mL) was added 1-chloro-<i>N</i>,<i>N</i>,2-trimethylpropenylamine (259 mg, 1.94 mmol) at 0 °C under a nitrogen atmosphere. Formation of the acyl chloride intermediate was monitored by TLC after quenching of an aliquot with MeOH to form the corresponding methyl ester. After completion of the reaction (2 h), 6-(trifluoromethyl)pyridin-2-amine (314 mg, 1.94 mmol) was added at 0 °C, followed by DIPEA (0.61 mL, 3.52 mmol), and the reaction mixture was further stirred for 16 h at RT. The mixture was then concentrated and purified by flash column chromatography (SiO<sub>2</sub>, <i>c</i>-hexane/EtOAc 1:0 to 0:1) to give <i>tert</i>-butyl (1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-((6-(trifluoromethyl)pyridin-2-yl)carbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate as a white solid (578 mg, yield 88%). TLC, <i>R</i><sub><i>f</i></sub> (EtOAc) 0.85. LC–MS (ESI, <i>m</i>/<i>z</i>) 372.3 [M + H]<sup>+</sup>, 370.2 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC, conditions d) 2.07 min (purity >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 10.9 (s, 1H), 8.38 (br d, <i>J</i> = 8.2 Hz, 1H), 8.10 (t, <i>J</i> = 7.9 Hz, 1H), 7.61 (d, <i>J</i> = 7.5 Hz, 1H), 4.20 (m, 1H), 3.43 (m, 1H), 2.33 (m, 1H), 2.15 (m, 1H), 1.61 (m, 1H), 1.42 (s, 3H), 1.25 (s, 6H), 0.76 (m, 1H), 0.41 (m, 1H).</div><div class="NLM_p">To a solution of <i>tert</i>-butyl (1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-((6-(trifluoromethyl)pyridin-2-yl)carbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate (550 mg, 1.26 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) was added TFA (0.97 mL, 12.6 mmol), and the solution was stirred for 2 h at RT. The volatiles were then evaporated, and the crude residue was dried under high vacuum to give the (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(6-(trifluoromethyl)pyridin-2-yl)-2-azabicyclo[3.1.0]hexane-3-carboxamide di(trifluoroacetate) salt as a pale colored oil. The material thus obtained was stored at 4 °C to avoid decomposition and was used without further purification in the next reaction step. LC–MS (ESI, <i>m</i>/<i>z</i>) 272.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 14.5 (s, 1H), 9.85 (br s, 1H), 9.27 (br s, 1H), 8.32 (br d, <i>J</i> = 8.2 Hz, 1H), 8.18 (t, <i>J</i> = 8.0 Hz, 1H), 7.71 (d, <i>J</i> = 7.6 Hz, 1H), 4.21 (m, 1H), 3.38 (m, 1H), 2.66 (dd, <i>J</i> = 12.8, 7.7 Hz, 1H), 2.13 (td, <i>J</i> = 11.8, 4.3 Hz, 1H), 1.86 (m, 1H), 0.85 (m, 2H).</div><div class="NLM_p last">(1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-[(1-carbamoyl-1<i>H</i>-indol-3-yl)-amide] 3-[(6-trifluoromethyl-pyridin-2-yl)-amide] (<b>25</b>) was obtained as a white solid (39 mg, yield 21%) according to General Procedure 2 from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(6-(trifluoromethyl)pyridin-2-yl)-2-azabicyclo[3.1.0]hexane-3-carboxamide di(trifluoroacetate) salt. TLC, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5) 0.35. <i>t</i><sub>R</sub> (HPLC conditions c) 3.91 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 473.2 [M + H]<sup>+</sup>, 945.3 [2M + H]<sup>+</sup>, 471.1 [M – H]<sup>−</sup>, 943.3 [2M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-d6): δ (ppm) 10.8 (s, 1H), 8.66 (s, 1H), 8.37 (d, <i>J</i> = 8.6 Hz, 1H), 8.27 (d, <i>J</i> = 8.3 Hz, 1H), 8.07 (t, <i>J</i> = 8.0 Hz, 1H), 7.99 (s, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 1H), 7.59 (d, <i>J</i> = 7.5 Hz, 1H), 7.37 (br s, 2H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.18 (t, <i>J</i> = 7.5 Hz, 1H), 4.39 (t, <i>J</i> = 8.0 Hz, 1H), 3.93 (m, 1H), 2.37 (dd, <i>J</i> = 12.9, 8.9 Hz, 1H), 2.16 (m, 1H), 1.80 (m, 1H), 0.84 (m, 1H), 0.54 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>20</sub>O<sub>3</sub>N<sub>6</sub>F<sub>3</sub> [M + H]<sup>+</sup> 473.15435; found, 473.15463.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 3-[(6-Bromo-pyridin-2-yl)-amide] 2-[(1-Carbamoyl-1<i>H</i>-indol-3-yl)-amide] (<b>26</b>)</h5><div class="NLM_p last">To a solution of ((1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid (6-bromo-pyridin-2-yl)-amide di(trifluoroacetate) salt<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (1.20 g, 3.03 mmol) and Et<sub>3</sub>N (1.26 mL, 9.09 mmol) in THF (0.4 mL) was added a suspension of <b>32</b> (610 mg, 3.03 mmol) in THF (40 mL). The solution was stirred at RT under nitrogen for 45 min, volatiles were then evaporated, and the residue was purified by prep HPLC (Waters SunFire C18-ODB; particle size 5 μm; column size 19 mm × 50 mm; eluent/gradient 20–100% CH<sub>3</sub>CN/H<sub>2</sub>O in 25 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA); flow rate 40 mL/min). To the combined pure fractions was added a saturated NaHCO<sub>3</sub> solution, the aqueous layer was extraced with CH<sub>2</sub>Cl<sub>2</sub>, the organics were dried (Na<sub>2</sub>SO<sub>4</sub>), and volatiles were removed under reduced pressure to give, after drying in vacuo, a white solid (1.4 g, yield 78%). TLC, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 9:1) 0.45. LC–MS (ESI, <i>m</i>/<i>z</i>) 483.1/485.2 [M + H]<sup>+</sup>, 965.3/967.3 [2M + H]<sup>+</sup>, 481.1/483.1 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions c) 3.85 min (purity 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.7 (br s, 1H), 8.66 (br s, 1H), 8.28 (d, <i>J</i> = 8.3 Hz, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 8.00 (s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.75 (t, <i>J</i> = 7.9 Hz, 1H), 7.38 (m, 2H), 7.35 (d, <i>J</i> = 7.6 Hz, 1H), 7.27 (t, <i>J</i> = 7.3 Hz, 1H), 7.20 (t, <i>J</i> = 7.1 Hz, 1H), 4.35 (t, <i>J</i> = 7.8 Hz, 1H), 3.93 (m, 1H), 2.38 (dd, <i>J</i> = 12.9, 8.9 Hz, 1H), 2.17 (m, 1H), 1.80 (m, 1H), 0.85 (m, 1H), 0.55 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>21</sub>H<sub>20</sub>O<sub>3</sub>N<sub>6</sub><sup>79</sup>Br [M + H]<sup>+</sup> 483.07748; found, 483.07721.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 3-(2-((1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-((2-Fluoro-3-(trifluoromethoxy)phenyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1<i>H</i>-indole-1-carboxamide (<b>27</b>)</h5><div class="NLM_p last">To a solution of (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(2-fluoro-3-(trifluoromethoxy)phenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoro acetate salt (59.3 mg, 0.14 mmol, prepared according to General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 2-fluoro-3-(trifluoromethoxy)aniline [CAS 1159512-64-7] and heating the reaction mixture at 70 °C in step A), (1-carbamoyl-1<i>H</i>-indol-3-yl)-acetic acid (<b>33</b>) (30 mg, 0.14 mmol) and HBTU (78 mg, 0.21 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) were added under a nitrogen atmosphere. DIPEA (96 μL, 0.55 mmol) and the reaction mixture were stirred at RT for 2 h. To the mixture was then added water and EtOAc, the layers were separated, and the aqueous phase was back-extracted twice with EtOAc. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by prep HPLC (Waters SunFire C18-ODB; particule size 5 μm; column size 30 mm × 100 mm; eluent/gradient 5% CH<sub>3</sub>CN/H<sub>2</sub>O 2.5 min, 5–100% CH<sub>3</sub>CN in H<sub>2</sub>O for 10 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH); flow rate 40 mL/min) to give after extraction and concentration of the pure fractions the title compound <b>27</b> as a white powder (40 mg, yield 58%). TLC, <i>R</i><sub><i>f</i></sub> (AcOEt) 0.7. LC–MS (ESI, <i>m</i>/<i>z</i>) 505.1 [M + H]<sup>+</sup>, 522.2 [M + 18]<sup>+</sup>, 503.1 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions a) 3.57 min (purity >99%). <i>t</i><sub>R</sub> (HPLC conditions d) 2.1 min (purity >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.95 (br s, 1H), 8.25 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (m, 1H), 7.78 (s, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (br s, 2H), 7.34–7.23 (m, 3H), 7.16 (t, <i>J</i> = 7.1 Hz, 1H), 4.49 (dd, <i>J</i> = 8.2, 6.1 Hz, 1H), 3.95 (s, 2H), 3.75 (m, 1H), 2.27 (m, 2H), 1.84 (m, 1H), 0.96 (m, 1H), 0.58 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>24</sub>H<sub>21</sub>O<sub>4</sub>N<sub>4</sub>F<sub>4</sub> [M + H]<sup>+</sup> 505.14934; found, 505.14948.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 1-{2-[(1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-(6-Bromo-pyridin-2-ylcarbamoyl)-2-aza-bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}-1<i>H</i>-indole-3-carboxylic Acid Amide (<b>28</b>)</h5><div class="NLM_p last">Beige solid (23 mg, yield 61%) prepared according to the procedure described for <b>27</b> from ((1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid (6-bromo-pyridin-2-yl)-amide di(trifluoroacetate) salt<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and 2-(3-carbamoyl-1<i>H</i>-indol-1-yl)acetic acid [CAS 1016689-54-5]. TLC, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 90:10) 0.45. <i>t</i><sub>R</sub> (HPLC conditions a) 2.62 min (purity >99%). <i>t</i><sub>R</sub> (HPLC conditions d) 1.65 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 482.1/484.1 [M + H]<sup>+</sup>, 499.2/501.2 [M + NH<sub>4</sub>]<sup>+</sup>, 480.1/482.1 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.8 (s, 1H), 8.15 (d, <i>J</i> = 7.8 Hz, 1H), 8.04 (d, <i>J</i> = 8.1 Hz, 1H), 7.98 (s, 1H), 7.72 (t, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 8.1 Hz, 1H), 7.33 (d, <i>J</i> = 7.7 Hz, 1H), 7.19 (m, 1H), 7.13 (t, <i>J</i> = 7.3 Hz, 1H), 5.48 (d, <i>J</i> = 17.3 Hz, 1H), 5.23 (d, <i>J</i> = 17.3 Hz, 1H), 4.45 (dd, <i>J</i> = 9.0, 5.4 Hz, 1H), 3.82 (m, 1H), 3.31 (s, 2H), 2.33 (m, 1H), 2.22 (m, 1H), 1.89 (m, 1H), 1.03 (m, 1H), 0.73 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub>N<sub>5</sub><sup>79</sup>Br [M + H]<sup>+</sup> 482.08223; found, 482.08221.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(2-(3-Acetyl-1<i>H</i>-indazol-1-yl)acetyl)-<i>N</i>-(6-bromopyridin-2-yl)-2-azabicyclo[3.1.0]hexane-3-carboxamide (<b>29</b>)</h5><div class="NLM_p last">White solid (30 mg, yield 79%) prepared according to the procedure described for <b>27</b> from ((1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid (6-bromo-pyridin-2-yl)-amide di(trifluoroacetate) salt<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and 2-(3-acetyl-1<i>H</i>-indazol-1-yl)acetic acid (<b>36</b>). TLC, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 90:10) 0.9. <i>t</i><sub>R</sub> (HPLC conditions a) 3.25 min (purity >99%). <i>t</i><sub>R</sub> (HPLC conditions d) 1.85 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 482.1/484.1 [M + H]<sup>+</sup>, 499.1/501.2 [M + NH<sub>4</sub>]<sup>+</sup>, 963.3/965.3 [2M + H]<sup>+</sup>, 980.3/982.3 [2M + NH<sub>4</sub>]<sup>+</sup>, 480.2/482.5 [M – H]<sup>−</sup>, 526.1/528.0 [M + HCOO]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.8 (s, 1H), 8.19 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (d, <i>J</i> = 8.1 Hz, 1H), 7.72 (m, 2H), 7.50 (t, <i>J</i> = 7.7 Hz, 1H), 7.36 (m, 2H), 5.95 (d, <i>J</i> = 17.2 Hz, 1H), 5.58 (d, <i>J</i> = 17.2 Hz, 1H), 4.46 (dd, <i>J</i> = 9.0, 5.4 Hz, 1H), 3.85 (m, 1H), 3.30 (s, 2H), 2.64 (s, 3H), 2.35 (dd, <i>J</i> = 13.1, 9.6 Hz, 1H), 2.23 (m, 1H), 1.92 (m, 1H), 1.02 (m, 1H), 0.80 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub>N<sub>5</sub><sup>79</sup>Br [M + H]<sup>+</sup> 482.08223; found, 482.08221.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 1-(2-((1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-((3-Bromo-2-fluorophenyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1<i>H</i>-indazole-3-carboxamide (<b>30</b>)</h5><div class="NLM_p last">White solid (30 mg, yield 61%) prepared according to the procedure described for <b>27</b> from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-<i>N</i>-(3-bromo-2-fluorophenyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide trifluoroacetate salt (prepared according to General Procedure 1 by starting from (1<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(<i>tert</i>-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid and 3-bromo-2-fluoroaniline and using CH<sub>2</sub>Cl<sub>2</sub> as the solvent in step A) and 2-(3-carbamoyl-1<i>H</i>-indazol-1-yl)acetic acid (<b>35</b>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> TLC, <i>R</i><sub><i>f</i></sub> (AcOEt) 0.6. <i>t</i><sub>R</sub> (HPLC conditions a) 3.18 min (purity >99%). <i>t</i><sub>R</sub> (HPLC conditions d) 1.90 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 517.1/519.1 [M + NH<sub>4</sub>]<sup>+</sup>, 498.1/500.1 [M – H]<sup>−</sup>, 544.1/546.0 [M + HCOO]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.84 (s, 1H), 8.19 (d, <i>J</i> = 8.3 Hz, 1H), 7.77 (m, 1H), 7.67 (br s, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 7.48–7.43 (m, 2H), 7.39 (br s, 1H), 7.28 (t, <i>J</i> = 7.6 Hz, 1H), 7.12 (td, <i>J</i> = 8.1, 1.2 Hz, 1H), 5.81 (d, <i>J</i> = 17.4 Hz, 1H), 5.51 (d, <i>J</i> = 17.4 Hz, 1H), 4.50 (dd, <i>J</i> = 8.6, 5.4 Hz, 1H), 3.80 (m, 1H), 2.28 (m, 2H), 1.92 (m, 1H), 1.03 (m, 1H), 0.77 (m, 1H). HRMS <i>m</i>/<i>z</i> (ESI) calcd for C<sub>22</sub>H<sub>20</sub>O<sub>3</sub>N<sub>5</sub><sup>79</sup>BrF [M + H]<sup>+</sup> 500.07281; found, 500.07271.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 3-Isocyanato-1-methyl-1<i>H</i>-indole (<b>31</b>)</h5><div class="NLM_p last">To a suspension of 1-methylindole-3-carboxylic acid (<b>44</b>) ([CAS 32387-21-6]; 700 mg, 4.00 mmol) in toluene (21 mL) under nitrogen was added triethylamine (Et<sub>3</sub>N; 556 μL, 4.00 mmol). After 15 min, diphenylphosphoryl azide (DPPA, 90% purity; 960 μL, 4.0 mmol) was added, and the reaction mixture was further stirred at RT for 8 h to give an orange solution. TLC indicated consumption of the starting material and formation of the acyl azide intermediate (<i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:1) 0.6). The mixture was concentrated under reduced pressure (<i><b>Caution!</b> Azides are potentially explosive substances and can decompose violently</i>), and the crude residue was purified by flash column chromatography (SiO<sub>2</sub>, <i>c</i>-hexane to <i>c</i>-hexane/EtOAc 3:2) to give the intermediate acyl azide (700 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.25 (s, 1H), 8.05 (d, <i>J</i> = 7.1 Hz, 1H), 7.59 (d, <i>J</i> = 7.6 Hz, 1H), 7.34–7.27 (m, 2H), 3.88 (s, 3H). The acyl azide intermediate (700 mg) was refluxed in toluene (20 mL) for 16 h. Toluene was evaporated under reduced pressure to give <b>31</b> as a slightly brown oil (609 mg, yield 89%), which was used without purification in the next step. TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:2) 0.35. <i>t</i><sub>R</sub> (HPLC conditions a): 3.85 min (purity >90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.60 (dt, <i>J</i> = 8.0, 0.9 Hz, 1H), 7.30 (m, 2H), 7.18 (ddd, <i>J</i> = 8.0, 6.3, 1.8 Hz, 1H), 6.91 (s, 1H), 3.75 (s, 3H).</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 3-Isocyanato-indole-1-carboxylic Acid Amide (<b>32</b>)</h5><div class="NLM_p">To a solution of 1<i>H</i>-indole-3-carboxylic acid (<b>41</b>) ([CAS 771-50-6]; 5.0 g, 31 mmol) in DMF (70 mL) under nitrogen atmosphere, cooled to 0 °C, was added cesium carbonate (11 g, 31 mmol) and benzyl bromide (4.05 mL, 34.1 mmol). The reaction mixture was stirred at RT for 48 h and then was poured into water. EtOAc was added, the layers were separated, and the aqueous phase was back-extracted three times with EtOAc. The combined organics were washed with water, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was taken up in Et<sub>2</sub>O, and the resulting precipitate was filtered off to give 1<i>H</i>-indole-3-carboxylic acid benzyl ester (<b>42</b>) as a white powder (6.46 g, yield 83%). TLC, <i>R</i><sub><i>f</i></sub> (<i>c</i>-hexane/EtOAc 1:1) 0.55. <i>t</i><sub>R</sub> (HPLC conditions a) 3.8 min (purity >99%). LC–MS (ESI, <i>m</i>/<i>z</i>) 252.1 [M + H]<sup>+</sup>, 274.0 [M + Na]<sup>+</sup>, 525.1 [2M + Na]<sup>+</sup>, 250.1 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 12.0 (s, 1H), 8.14 (s, 1H), 7.98 (d, <i>J</i> = 6.8 Hz, 1H), 7.48 (m, 3H), 7.40 (m, 2H), 7.33 (m, 1H), 7.19 (m, 2H), 5.33 (s, 2H).</div><div class="NLM_p">To a solution of <b>42</b> (3.50 g, 13.9 mmol) in tetrahydrofuran (THF; 70 mL), cooled to 5 °C under a nitrogen atmosphere, was added sodium hydride (NaH, 60% in mineral oil; 557 mg, 13.9 mmol). The mixture was stirred at 5 °C for 30 min, followed by slow dropwise addition of chlorosulfonyl isocyanate (2.42 mL, 27.9 mmol) while maintaining the temperature between 5 and 10 °C. The pale yellow solution was further stirred at RT for 3.5 h. Acetic acid (22.5 mL) was added (exothermic), and the resulting solution was stirred at RT for 1.5 h, followed by addition of ice cubes and water (100 mL). The white thick suspension was stirred at RT for 30 min. The precipitate formed was then filtered off, taken up in MeOH, and filtered off again to afford 1-carbamoyl-1<i>H</i>-indole-3-carboxylic acid benzyl ester (<b>43</b>) as a white powder (1.19 g, yield 29%). LC–MS (ESI, <i>m</i>/<i>z</i>) 295.1 [M + H]<sup>+</sup>, 317.0 [M + Na]<sup>+</sup>, 611.0 [2M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.64 (s, 1H), 8.29 (d, <i>J</i> = 7.6 Hz, 1H), 8.04 (d, <i>J</i> = 7.35 Hz, 1H), 7.90 (m, 2H), 7.50 (m, 2H), 7.42 (m, 2H), 7.36–7.30 (m, 3H), 5.38 (s, 2H).</div><div class="NLM_p">To a solution of <b>43</b> (1.33 g, 4.52 mmol) in a mixture of DMF/THF 1:1 (28 mL) was added Pd/10% C (250 mg), and the solution was degassed three times by replacing air with nitrogen and then nitrogen by hydrogen gas. The reaction mixture was stirred overnight, and the catalyst was then removed by filtration through a pad of Celite followed by washing with THF. The solvents were concentrated under high vacuum to give a yellowish solid, which was taken up in Et<sub>2</sub>O and filtered off to afford 1-carbamoyl-1<i>H</i>-indole-3-carboxylic acid (<b>45</b>) as a solid (900 mg, yield 100%). TLC, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 9:1) 0.25. LC–MS (ESI, <i>m</i>/<i>z</i>) 205.1 [M + H]<sup>+</sup>, 249.1 [M + HCOO]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 12.6 (m, 1H), 8.55 (s, 1H), 8.29 (d, <i>J</i> = 7.85 Hz, 1H), 8.06 (d, <i>J</i> = 7.35 Hz, 1H), 7.85 (m, 2H), 7.34–7.27 (m, 2H).</div><div class="NLM_p last">To a white suspension of <b>45</b> (6.00 g, 29.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (80 mL) under nitrogen was added Et<sub>3</sub>N (4.50 mL, 32.3 mmol) at 12–18 °C. After stirring for 1 h at −15 °C, DPPA (7.0 mL, 32.3 mmol) was added over 10 min to the colorless solution, and the reaction mixture was stirred at 15 °C for 7 h. The white suspension was filtered off, and the precipitate was washed with cold CH<sub>2</sub>Cl<sub>2</sub> (10 mL) to give the intermediate acyl azide. The wet cake was stored under an argon atmosphere at −30 °C and used without purification in the following reaction step (<i><b>Warning!</b> The acyl azide intermediate has a relatively low onset temperature of decomposition with a large energy release</i> (dynamic DSC, onset <i>T</i> = 139.6 °C, 963 J/g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.70 (s, 1H), 8.30 (d, <i>J</i> = 7.35 Hz, 1H), 8.11 (d, <i>J</i> = 6.50 Hz, 1H), 8.04 (m, 2H), 7.38 (m, 2H). The wet acyl azide intermediate was added portionwise (about 1–1.5 g as white suspension in toluene (5 mL) every 1.5 h) to toluene (125 mL) heated at 100–105 °C. Five minutes after the addition of one portion of the acyl azide suspension, the reaction mixture became colorless, and HPLC after 30 min indicated disappearance of the azide. This procedure was repeated until full consumption of the azide was accomplished. The reaction mixture was allowed to warm to RT, the yellow suspension was filtered, and the filtrate was concentrated under reduced pressure to give 3-isocyanato-indole-1-carboxylic acid amide (<b>32</b>) as a white powder (3.06 g, yield 52%), which was stored at 4 °C under an argon atmosphere before use without further purification in the next reaction step. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 8.19 (d, <i>J</i> = 8.4 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (m, 1H), 7.35 (m, 1H), 7.26 (s, 1H), 5.39 (m, 2H).</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (1-Carbamoyl-1<i>H</i>-indol-3-yl)-acetic Acid (<b>33</b>)</h5><div class="NLM_p">To a solution of (1<i>H</i>-indol-3-yl)-acetic acid ethyl ester (<b>46</b>) ([CAS 778-82-5]; 2.50 g, 12.3 mmol) in THF (58 mL), cooled to 0 °C, was added NaH (60% in mineral oil; 0.354 g, 14.8 mmol) portionwise under an argon atmosphere. The dark brown solution was stirred at 0 °C for 45 min, followed by dropwise addition of chlorosulfonylisocyanate (CSI; 2.14 mL, 24.6 mmol). The reaction mixture was allowed to warm to RT overnight with stirring. Acetic acid (3 mL) was then added to the mixture, which was stirred at RT for another 20 min. Wet ice was added, and the mixture was further stirred for 60 min, then diluted with water and extracted three times with EtOAc. The combined organics were washed with brine, dried (phase separator), and concentrated in vacuo. The residual oil was purified by flash column chromatography (SiO<sub>2</sub>, <i>c</i>-hexane/EtOAc 3:1 to 3:2) to give (1-carbamoyl-1<i>H</i>-indol-3-yl)-acetic acid ethyl ester (<b>47</b>) as a brownish solid (2.0 g, yield 75%). TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:1) 0.35. LC–MS (ESI, <i>m</i>/<i>z</i>) 247 [M + H]<sup>+</sup>, 493 [2M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC conditions b) 3.51 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.24 (d, <i>J</i> = 8.35 Hz, 1H), 7.76 (s, 1H), 7.54 (d, <i>J</i> = 7.85 Hz, 1H), 7.52 (br s, 2H), 7.25 (t, <i>J</i> = 7.7 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 4.10 (q, <i>J</i> = 7.1 Hz, 2H), 3.75 (s, 2H), 1.19 (t, <i>J</i> = 7.1 Hz, 3H).</div><div class="NLM_p last">To a suspension of <b>47</b> (2.00 g, 6.09 mmol) in MeOH (61 mL) and water (6.1 mL) was added a 1 N aqueous solution of NaOH (12.2 mL, 12.2 mmol), and the resulting yellow solution was stirred at RT for 4 h. The reaction mixture was concentrated under reduced pressure, and the residue was suspended in aqueous 1 N HCl. The aqueous layer was extracted with EtOAc (3×); the combined organics were dried (phase separator) and concentrated in vacuo to afford the crude product <b>33</b> as a brownish solid (1.02 g, yield 95%), which was used directly in the next step. LC–MS (ESI, <i>m</i>/<i>z</i>) 219 [M + H]<sup>+</sup>, 437 [2M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC conditions b) 2.16 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.74 (s, 1H), 7.53 (d, <i>J</i> = 7.7 Hz, 1H), 7.50 (br s, 2H), 7.24 (t, <i>J</i> = 7.6 Hz, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 3.64 (s, 2H).</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 2-(3-Acetyl)-1<i>H</i>-indazol-1-yl)acetic Acid (<b>36</b>)</h5><div class="NLM_p">To a solution of 1-(1<i>H</i>-indazol-3-yl)ethanone (<b>48</b>) ([CAS 4498-72-0]; 2.00 g, 12.5 mmol) in acetonitrile (50 mL) was added K<sub>2</sub>CO<sub>3</sub> (3.97 g, 28.7 mmol) and <i>tert</i>-butyl 2-bromoacetate (3.41 g, 17.5 mmol). The reaction mixture was stirred for 18 h at reflux temperature. After cooling to RT, the mixture was filtered, and the filtrate was evaporated under reduced pressure to afford crude <i>tert</i>-butyl 2-(3-acetyl-1<i>H</i>-indazol-1-yl)acetate (<b>49</b>) as a yellow oil. LC–MS (ESI, <i>m</i>/<i>z</i>) 275 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC conditions e) 5.04 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.21 (d, <i>J</i> = 8.1 Hz, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 7.52 (t, <i>J</i> = 7.9 Hz, 1H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 5.46 (s, 2H), 2.64 (s, 3H), 1.43 (s, 9H).</div><div class="NLM_p last">To a solution of <b>49</b> (12.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (45 mL) was added TFA (15 mL, 14.4 mmol) and stirring was continued at RT overnight. The reaction mixture was evaporated, the residue was taken up in MeOH, and volatiles were removed again under reduced pressure to afford <b>36</b> as a yellowish solid (2.97 g, yield 100% over two reaction steps). The material thus obtained was used directly in the next step without further purification. LC–MS (ESI, <i>m</i>/<i>z</i>) 219.1 [M + H]<sup>+</sup>, 217.1 [M – H]<sup>−</sup>. <i>t</i><sub>R</sub> (HPLC conditions e) 3.48 min (purity 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 13.3 (br s, 1H), 8.21 (d, <i>J</i> = 8.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.5 Hz, 1H), 7.51 (t, <i>J</i> = 7.7 Hz, 1H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 5.46 (s, 2H), 2.64 (s, 3H).</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (2<i>S</i>,4<i>R</i>)- and (2<i>S</i>,4<i>S</i>)-2-(3-Trifluoromethoxy-phenylcarbamoyl)-4-methyl-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>39</b> and <b>40</b>)</h5><div class="NLM_p">To a suspension of <i>N</i>-Boc-4-methylene-<span class="smallcaps smallerCapital">l</span>-proline (<b>37</b>) ([CAS 84348-38-9]; 1.00 g, 4.40 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) were added 3-(trifluoromethoxy)aniline (0.71 mL, 5.28 mmol), HBTU (1.14 g, 6.60 mmol), and DIPEA (1.51 mL, 8.80 mmol). The reaction mixture was stirred at RT for 2 days under a nitrogen atmosphere and then was successively washed with 30 mL of a saturated aqueous NaHCO<sub>3</sub> solution and aqueous 1 N HCl. The organic layers were dried (phase separator) and concentrated under vacuum. The crude residue was purified by flash column chromatography (SiO<sub>2</sub>, <i>c</i>-hexane/EtOAc 65:35) to afford (<i>S</i>)-2-(3-trifluoromethoxy-phenylcarbamoyl)-4-methylene-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>38</b>) as a yellow oil (1.7 g, yield 100%). TLC, <i>R</i><sub><i>f</i></sub> (c-hexane/EtOAc 1:1) 0.55. LC–MS (ESI, <i>m</i>/<i>z</i>) 287.0 [M – Boc]<sup>+</sup>, 385.0 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 10.4 (s, 1H), 7.77 (s, 1H), 7.50–7.42 (m, 2H), 7.04 (br d, <i>J</i> = 7.8 Hz, 1H), 5.00 (m, 2H), 4.41 (m, 1H), 4.06–3.94 (m, 2H), 3.01 (m, 1H), 2.58 (m, 1H), 1.40 (s, 4H), 1.28 (s, 5H).</div><div class="NLM_p last">To a solution of <b>38</b> (0.50 g, 1.29 mmol) in EtOAc (15 mL) was added Pd/C (10%) (50 mg), and the solution was degassed three times by replacing air with nitrogen and then nitrogen with hydrogen gas. The reaction mixture was stirred at RT overnight then was filtered over a pad of Celite followed by washing the residual catalyst with EtOAc and the evaporation of solvents. The crude material was purified by prep HPLC (Waters SunFire C18-ODB; particle size 5 μm; column size 30 mm × 100 mm; eluent/gradient 20–100% CH<sub>3</sub>CN in H<sub>2</sub>O for 20 min, 100% CH<sub>3</sub>CN/2 min (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA); flow rate 40 mL/min; loading 150 mg per run) to afford after lyophilization of the corresponding fractions the two title compounds as pure diastereoisomers: (2<i>S</i>,4<i>S</i>)-2-(3-Trifluoromethoxy-phenylcarbamoyl)-4-methyl-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>40</b>) as a white foam (270 mg, yield 53%). <i>t</i><sub>R</sub> (HPLC, conditions b) 5.34 min. LC–MS (ESI, <i>m</i>/<i>z</i>) 387.0 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm): 10.3 (s, 1H), 7.80 (m, 1H), 7.53 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (t, <i>J</i> = 8.2 Hz, 1H), 7.04 (br d, <i>J</i> = 8.1 Hz, 1H), 4.19 (m, 1H, H<sub>2</sub>), 3.62 (m, 1H, H<sub>5</sub>), 2.87 (m, 1H, H<sub>5</sub>), 2.35 (m, 1H, H<sub>3</sub>), 2.22 (m, 1H, H<sub>4</sub>), 1.47 (m, 1H, H<sub>3</sub>), 1.39 (s, 3H), 1.34 (s, 6H), 1.03 (d, <i>J</i> = 6.6 Hz, 3H); the ROESY NMR spectrum showed NOE effects between H<sub>2</sub> and H<sub>4</sub> in line with absolute (2<i>S</i>,4<i>S</i>)-configuration. (2<i>S</i>,4<i>R</i>)-2-(3-Trifluoromethoxy-phenylcarbamoyl)-4-methyl-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>39</b>) as a white foam (35 mg, yield 7%): <i>t</i><sub>R</sub> (HPLC, conditions b) 5.53 min. LC–MS (ESI, <i>m</i>/<i>z</i>) 387.0 [M – H]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm): 10.3 (m, 1H), 7.80 (s, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (t, <i>J</i> = 8.2 Hz, 1H), 7.05 (br d, <i>J</i> = 8.1 Hz, 1H), 4.28 (m, 1H, H<sub>2</sub>), 3.61 (m, 1H, H<sub>5</sub>), 2.89 (m, 1H, H<sub>5</sub>), 2.38 (m, 1H, H<sub>4</sub>), 2.02 (m, 1H, H<sub>3</sub>), 1.86 (m, 1H, H<sub>3</sub>), 1.41 (s, 4H), 1.27 (s, 5H), 1.00 (d, <i>J</i> = 6.6 Hz, 3H); the ROESY NMR spectrum showed NOE effects between H<sub>2</sub> and the methyl substituent, indicating absolute (2<i>S</i>,4<i>R</i>)-configuration.</div></div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Cynomolgus Monkey ex Vivo Complement Activation</h3><div class="NLM_p last">Animal studies were conducted in accordance with Novartis Animal Care and Use Committee-approved protocols and in line with facility Standard Operating Procedures (SOPs). Inhibitor <b>2</b> was formulated in 0.5% (w/v) Tween 80 in water and administered by oral gavage at 10 or 50 mg/kg to male cynomolgus monkeys, 2–4 years of age, weighing 1.8–4 kg. Blood samples were collected once during the pretest period (baseline sample). Additional samples were taken at the 4, 7, and 24 h time points after dosing. The serum collection tubes were allowed to clot at room temperature for at least 30 min, then centrifuged, and the serum samples were obtained. Serum was diluted 50% into GVB buffer (Boston Bioproducts) containing 4 mM MgCl<sub>2</sub> and 20 mM EGTA (the final concentrations were 2 and 10 mM, respectively). ELISA plates (black Maxisorp, NUNC) were coated with 1 mg/mL zymosan A (Sigma) in carbonate buffer, pH 9.5 (Sigma). Serum–buffer mixture was transferred to the plate and incubated at 37 °C for 30 min. MAC complex deposited on the plate was detected by 1 h incubation with an alkaline phosphatase-conjugated mouse anti-human C9 neo-epitope monoclonal antibody (clone AE11, Diatec; 0.25 μg/mL). After washing, substrate 4-MUP (Fisher) at 0.18 mg/mL in 0.1 M Tris-HCl (pH 9.0) containing 2 mM MgCl<sub>2</sub> was added, and the plate was incubated for 30 min. Plates were read at 355 nm excitation/460 nm emission wavelengths on a suitable fluorometer. The raw data obtained (in relative fluorescence units, RFU) were exported into GraphPad Prism. The negative control signal (serum plus 25 mM EDTA for complete complement inhibition) was subtracted from all samples for each individual. MAC deposition in each individual animal’s baseline sample was considered to be 100% complement activity for that individual. The MAC deposition in each treated sample from the same individual was determined. Percent ex vivo AP activity was calculated as (baseline RFU – post-treatment RFU) × 100. Alternatively, % inhibition of ex vivo MAC deposition was calculated as [(baseline RFU– post-treatment RFU)/(baseline RFU)] × 100.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00425">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00425" class="ext-link">10.1021/acs.jmedchem.7b00425</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystallographic structure determination of FD in complex with compounds <b>5</b>, <b>7</b>, <b>13</b>, <b>14</b>, <b>18</b>, and <b>2</b>, complement FD thioesterolysis assay, membrane attack complex formation assay in 50% human whole blood or in 50% human or cynomolgus monkey serum, <i>in vivo</i> studies in LPS-induced AP activation in mice expressing human FD, and pharmacokinetic studies for <b>7</b>, Sprague–Dawley rat pharmacokinetic study and ocular PK in Brown Norway rats (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_001.pdf">jm7b00425_si_001.pdf (235.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_002.csv">jm7b00425_si_002.csv (2.97 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of complement Factor D with compounds <b>5</b>, <b>7</b>, <b>13</b>, <b>14</b>, <b>18</b>, and <b>2</b> can be accessed using PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT">5NAT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR">5NAR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW">5NAW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA">5NBA</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6">5NB6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7">5NB7</a>, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00425" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwige Lorthiois</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6147-9321" title="Orcid link">http://orcid.org/0000-0002-6147-9321</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dfbabba8b6b8baf1b3b0adabb7b6b0b6ac9fb1b0a9beadabb6acf1bcb0b2"><span class="__cf_email__" data-cfemail="640100130d03014a080b16100c0d0b0d17240a0b120516100d174a070b09">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Maibaum</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#472d322235202229182c2b263234692a262e2526322a072928312635332e346924282a"><span class="__cf_email__" data-cfemail="751f00100712101b2a1e191400065b18141c17140018351b1a031407011c065b161a18">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Anderson</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Vulpetti</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3114-8679" title="Orcid link">http://orcid.org/0000-0002-3114-8679</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Rogel</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic Cumin</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nils Ostermann</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Steinbacher</span> - <span class="hlFld-Affiliation affiliation">Proteros
Biostructures GmbH, D-82152 Planegg-Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aengus Mac Sweeney</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Omar Delgado</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sha-Mei Liao</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Randl</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Rüdisser</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Solene Dussauge</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamal Fettis</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Kieffer</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea de Erkenez</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis Yang</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Constanze Hartwieg</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Upendra A. Argikar</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0939-0813" title="Orcid link">http://orcid.org/0000-0002-0939-0813</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura R. La Bonte</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald Newton</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viral Kansara</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanie Flohr</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrich Hommel</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Jaffee</span> - <span class="hlFld-Affiliation affiliation">Novartis
Pharma AG, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d172e8283-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Frederic Villard, Corinne Durand, Fabien Tritsch, Mickael Sorge, Celine Dentel, Wendy Lee, Ann Brown, and Jaimie Spear for for their excellent technical assistance, Heiner Schutz for preparation of larger quantities of the isocyanate intermediate, Nathalie Gradoux for IC<sub>50</sub> determinations, and Susanne Glowienke and Wilfried Frieauff for performing the Ames and MNT assays, respectively. R. Sedrani is thanked for continuing helpful discussion.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> Abbreviations</h2><tr><td class="NLM_term">AP</td><td class="NLM_def"><p class="first last">alternative pathway</p></td></tr><tr><td class="NLM_term">FB</td><td class="NLM_def"><p class="first last">factor B</p></td></tr><tr><td class="NLM_term">FD</td><td class="NLM_def"><p class="first last">factor D</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fragment based screening</p></td></tr><tr><td class="NLM_term">MAC</td><td class="NLM_def"><p class="first last">membrane attack complex</p></td></tr><tr><td class="NLM_term">AMD</td><td class="NLM_def"><p class="first last">age-related macular degeneration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajishengallis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Complement: a key system for immune surveillance and homeostasis</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span><span class="refDoi"> DOI: 10.1038/ni.1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fni.1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=20720586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCmtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=785-797&author=D.+Ricklinauthor=G.+Hajishengallisauthor=K.+Yangauthor=J.+D.+Lambris&title=Complement%3A+a+key+system+for+immune+surveillance+and+homeostasis&doi=10.1038%2Fni.1923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Complement: a key system for immune surveillance and homeostasis</span></div><div class="casAuthors">Ricklin, Daniel; Hajishengallis, George; Yang, Kun; Lambris, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-797</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nearly a century after the significance of the human complement system was recognized, we have come to realize that its functions extend far beyond the elimination of microbes.  Complement acts as a rapid and efficient immune surveillance system that has distinct effects on healthy and altered host cells and foreign intruders.  By eliminating cellular debris and infectious microbes, orchestrating immune responses and sending 'danger' signals, complement contributes substantially to homeostasis, but it can also take action against healthy cells if not properly controlled.  This review describes our updated view of the function, structure and dynamics of the complement network, highlights its interconnection with immunity at large and with other endogenous pathways, and illustrates its multiple roles in homeostasis and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx5zRC2bFGqLVg90H21EOLACvtfcHk0linM-dRmi84Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCmtbfO&md5=9fd72883ccfb6bf77b4bdebe82197d11</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni.1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1923%26sid%3Dliteratum%253Aachs%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DHajishengallis%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DComplement%253A%2520a%2520key%2520system%2520for%2520immune%2520surveillance%2520and%2520homeostasis%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D785%26epage%3D797%26doi%3D10.1038%2Fni.1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zarkadis, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastellos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Phylogenetic aspects of the complement system</span> <span class="citation_source-journal">Dev. Comp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1016/S0145-305X(01)00034-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS0145-305X%2801%2900034-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=745-762&author=I.+K.+Zarkadisauthor=D.+Mastellosauthor=J.+D.+Lambris&title=Phylogenetic+aspects+of+the+complement+system&doi=10.1016%2FS0145-305X%2801%2900034-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0145-305X%2801%2900034-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-305X%252801%252900034-9%26sid%3Dliteratum%253Aachs%26aulast%3DZarkadis%26aufirst%3DI.%2BK.%26aulast%3DMastellos%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DPhylogenetic%2520aspects%2520of%2520the%2520complement%2520system%26jtitle%3DDev.%2520Comp.%2520Immunol.%26date%3D2001%26volume%3D25%26spage%3D745%26epage%3D762%26doi%3D10.1016%2FS0145-305X%2801%2900034-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Complement-targeted therapeutics</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1038/nbt1342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnbt1342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1265-1275&author=D.+Ricklinauthor=J.+D.+Lambris&title=Complement-targeted+therapeutics&doi=10.1038%2Fnbt1342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnbt1342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1342%26sid%3Dliteratum%253Aachs%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DComplement-targeted%2520therapeutics%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1265%26epage%3D1275%26doi%3D10.1038%2Fnbt1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Complement factor D, a novel serine protease</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1002/pro.5560050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fpro.5560050401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=8845746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=553-564&author=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Complement+factor+D%2C+a+novel+serine+protease&doi=10.1002%2Fpro.5560050401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D, a novel serine protease</span></div><div class="casAuthors">Volanakis, John E.; Narayana, Sthanam V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with many refs.  Factor D is unique among serine proteases in that it requires neither enzymic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control.  Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity.  These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations.  Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-WO4fTyq7LVg90H21EOLACvtfcHk0linM-dRmi84Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D&md5=d55e7afa5c827b02023dd94994690eaa</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560050401%26sid%3Dliteratum%253Aachs%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DComplement%2520factor%2520D%252C%2520a%2520novel%2520serine%2520protease%26jtitle%3DProtein%2520Sci.%26date%3D1996%26volume%3D5%26spage%3D553%26epage%3D564%26doi%3D10.1002%2Fpro.5560050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Structures of native and complexed complement factor D: Implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1081</span><span class="refDoi"> DOI: 10.1006/jmbi.1998.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1006%2Fjmbi.1998.2089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1061-1081&author=H.+Jingauthor=Y.+S.+Babuauthor=D.+Mooreauthor=J.+M.+Kilpatrickauthor=X.-Y.+Liuauthor=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Structures+of+native+and+complexed+complement+factor+D%3A+Implications+of+the+atypical+His57+conformation+and+self-inhibitory+loop+in+the+regulation+of+specific+serine+protease+activity&doi=10.1006%2Fjmbi.1998.2089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2089%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DH.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DKilpatrick%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DX.-Y.%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DStructures%2520of%2520native%2520and%2520complexed%2520complement%2520factor%2520D%253A%2520Implications%2520of%2520the%2520atypical%2520His57%2520conformation%2520and%2520self-inhibitory%2520loop%2520in%2520the%2520regulation%2520of%2520specific%2520serine%2520protease%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D282%26spage%3D1061%26epage%3D1081%26doi%3D10.1006%2Fjmbi.1998.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span><span class="refDoi"> DOI: 10.1093/emboj/18.4.804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1093%2Femboj%2F18.4.804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=804-814&author=H.+Jingauthor=K.+J.+Maconauthor=D.+Mooreauthor=L.+J.+DeLucasauthor=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Structural+basis+of+profactor+D+activation%3A+from+a+highly+flexible+zymogen+to+a+novel+self-inhibited+serine+protease%2C+complement+factor+D&doi=10.1093%2Femboj%2F18.4.804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.4.804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.4.804%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DH.%26aulast%3DMacon%26aufirst%3DK.%2BJ.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DDeLucas%26aufirst%3DL.%2BJ.%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DStructural%2520basis%2520of%2520profactor%2520D%2520activation%253A%2520from%2520a%2520highly%2520flexible%2520zymogen%2520to%2520a%2520novel%2520self-inhibited%2520serine%2520protease%252C%2520complement%2520factor%2520D%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D804%26epage%3D814%26doi%3D10.1093%2Femboj%2F18.4.804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Taylor, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bixler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budman, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpusas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safari-Fard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">Induced fit activation mechanism of the exceptionally specific serine protease, Complement Factor D</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">–</span> <span class="NLM_lpage">2859</span><span class="refDoi"> DOI: 10.1021/bi982140f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi982140f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2849-2859&author=F.+R.+Taylorauthor=S.+A.+Bixlerauthor=J.+I.+Budmanauthor=D.+Wenauthor=M.+Karpusasauthor=S.+T.+Ryanauthor=G.+J.+Jaworskiauthor=A.+Safari-Fardauthor=S.+Pollardauthor=A.+Whitty&title=Induced+fit+activation+mechanism+of+the+exceptionally+specific+serine+protease%2C+Complement+Factor+D&doi=10.1021%2Fbi982140f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fbi982140f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982140f%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DF.%2BR.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DBudman%26aufirst%3DJ.%2BI.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DS.%2BT.%26aulast%3DJaworski%26aufirst%3DG.%2BJ.%26aulast%3DSafari-Fard%26aufirst%3DA.%26aulast%3DPollard%26aufirst%3DS.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DInduced%2520fit%2520activation%2520mechanism%2520of%2520the%2520exceptionally%2520specific%2520serine%2520protease%252C%2520Complement%2520Factor%2520D%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D2849%26epage%3D2859%26doi%3D10.1021%2Fbi982140f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Forneris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzekou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span> </span><span class="NLM_article-title">Structures of C3b in complex with factors B and D give insight into complement convertase formation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1816</span><span class="NLM_x">–</span> <span class="NLM_lpage">1820</span><span class="refDoi"> DOI: 10.1126/science.1195821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1126%2Fscience.1195821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21205667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2jtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1816-1820&author=F.+Fornerisauthor=D.+Ricklinauthor=J.+Wuauthor=A.+Tzekouauthor=R.+S.+Wallaceauthor=J.+D.+Lambrisauthor=P.+Gros&title=Structures+of+C3b+in+complex+with+factors+B+and+D+give+insight+into+complement+convertase+formation&doi=10.1126%2Fscience.1195821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation</span></div><div class="casAuthors">Forneris, Federico; Ricklin, Daniel; Wu, Jin; Tzekou, Apostolia; Wallace, Rachel S.; Lambris, John D.; Gros, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6012</span>),
    <span class="NLM_cas:pages">1816-1820</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of the complement cascade induces inflammatory responses and marks cells for immune clearance.  In the central complement-amplification step, a complex consisting of surface-bound C3b and factor B is cleaved by factor D to generate active convertases on targeted surfaces.  We present crystal structures of the pro-convertase C3bB at 4 angstrom resoln. and its complex with factor D at 3.5 angstrom resoln.  Our data show how factor B binding to C3b forms an open "activation" state of C3bB.  Factor D specifically binds the open conformation of factor B through a site distant from the catalytic center and is activated by the substrate, which displaces factor D's self-inhibitory loop.  This concerted proteolytic mechanism, which is cofactor-dependent and substrate-induced, restricts complement amplification to C3b-tagged target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0MfnHYjx4LLVg90H21EOLACvtfcHk0liVkYq29b3x2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2jtbvK&md5=8b9967b841de551442fa949d7ab7bab8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1195821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1195821%26sid%3Dliteratum%253Aachs%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DTzekou%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DR.%2BS.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26aulast%3DGros%26aufirst%3DP.%26atitle%3DStructures%2520of%2520C3b%2520in%2520complex%2520with%2520factors%2520B%2520and%2520D%2520give%2520insight%2520into%2520complement%2520convertase%2520formation%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1816%26epage%3D1820%26doi%3D10.1126%2Fscience.1195821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fettis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussauge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span> </span><span class="NLM_article-title">Small-molecule factor D inhibitors targeting the alternative complement pathway</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span><span class="refDoi"> DOI: 10.1038/nchembio.2208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnchembio.2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=27775713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1105-1110&author=J.+Maibaumauthor=S.-M.+Liaoauthor=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=S.+Rudisserauthor=E.+Lorthioisauthor=P.+Erbelauthor=B.+Kinzelauthor=F.+A.+Kolbauthor=S.+Barbieriauthor=J.+Wagnerauthor=C.+Durandauthor=K.+Fettisauthor=S.+Dussaugeauthor=N.+Hughesauthor=O.+Delgadoauthor=U.+Hommelauthor=T.+Gouldauthor=A.+Mac+Sweeneyauthor=B.+Gerhartzauthor=F.+Cuminauthor=S.+Flohrauthor=A.+Schubartauthor=B.+Jaffeeauthor=R.+Harrisonauthor=A.+M.+Risitanoauthor=J.+Ederauthor=K.+Anderson&title=Small-molecule+factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1038%2Fnchembio.2208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule factor D inhibitors targeting the alternative complement pathway</span></div><div class="casAuthors">Maibaum, Jurgen; Liao, Sha-Mei; Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Kolb, Fabrice A.; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Delgado, Omar; Hommel, Ulrich; Gould, Ty; Mac Sweeney, Aengus; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Jaffee, Bruce; Harrison, Richard; Risitano, Antonio Maria; Eder, Jorg; Anderson, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1105-1110</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Complement is a key component of the innate immune system, recognizing pathogens and promoting their elimination.  Complement component 3 (C3) is the central component of the system.  Activation of C3 can be initiated by three distinct routes-the classical, the lectin and the alternative pathways-with the alternative pathway also acting as an amplification loop for the other two pathways.  The protease factor D (FD) is essential for this amplification process, which, when dysregulated, predisposes individuals to diverse disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH).  Here the authors describe the identification of potent and selective small-mol. inhibitors of FD.  These inhibitors efficiently block alternative pathway (AP) activation and prevent both C3 deposition onto, and lysis of, PNH erythrocytes.  Their oral administration inhibited lipopolysaccharide-induced AP activation in FD-humanized mice.  These data demonstrate the feasibility of inhibiting the AP with small-mol. antagonists and support the development of FD inhibitors for the treatment of complement-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28_wznUz9QLVg90H21EOLACvtfcHk0lhpPPWeJMGh2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P&md5=270ea1f129b3e25c22680e74f82ffc36</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2208%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DKolb%26aufirst%3DF.%2BA.%26aulast%3DBarbieri%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26atitle%3DSmall-molecule%2520factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1105%26epage%3D1110%26doi%3D10.1038%2Fnchembio.2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüdisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Structure-based library design and fragment screening for the identification of reversible complement Factor D protease inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1958</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1946-1958&author=A.+Vulpettiauthor=S.+Randlauthor=S.+R%C3%BCdisserauthor=N.+Ostermannauthor=P.+Erbelauthor=A.+Mac+Sweeneyauthor=T.+Zollerauthor=B.+Salemauthor=B.+Gerhartzauthor=F.+Cuminauthor=U.+Hommelauthor=C.+Dalvitauthor=E.+Lorthioisauthor=J.+Maibaum&title=Structure-based+library+design+and+fragment+screening+for+the+identification+of+reversible+complement+Factor+D+protease+inhibitors&doi=10.1021%2Facs.jmedchem.6b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors</span></div><div class="casAuthors">Vulpetti, Anna; Randl, Stefan; Rudisser, Simon; Ostermann, Nils; Erbel, Paul; Mac Sweeney, Aengus; Zoller, Thomas; Salem, Bahaa; Gerhartz, Bernd; Cumin, Frederic; Hommel, Ulrich; Dalvit, Claudio; Lorthiois, Edwige; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1958</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic dysregulation of alternative complement pathway activation has been assocd. with diverse clin. disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinurea.  Factor D is a trypsin-like serine protease with a narrow specificity for arginine in the P1 position, which catalyzes the first enzymic reaction of the amplification loop of the alternative pathway.  In this paper, the authors describe two hit finding approaches leading to the discovery of new chem. matter for this pivotal protease of the complement system: in silico active site mapping for hot spots identification to guide rational structure-based design and NMR screening of focused and diverse fragment libraries.  The wealth of information gathered by these complementary approaches enabled the identification of ligands binding to different sub-pockets of the latent Factor D conformation and was instrumental for understanding the binding requirements for the generation of the first known potent noncovalent reversible Factor D inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPFgFvVDvCyrVg90H21EOLACvtfcHk0lhpPPWeJMGh2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D&md5=179ea6dc5fb9ccb60931da60f23e6381</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01684%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DS.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DStructure-based%2520library%2520design%2520and%2520fragment%2520screening%2520for%2520the%2520identification%2520of%2520reversible%2520complement%2520Factor%2520D%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1946%26epage%3D1958%26doi%3D10.1021%2Facs.jmedchem.6b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Morikis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Structural aspects and design of low-molecular-mass complement inhibitors</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1042/bst0301026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1042%2Fbst0301026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=12440966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=1026-1036&author=D.+Morikisauthor=J.+D.+Lambris&title=Structural+aspects+and+design+of+low-molecular-mass+complement+inhibitors&doi=10.1042%2Fbst0301026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects and design of low-molecular-mass complement inhibitors</span></div><div class="casAuthors">Morikis, D.; Lambris, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1026-1036</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  We present a mini-review on the structure-based design of three promising complement inhibitors.  Firstly, we review compstatin, a 13-residue cyclic peptide that binds to C3 and inhibits the cleavage of C3 to C3a and C3b.  Secondly, we review a six-residue cyclic peptide that binds to C5aR and antagonizes the binding of C5a to its receptor C5aR.  Finally, we review three small mols. that bind to Factor D and inhibit the enzymic action of Factor D, during which Factor D proteolytically cleaves Factor B in complex with C3 or C3b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHnN6gQihz2rVg90H21EOLACvtfcHk0lhpPPWeJMGh2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2isb8%253D&md5=02ac5a9db829994c0e512aaeea0d7e2c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2Fbst0301026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0301026%26sid%3Dliteratum%253Aachs%26aulast%3DMorikis%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DStructural%2520aspects%2520and%2520design%2520of%2520low-molecular-mass%2520complement%2520inhibitors%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2002%26volume%3D30%26spage%3D1026%26epage%3D1036%26doi%3D10.1042%2Fbst0301026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Katschke, K. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hass, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Lookeren Campagne, M.</span><span> </span><span class="NLM_article-title">Inhibiting alternative pathway complement activation by targeting the factor D exosite</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">12886</span><span class="NLM_x">–</span> <span class="NLM_lpage">12892</span><span class="refDoi"> DOI: 10.1074/jbc.M112.345082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1074%2Fjbc.M112.345082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=12886-12892&author=K.+J.+Katschkeauthor=P.+Wuauthor=R.+Ganesanauthor=R.+F.+Kelleyauthor=M.+A.+Mathieuauthor=P.+E.+Hassauthor=J.+Murrayauthor=D.+Kirchhoferauthor=C.+Wiesmannauthor=M.+van+Lookeren+Campagne&title=Inhibiting+alternative+pathway+complement+activation+by+targeting+the+factor+D+exosite&doi=10.1074%2Fjbc.M112.345082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.345082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.345082%26sid%3Dliteratum%253Aachs%26aulast%3DKatschke%26aufirst%3DK.%2BJ.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DR.%2BF.%26aulast%3DMathieu%26aufirst%3DM.%2BA.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3Dvan%2BLookeren%2BCampagne%26aufirst%3DM.%26atitle%3DInhibiting%2520alternative%2520pathway%2520complement%2520activation%2520by%2520targeting%2520the%2520factor%2520D%2520exosite%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D12886%26epage%3D12892%26doi%3D10.1074%2Fjbc.M112.345082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mastellos, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancopoulou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkinos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber-Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajishengallis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biglarnia, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1111/eci.12419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1111%2Feci.12419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25678219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=423-440&author=D.+C.+Mastellosauthor=D.+Yancopoulouauthor=P.+Kokkinosauthor=M.+Huber-Langauthor=G.+Hajishengallisauthor=A.+R.+Biglarniaauthor=F.+Lupuauthor=B.+Nilssonauthor=A.+M.+Risitanoauthor=D.+Ricklinauthor=J.+D.+Lambris&title=Compstatin%3A+a+C3-targeted+complement+inhibitor+reaching+its+prime+for+bedside+intervention&doi=10.1111%2Feci.12419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention</span></div><div class="casAuthors">Mastellos, Dimitrios C.; Yancopoulou, Despina; Kokkinos, Petros; Huber-Lang, Markus; Hajishengallis, George; Biglarnia, Ali R.; Lupu, Florea; Nilsson, Bo; Risitano, Antonio M.; Ricklin, Daniel; Lambris, John D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-440</span>CODEN:
                <span class="NLM_cas:coden">EJCIB8</span>;
        ISSN:<span class="NLM_cas:issn">0014-2972</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There is a growing awareness that complement plays an integral role in human physiol. and disease, transcending its traditional perception as an accessory system for pathogen clearance and opsonic cell killing.  As the list of pathologies linked to dysregulated complement activation grows longer, it has become clear that targeted modulation of this innate immune system opens new windows of therapeutic opportunity for anti-inflammatory drug design.  Indeed, the introduction of the first complement-targeting drugs has reignited a vibrant interest in the clin. translation of complement-based inhibitors.  Compstatin was discovered as a cyclic peptide that inhibits complement activation by binding C3 and interfering with convertase formation and C3 cleavage.  As the convergence point of all activation pathways and a mol. hub for crosstalk with multiple pathogenic pathways, C3 represents an attractive target for therapeutic modulation of the complement cascade.  A multidisciplinary drug optimization effort encompassing rational 'wet' and in silico synthetic approaches and an array of biophys., structural and anal. tools has culminated in an impressive structure-function refinement of compstatin, yielding a series of analogs that show promise for a wide spectrum of clin. applications.  These new derivs. have improved inhibitory potency and pharmacokinetic profiles and show efficacy in clin. relevant primate models of disease.  This review provides an up-to-date survey of the drug design effort placed on the compstatin family of C3 inhibitors, highlighting the most promising drug candidates.  It also discusses translational challenges in complement drug discovery and peptide drug development and reviews concerns related to systemic C3 interception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXFg7iERaJbVg90H21EOLACvtfcHk0lhB5oa9-aOX7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKjt74%253D&md5=81d73c3a2f7b39c9ae7415d466c7b294</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Feci.12419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Feci.12419%26sid%3Dliteratum%253Aachs%26aulast%3DMastellos%26aufirst%3DD.%2BC.%26aulast%3DYancopoulou%26aufirst%3DD.%26aulast%3DKokkinos%26aufirst%3DP.%26aulast%3DHuber-Lang%26aufirst%3DM.%26aulast%3DHajishengallis%26aufirst%3DG.%26aulast%3DBiglarnia%26aufirst%3DA.%2BR.%26aulast%3DLupu%26aufirst%3DF.%26aulast%3DNilsson%26aufirst%3DB.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DCompstatin%253A%2520a%2520C3-targeted%2520complement%2520inhibitor%2520reaching%2520its%2520prime%2520for%2520bedside%2520intervention%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D45%26spage%3D423%26epage%3D440%26doi%3D10.1111%2Feci.12419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavriilaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanassi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podos, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, R. A.</span><span> </span><span class="NLM_article-title">Small-molecule Factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span><span class="refDoi"> DOI: 10.3324/haematol.2016.153312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.3324%2Fhaematol.2016.153312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2017&pages=466-475&author=X.+Yuanauthor=E.+Gavriilakiauthor=A.+C.+Bainesauthor=J.+A.+Thanassiauthor=G.+Yangauthor=S.+D.+Podosauthor=Y.+Huangauthor=M.+Huangauthor=R.+A.+Brodsky&title=Small-molecule+Factor+D+inhibitors+selectively+block+the+alternative+pathway+of+complement+in+paroxysmal+nocturnal+hemoglobinuria+and+atypical+hemolytic+uremic+syndrome&doi=10.3324%2Fhaematol.2016.153312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2016.153312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2016.153312%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DGavriilaki%26aufirst%3DE.%26aulast%3DBaines%26aufirst%3DA.%2BC.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DBrodsky%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520Factor%2520D%2520inhibitors%2520selectively%2520block%2520the%2520alternative%2520pathway%2520of%2520complement%2520in%2520paroxysmal%2520nocturnal%2520hemoglobinuria%2520and%2520atypical%2520hemolytic%2520uremic%2520syndrome%26jtitle%3DHaematologica%26date%3D2017%26volume%3D102%26spage%3D466%26epage%3D475%26doi%3D10.3324%2Fhaematol.2016.153312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.9997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands&doi=10.1073%2Fpnas.96.18.9997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lhB5oa9-aOX7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002%26doi%3D10.1073%2Fpnas.96.18.9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZcPdZThe0dRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J. T.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1016/S1359-6446(05)03386-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery&doi=10.1016%2FS1359-6446%2805%2903386-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eZcPdZThe0dRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469%26doi%3D10.1016%2FS1359-6446%2805%2903386-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The role of molecular size in ligand efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+role+of+molecular+size+in+ligand+efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0lihVYw8Ac-amQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520role%2520of%2520molecular%2520size%2520in%2520ligand%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug+like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljV9RRJxDp0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug%2520like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of binding efficiencies of drugs and their leads in successful drug discovery programs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Analysis of the Binding Efficiencies of Drugs and their Leads in Successful Drug Discovery Programs</span></div><div class="casAuthors">Perola, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2986-2997</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to investigate the evolution of binding efficiency in successful drug discovery programs, a data set of 60 lead/drug pairs with known binding affinities has been compiled and analyzed.  Low-end thresholds for the binding efficiencies of viable leads and drugs have been derived.  On av., the drugs in the set are significantly larger and more potent but have similar lipophilicity relative to their originating leads, suggesting that the ability to maintain low levels of lipophilicity while increasing mol. wt. is one of the keys to a successful drug discovery program.  A no. of examples demonstrate that large increases in binding efficiency from leads to more elaborate drugs sharing the same scaffold can be achieved.  The importance of dissecting a lead structure to identify the most efficient fragments and the option of sacrificing binding efficiency to optimize other properties are discussed, and relevant examples are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRqzYFBuX2Q7Vg90H21EOLACvtfcHk0ljV9RRJxDp0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D&md5=a7eaad792f1518d093588951df64d22f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljV9RRJxDp0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shultz, M. D.</span><span> </span><span class="NLM_article-title">The thermodynamic basis for the use of lipophilic efficiency in enthalpic optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5992</span><span class="NLM_x">–</span> <span class="NLM_lpage">6000</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2013.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=24054120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5992-6000&author=M.+D.+Shultz&title=The+thermodynamic+basis+for+the+use+of+lipophilic+efficiency+in+enthalpic+optimization&doi=10.1016%2Fj.bmcl.2013.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5992-6000</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Approaches to improve the efficiency of mol. optimizations have received great attention and numerous efficiency metrics have been introduced to assist in this effort.  Optimization of properties is equally important to optimization of potency and therefore these metrics contain potency vs. property calcns.  Widespread use of a metric does not guarantee its accuracy and a further understanding of which, if any, metric increases the probability of success was sought.  An anal. of LE, LELP and LipE based on theor. and exptl. data was performed demonstrating that LipE most strongly correlates with compd. quality as defined by enthalpy-driven binding.  The basis for the prioritization of LipE over other metrics in enthalpic optimizations is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuMO74LdKnbVg90H21EOLACvtfcHk0ljZ1u0s-Ck4fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P&md5=23d948d1135eeefdfebc60846f28ec2b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DThe%2520thermodynamic%2520basis%2520for%2520the%2520use%2520of%2520lipophilic%2520efficiency%2520in%2520enthalpic%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5992%26epage%3D6000%26doi%3D10.1016%2Fj.bmcl.2013.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Escobar, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowienke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galloway, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, B.</span><span> </span><span class="NLM_article-title">Bacterial mutagenicity screening in the pharmaceutical industry</span> <span class="citation_source-journal">Mutat. Res., Rev. Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">752</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.mrrev.2012.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.mrrev.2012.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvV2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=752&publication_year=2013&pages=99-118&author=P.+A.+Escobarauthor=R.+A.+Kemperauthor=J.+Tarcaauthor=J.+Nicoletteauthor=M.+Kenyonauthor=S.+Glowienkeauthor=S.+G.+Sawantauthor=J.+Christensenauthor=T.+E.+Johnsonauthor=C.+McKnightauthor=G.+Wardauthor=S.+M.+Gallowayauthor=L.+Custerauthor=E.+Gockeauthor=M.+R.+O%E2%80%99Donovanauthor=K.+Braunauthor=R.+D.+Snyderauthor=B.+Mahadevan&title=Bacterial+mutagenicity+screening+in+the+pharmaceutical+industry&doi=10.1016%2Fj.mrrev.2012.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial mutagenicity screening in the pharmaceutical industry</span></div><div class="casAuthors">Escobar, P. A.; Kemper, R. A.; Tarca, J.; Nicolette, J.; Kenyon, M.; Glowienke, S.; Sawant, S. G.; Christensen, J.; Johnson, T. E.; McKnight, C.; Ward, G.; Galloway, S. M.; Custer, L.; Gocke, E.; O'Donovan, M. R.; Braun, K.; Snyder, R. D.; Mahadevan, B.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">752</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-118</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Genetic toxicity testing is used as an early surrogate for carcinogenicity testing.  Genetic toxicity testing is also required by regulatory agencies to be conducted prior to initiation of first in human clin. trials and subsequent marketing for most small mol. pharmaceutical compds.  To reduce the chances of advancing mutagenic pharmaceutical candidates through the drug discovery and development processes, companies have focused on developing testing strategies to maximize hazard identification while minimizing resource expenditure due to late stage attrition.  With a large no. of testing options, consensus has not been reached on the best mutagenicity platform to use or on the best time to use a specific test to aid in the selection of drug candidates for development.  Most companies use a process in which compds. are initially screened for mutagenicity early in drug development using tests that require only a few milligrams of compd. and then follow those studies up with a more robust mutagenicity test prior to selecting a compd. for full development.This review summarizes the current applications of bacterial mutagenicity assays utilized by pharmaceutical companies in early and late discovery programs.  The initial impetus for this review was derived from a workshop on bacterial mutagenicity screening in the pharmaceutical industry presented at the 40th Annual Environmental Mutagen Society Meeting held in St. Louis, MO in Oct., 2009.  However, included in this review are succinct summaries of use and interpretation of genetic toxicity assays, several mutagenicity assays that were not presented at the meeting, and updates to testing strategies resulting in current state-of the art description of best practices.  In addn., here we discuss the advantages and liabilities of many broadly used mutagenicity screening platforms and strategies used by pharmaceutical companies.  The sensitivity and specificity of these early mutagenicity screening assays using proprietary compds. and their concordance (predictivity) with the regulatory bacterial mutation test are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUdQuOZSGkLVg90H21EOLACvtfcHk0ljZ1u0s-Ck4fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvV2ksg%253D%253D&md5=9fd2eeed7c14cfeb833491c751854623</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.mrrev.2012.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrrev.2012.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DEscobar%26aufirst%3DP.%2BA.%26aulast%3DKemper%26aufirst%3DR.%2BA.%26aulast%3DTarca%26aufirst%3DJ.%26aulast%3DNicolette%26aufirst%3DJ.%26aulast%3DKenyon%26aufirst%3DM.%26aulast%3DGlowienke%26aufirst%3DS.%26aulast%3DSawant%26aufirst%3DS.%2BG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DG.%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26aulast%3DCuster%26aufirst%3DL.%26aulast%3DGocke%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BR.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DSnyder%26aufirst%3DR.%2BD.%26aulast%3DMahadevan%26aufirst%3DB.%26atitle%3DBacterial%2520mutagenicity%2520screening%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DMutat.%2520Res.%252C%2520Rev.%2520Mutat.%2520Res.%26date%3D2013%26volume%3D752%26spage%3D99%26epage%3D118%26doi%3D10.1016%2Fj.mrrev.2012.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Frieauff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martus, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhajouji, A.</span><span> </span><span class="NLM_article-title">Automatic analysis of the micronucleus test in primary human lymphocytes using image analysis</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1093/mutage/ges047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1093%2Fmutage%2Fges047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=15-23&author=W.+Frieauffauthor=H.+J.+Martusauthor=W.+Suterauthor=A.+Elhajouji&title=Automatic+analysis+of+the+micronucleus+test+in+primary+human+lymphocytes+using+image+analysis&doi=10.1093%2Fmutage%2Fges047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fges047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fges047%26sid%3Dliteratum%253Aachs%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DMartus%26aufirst%3DH.%2BJ.%26aulast%3DSuter%26aufirst%3DW.%26aulast%3DElhajouji%26aufirst%3DA.%26atitle%3DAutomatic%2520analysis%2520of%2520the%2520micronucleus%2520test%2520in%2520primary%2520human%2520lymphocytes%2520using%2520image%2520analysis%26jtitle%3DMutagenesis%26date%3D2013%26volume%3D28%26spage%3D15%26epage%3D23%26doi%3D10.1093%2Fmutage%2Fges047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0ljsBxSu6MwVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Böhm, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.-J.+B%C3%B6hmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+M%C3%BCllerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2eanELC_atEJFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.-J.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+M%C3%BCllerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceuticals: Looking Beyond Intuition</span></div><div class="casAuthors">Mueller, Klaus; Faeh, Christoph; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-1886</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all phys. and adsorption, distribution, metab., and excretion properties of a lead compd.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on mol. conformation of the drug, has only recently begun.  Here, we review exptl. progress in this vein and add complementary anal. based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwX-YnONRc3LVg90H21EOLACvtfcHk0ljsBxSu6MwVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN&md5=f804876c801518e48d0bdb7d87b7fb1c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span> </span><span class="NLM_article-title">Fluorine in drug design: A case study with fluoroanisoles</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1002/cmdc.201402555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcmdc.201402555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25755132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=715-726&author=L.+Xingauthor=D.+C.+Blakemoreauthor=A.+Narayananauthor=R.+Unwallaauthor=F.+Loveringauthor=R.+A.+Dennyauthor=H.+Zhouauthor=M.+E.+Bunnage&title=Fluorine+in+drug+design%3A+A+case+study+with+fluoroanisoles&doi=10.1002%2Fcmdc.201402555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Drug Design: A Case Study with Fluoroanisoles</span></div><div class="casAuthors">Xing, Li; Blakemore, David C.; Narayanan, Arjun; Unwalla, Ray; Lovering, Frank; Denny, R. Aldrin; Zhou, Huanyu; Bunnage, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Anisole and fluoroanisoles display distinct conformational preferences, as evident from a survey of their crystal structures.  In addn. to altering the free ligand conformation, various degrees of fluorination have a strong impact on physicochem. and pharmacokinetic properties.  Anal. of anisole and fluoroanisole matched mol. pairs in the Pfizer corporate database reveals interesting trends: (1) PhOCF3 increases log D by ∼1 log unit over PhOCH3 compds.; (2) PhOCF3 shows lower passive permeability despite its higher lipophilicity; and (3) PhOCF3 does not appreciably improve metabolic stability over PhOCH3.  Emerging from the investigation, difluoroanisole (PhOCF2H) strikes a better balance of properties with noticeable advantages of log D and transcellular permeability over PhOCF3.  Synthetic assessment illustrates that the routes to access difluoroanisoles are often more straightforward than those for trifluoroanisoles.  Whereas replacing PhOCH3 with PhOCF3 is a common tactic to optimize ADME properties, the anal. suggests PhOCF2H may be a more attractive alternative, and greater exploitation of this motif is recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4j7y_ly3TGrVg90H21EOLACvtfcHk0ljsBxSu6MwVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWku7Y%253D&md5=45dbead703594c31581cc6c7e62d1b81</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402555%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DFluorine%2520in%2520drug%2520design%253A%2520A%2520case%2520study%2520with%2520fluoroanisoles%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D715%26epage%3D726%26doi%3D10.1002%2Fcmdc.201402555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">–</span> <span class="NLM_lpage">16794</span><span class="refDoi"> DOI: 10.1073/pnas.0407607101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules&doi=10.1073%2Fpnas.0407607101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-X···O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the X···O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Å for Cl···O, 3.37 Å for Br···O, and 3.50 Å for I···O) and can conform to the geometry seen in small mols., with the C-X···O angle ≈165° (consistent with a strong directional polarization of the halogen) and the X···O-Y angle ≈120°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized π-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0ljhgWzL7SBySw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794%26doi%3D10.1073%2Fpnas.0407607101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Voth, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds as orthogonal molecular interactions to hydrogen bonds</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1038/nchem.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnchem.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21378804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlSlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=74-79&author=A.+R.+Vothauthor=P.+Khuuauthor=K.+Oishiauthor=P.+S.+Ho&title=Halogen+bonds+as+orthogonal+molecular+interactions+to+hydrogen+bonds&doi=10.1038%2Fnchem.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds as orthogonal molecular interactions to hydrogen bonds</span></div><div class="casAuthors">Voth, Andrea Regier; Khuu, Patricia; Oishi, Keita; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Halogen bonds (X-bonds) are shown to be geometrically perpendicular to and energetically independent of hydrogen bonds (H-bonds) that share a common carbonyl oxygen acceptor.  This orthogonal relationship is accommodated by the in-plane and out-of-plane electroneg. potentials of the oxygen, which are differentially populated by H- and X-bonds.  Furthermore, the local conformation of a peptide helps to define the geometry of the H-bond and thus the oxygen surface that is accessible for X-bonding.  These electrostatic and steric forces conspire to impose a strong preference for the orthogonal geometry of X- and H-bonds.  Thus, the optimum geometry of an X-bond can be predicted from the pattern of H-bonds in a folded protein, enabling X-bonds to be introduced to improve ligand affinities without disrupting these structurally important interactions.  This concept of orthogonal mol. interactions can be exploited for the rational design of halogenated ligands as inhibitors and drugs, and in biomol. engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBR3qQ1-IvprVg90H21EOLACvtfcHk0ljhgWzL7SBySw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlSlsb4%253D&md5=fd9ef235df86c00261b9bd0a782f88c2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchem.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.112%26sid%3Dliteratum%253Aachs%26aulast%3DVoth%26aufirst%3DA.%2BR.%26aulast%3DKhuu%26aufirst%3DP.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520as%2520orthogonal%2520molecular%2520interactions%2520to%2520hydrogen%2520bonds%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D74%26epage%3D79%26doi%3D10.1038%2Fnchem.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0ljhgWzL7SBySw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Parisini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metrangolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terraneo, G.</span><span> </span><span class="NLM_article-title">Halogen bonding in halocarbon–protein complexes: a structural survey</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span><span class="refDoi"> DOI: 10.1039/c0cs00177e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1039%2Fc0cs00177e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21365086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVWju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=2267-2278&author=E.+Parisiniauthor=P.+Metrangoloauthor=T.+Pilatiauthor=G.+Resnatiauthor=G.+Terraneo&title=Halogen+bonding+in+halocarbon%E2%80%93protein+complexes%3A+a+structural+survey&doi=10.1039%2Fc0cs00177e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonding in halocarbon-protein complexes: a structural survey</span></div><div class="casAuthors">Parisini, Emilio; Metrangolo, Pierangelo; Pilati, Tullio; Resnati, Giuseppe; Terraneo, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2267-2278</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Halogen bonding was extensively described in the context of a variety of self-assembled supramol. systems and efficiently used in the rational design of materials with specific structural properties.  However, it has so far received only little recognition for its possible role in the stabilization of small mol.-protein complexes.  In this tutorial review, the authors provide a few examples of halogen bonds occurring between small halogen-substituted ligands and their biol. substrates.  Examples were drawn from a diverse set of compds., ranging from chem. additives and possible environmental agents such as triclosan to pharmacol. active principles such as the volatile anesthetic halothane or HIV-1 reverse transcriptase inhibitors or a subset of nonsteroidal antiinflammatory drugs (NSAIDs) that are halogen-substituted.  The crystal structures presented here, where iodine, bromine, or chlorine atoms function as halogen bonding donors and a variety of electron rich sites, such as oxygen, nitrogen and sulfur atoms, as well as arom. π-electron systems, function as halogen bonding acceptors, prove how halogen bonds can occur in biol. systems and provide a class of highly directional stabilizing contacts that can be exploited in the process of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7H2tafSt7bVg90H21EOLACvtfcHk0ljWeBhzEDXBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVWju7g%253D&md5=a5834e03eecc4d8b32acf6149f3a1b81</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0cs00177e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cs00177e%26sid%3Dliteratum%253Aachs%26aulast%3DParisini%26aufirst%3DE.%26aulast%3DMetrangolo%26aufirst%3DP.%26aulast%3DPilati%26aufirst%3DT.%26aulast%3DResnati%26aufirst%3DG.%26aulast%3DTerraneo%26aufirst%3DG.%26atitle%3DHalogen%2520bonding%2520in%2520halocarbon%25E2%2580%2593protein%2520complexes%253A%2520a%2520structural%2520survey%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D2267%26epage%3D2278%26doi%3D10.1039%2Fc0cs00177e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span> </span><span class="NLM_article-title">Intermolecular and intramolecular hydrogen bonds involving fluorine atoms: Implications for recognition, selectivity, and chemical properties</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1002/cmdc.201100483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcmdc.201100483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=22262517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=262-272&author=C.+Dalvitauthor=A.+Vulpetti&title=Intermolecular+and+intramolecular+hydrogen+bonds+involving+fluorine+atoms%3A+Implications+for+recognition%2C+selectivity%2C+and+chemical+properties&doi=10.1002%2Fcmdc.201100483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties</span></div><div class="casAuthors">Dalvit, Claudio; Vulpetti, Anna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A correlation between 19F NMR isotropic chem. shift and close intermol. F···H-X contacts (with X = N or O) has been identified upon anal. of the X-ray crystal structures of fluorinated mols. listed in the Cambridge Structural Database (CSD).  An optimal F···X distance involving primary and shielded secondary fluorine atoms in hydrogen-bond formation along with a correlation between F···H distance and F···H-X angle were also derived from the anal.  The hydrogen bonds involving fluorine are relevant, not only for the recognition mechanism and stabilization of a preferred conformation, but also for improvement in the permeability of the mols., as shown with examples taken from a proprietary database.  Results of an anal. of the small no. of fluorine-contg. natural products listed in the Protein Data Bank (PDB) appear to strengthen the derived correlation between 19F NMR isotropic chem. shift and interactions involving fluorine (also known as the "rule of shielding") and provides a hypothesis for the recognition mechanism and catalytic activity of specific enzymes.  Novel chem. scaffolds, based on the rule of shielding, have been designed for recognizing distinct structural motifs present in proteins.  It is envisaged that this approach could find useful applications in drug design for the efficient optimization of chem. fragments or promising compds. by increasing potency and selectivity against the desired biomol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtfxYsmG4NrVg90H21EOLACvtfcHk0ljWeBhzEDXBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D&md5=21efccc023f44ed600725e2a834222ae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100483%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DIntermolecular%2520and%2520intramolecular%2520hydrogen%2520bonds%2520involving%2520fluorine%2520atoms%253A%2520Implications%2520for%2520recognition%252C%2520selectivity%252C%2520and%2520chemical%2520properties%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D262%26epage%3D272%26doi%3D10.1002%2Fcmdc.201100483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span><span class="refDoi"> DOI: 10.1007/s00894-011-1015-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1007%2Fs00894-011-1015-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21369930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKgsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3309-3318&author=K.+E.+Rileyauthor=J.+S.+Murrayauthor=J.+Fanfrlikauthor=J.+Rezacauthor=R.+J.+Solaauthor=M.+C.+Conchaauthor=F.+M.+Ramosauthor=P.+Politzer&title=Halogen+bond+tunability+I%3A+the+effects+of+aromatic+fluorine+substitution+on+the+strengths+of+halogen-bonding+interactions+involving+chlorine%2C+bromine%2C+and+iodine&doi=10.1007%2Fs00894-011-1015-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine</span></div><div class="casAuthors">Riley, Kevin E.; Murray, Jane S.; Fanfrlik, Jindrich; Rezac, Jan; Sola, Ricardo J.; Concha, Monica C.; Ramos, Felix M.; Politzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the past several years, halogen bonds are relevant in crystal engineering and biomedical applications.  One of the reasons for the utility of these types of noncovalent interactions in the development of, for example, pharmaceutical ligands is that their strengths and geometric properties are very tunable.  That is, substitution of atoms or chem. groups in the vicinity of a halogen can have a very strong effect on the strength of the halogen bond.  The authors study halogen-bonding interactions involving aromatically-bound halogens (Cl, Br, and I) and a carbonyl oxygen.  The properties of these halogen bonds are modulated by substitution of arom. hydrogens with fluorines, which are very electroneg.  These types of substitutions have dramatic effects on the strengths of the halogen bonds, leading to interactions that can be up to 100% stronger.  Very good correlations are obtained between the interaction energies and the magnitudes of the pos. electrostatic potentials (σ-holes) on the halogens.  The substitution of fluorines in systems contg. smaller halogens results in electrostatic potentials resembling those of systems with larger halogens, with correspondingly stronger interaction energies.  Also arom. fluorine substitutions affect the optimal geometries of the halogen-bonded complexes, often as the result of secondary interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZIKmPNfePKbVg90H21EOLACvtfcHk0ljWeBhzEDXBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKgsrrF&md5=4992c9015ff429af1c2d83be574411e6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1015-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1015-6%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DRezac%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DR.%2BJ.%26aulast%3DConcha%26aufirst%3DM.%2BC.%26aulast%3DRamos%26aufirst%3DF.%2BM.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DHalogen%2520bond%2520tunability%2520I%253A%2520the%2520effects%2520of%2520aromatic%2520fluorine%2520substitution%2520on%2520the%2520strengths%2520of%2520halogen-bonding%2520interactions%2520involving%2520chlorine%252C%2520bromine%252C%2520and%2520iodine%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2011%26volume%3D17%26spage%3D3309%26epage%3D3318%26doi%3D10.1007%2Fs00894-011-1015-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4651</span><span class="NLM_x">–</span> <span class="NLM_lpage">4659</span><span class="refDoi"> DOI: 10.1007/s00894-012-1428-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1007%2Fs00894-012-1428-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=22643966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4651-4659&author=K.+E.+Rileyauthor=J.+S.+Murrayauthor=J.+Fanfrlikauthor=J.+Rezacauthor=R.+J.+Solaauthor=M.+C.+Conchaauthor=F.+M.+Ramosauthor=P.+Politzer&title=Halogen+bond+tunability+II%3A+the+varying+roles+of+electrostatic+and+dispersion+contributions+to+attraction+in+halogen+bonds&doi=10.1007%2Fs00894-012-1428-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds</span></div><div class="casAuthors">Riley, Kevin E.; Murray, Jane S.; Fanfrlik, Jindrich; Rezac, Jan; Sola, Ricardo J.; Concha, Monica C.; Ramos, Felix M.; Politzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4651-4659</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In a previous study we investigated the effects of arom. fluorine substitution on the strengths of the halogen bonds in halobenzene...acetone complexes (halo = chloro, bromo, and iodo).  In this work, we have examd. the origins of these halogen bonds (excluding the iodo systems), more specifically, the relative contributions of electrostatic and dispersion forces in these interactions and how these contributions change when halogen σ-holes are modified.  These studies have been carried out using d. functional symmetry adapted perturbation theory (DFT-SAPT) and through analyses of intermol. correlation energies and mol. electrostatic potentials.  It is found that electrostatic and dispersion contributions to attraction in halogen bonds vary from complex to complex, but are generally quite similar in magnitude.  Not surprisingly, increasing the size and pos. nature of a halogen's σ-hole dramatically enhances the strength of the electrostatic component of the halogen bonding interaction.  Not so obviously, halogens with larger, more pos. σ-holes tend to exhibit weaker dispersion interactions, which is attributable to the lower local polarizabilities of the larger σ-holes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_e4IgsyVCbVg90H21EOLACvtfcHk0lh7x1C2qe2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlt7nM&md5=57e1f70c9c039a0d8f491b119e125b2d</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1428-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1428-x%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DRezac%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DR.%2BJ.%26aulast%3DConcha%26aufirst%3DM.%2BC.%26aulast%3DRamos%26aufirst%3DF.%2BM.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DHalogen%2520bond%2520tunability%2520II%253A%2520the%2520varying%2520roles%2520of%2520electrostatic%2520and%2520dispersion%2520contributions%2520to%2520attraction%2520in%2520halogen%2520bonds%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D4651%26epage%3D4659%26doi%3D10.1007%2Fs00894-012-1428-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobza, P.</span><span> </span><span class="NLM_article-title">Strength and character of halogen bonds in protein–ligand complexes</span> <span class="citation_source-journal">Cryst. Growth Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4272</span><span class="NLM_x">–</span> <span class="NLM_lpage">4278</span><span class="refDoi"> DOI: 10.1021/cg200882f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg200882f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Sltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=4272-4278&author=K.+E.+Rileyauthor=P.+Hobza&title=Strength+and+character+of+halogen+bonds+in+protein%E2%80%93ligand+complexes&doi=10.1021%2Fcg200882f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32cR"><div class="casContent"><span class="casTitleNuber">32c</span><div class="casTitle"><span class="NLM_cas:atitle">Strength and Character of Halogen Bonds in Protein-Ligand Complexes</span></div><div class="casAuthors">Riley, Kevin E.; Hobza, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4272-4278</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study we investigate the strength and character of eight halogen bonding interactions from six protein-ligand complexes.  The halogen bonding complexes investigated here were selected because of their favorable halogen bond characteristics.  Interaction energies of model systems derived from protein-ligand complexes are computed at the MP2/aug-cc-pVDZ level of theory, and the relative contributions of electrostatics and dispersion are estd. by computing ΔE(HF)/ΔE(MP2) ratios.  The relationship between these ratios and DFT-SAPT Eelec/Edisp results is calibrated using smaller model systems in order to gain a qual. understanding of the relative roles that electrostatics and dispersion play in these halogen bonds.  Electrostatic potentials for the halogen bonding ligands are also generated in order to study the relationship between halogen bond strengths and halogen σ-hole size (and charge).  It is found that the strength and character of the protein-ligand halogen bonds investigated here are strongly dependent on geometric factors and σ-hole characteristics.  Many of the halogen bonds studied here, esp. those with favorable geometric and electrostatic properties, are found to be of sufficient magnitude to make significant contributions to protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtt8FGL0esPbVg90H21EOLACvtfcHk0lh7x1C2qe2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Sltr3E&md5=d4412eba0b06264bb17c3842f319096a</span></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=10.1021%2Fcg200882f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg200882f%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DHobza%26aufirst%3DP.%26atitle%3DStrength%2520and%2520character%2520of%2520halogen%2520bonds%2520in%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2011%26volume%3D11%26spage%3D4272%26epage%3D4278%26doi%3D10.1021%2Fcg200882f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delproposto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span> </span><span class="NLM_article-title">Buried hydrogen bond interactions contribute to the high potency of complement factor D inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1092-1096&author=C.-Y.+Yangauthor=J.+G.+Phillipsauthor=J.+A.+Stuckeyauthor=L.+Baiauthor=H.+Sunauthor=J.+Delpropostoauthor=W.+C.+Brownauthor=K.+Chinnaswamy&title=Buried+hydrogen+bond+interactions+contribute+to+the+high+potency+of+complement+factor+D+inhibitors&doi=10.1021%2Facsmedchemlett.6b00299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00299%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DPhillips%26aufirst%3DJ.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DDelproposto%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DChinnaswamy%26aufirst%3DK.%26atitle%3DBuried%2520hydrogen%2520bond%2520interactions%2520contribute%2520to%2520the%2520high%2520potency%2520of%2520complement%2520factor%2520D%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1092%26epage%3D1096%26doi%3D10.1021%2Facsmedchemlett.6b00299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">The crystal complex structure of a structurally related compound, the preparation of which had been directly inspired by our work (WO2012093101), bound to recombinant human FD at very low 3.15 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TCA">5TCA</a>) has been reported recently (see ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lh7x1C2qe2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Conrow, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, W. D.</span><span> </span><span class="NLM_article-title">Diazidomethane explosion</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1021/op8000977</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8000977" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVeitLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1285-1286&author=R.+E.+Conrowauthor=W.+D.+Dean&title=Diazidomethane+explosion&doi=10.1021%2Fop8000977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Diazidomethane Explosion</span></div><div class="casAuthors">Conrow, Raymond E.; Dean, W. Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1285-1286</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An explosion which caused extensive damage to a 20-L rotary evaporator and nearby equipment in a kilo lab. was detd. to have been caused by diazidomethane accumulated in the condenser.  Factors contributing to this incident are discussed and safer alternative procedures are recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKi7tHWrmyLVg90H21EOLACvtfcHk0lgXRlYPqBIQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVeitLnJ&md5=6011ed28a24fd01dc1bfdd20726e3fa7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fop8000977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8000977%26sid%3Dliteratum%253Aachs%26aulast%3DConrow%26aufirst%3DR.%2BE.%26aulast%3DDean%26aufirst%3DW.%2BD.%26atitle%3DDiazidomethane%2520explosion%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1285%26epage%3D1286%26doi%3D10.1021%2Fop8000977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">Warning! The acyl azide intermediate has a relatively low onset temperature of decomposition with a large energy release (dynamic DSC, onset <i>T</i> = 139.6 °C, 963 J/g).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Schramm, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triebwasser, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seddon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, J. P.</span><span> </span><span class="NLM_article-title">Genetic variants in the complement system predisposing to age-related macular degeneration: a review</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1016/j.molimm.2014.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.molimm.2014.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25034031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=118-125&author=E.+C.+Schrammauthor=S.+J.+Clarkauthor=M.+P.+Triebwasserauthor=S.+Raychaudhuriauthor=J.+M.+Seddonauthor=J.+P.+Atkinson&title=Genetic+variants+in+the+complement+system+predisposing+to+age-related+macular+degeneration%3A+a+review&doi=10.1016%2Fj.molimm.2014.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in the complement system predisposing to age-related macular degeneration</span></div><div class="casAuthors">Schramm, Elizabeth C.; Clark, Simon J.; Triebwasser, Michael P.; Raychaudhuri, Soumya; Seddon, Johanna M.; Atkinson, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Age-related macular degeneration (AMD) is a major cause of visual impairment in the western world.  It is characterized by the presence of lipoproteinaceous deposits (drusen) in the inner layers of the retina.  Immunohistochem. studies identified deposition of complement proteins in the drusen as well as in the choroid.  In the last decade, genetic studies have linked both common and rare variants in genes of the complement system to increased risk of development of AMD.  Here, we review the variants described to date and discuss the functional implications of dysregulation of the alternative pathway of complement in AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5ZQzYfD307Vg90H21EOLACvtfcHk0lgXRlYPqBIQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK&md5=8b8ec6496b04e1a7748b2817045d2eb1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2014.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2014.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DE.%2BC.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26aulast%3DTriebwasser%26aufirst%3DM.%2BP.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DAtkinson%26aufirst%3DJ.%2BP.%26atitle%3DGenetic%2520variants%2520in%2520the%2520complement%2520system%2520predisposing%2520to%2520age-related%2520macular%2520degeneration%253A%2520a%2520review%26jtitle%3DMol.%2520Immunol.%26date%3D2014%26volume%3D61%26spage%3D118%26epage%3D125%26doi%3D10.1016%2Fj.molimm.2014.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b','cit32c'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10533-10593. <a href="https://doi.org/10.1021/acs.jmedchem.9b01033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOcular%252BDisease%252BTherapeutics%25253A%252BDesign%252Band%252BDelivery%252Bof%252BDrugs%252Bfor%252BDiseases%252Bof%252Bthe%252BEye%26aulast%3DCheng%26aufirst%3DKuei-Ju%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28062019%26date%3D02062020%26volume%3D63%26issue%3D19%26spage%3D10533%26epage%3D10593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki, Karen Anderson, Aengus Mac Sweeney, Sha-Mei Liao, Upendra A. Argikar, Keith Jendza, Chun Zhang, James Powers, Daniel W. Klosowski, Maura Crowley, Toshio Kawanami, Jian Ding, Myriam April, Cornelia Forster, Michael Serrano-Wu, Michael Capparelli, Rrezarta Ramqaj, Catherine Solovay, Frederic Cumin, Thomas M. Smith, Luciana Ferrara, Wendy Lee, Debby Long, Melissa Prentiss, Andrea De Erkenez, Louis Yang, Fang Liu, Holger Sellner, Finton Sirockin, Eric Valeur, Paulus Erbel, Daniela Ostermeier, Paul Ramage, Bernd Gerhartz, Anna Schubart, Stefanie Flohr, Nathalie Gradoux, Roland Feifel, Barbara Vogg, Christian Wiesmann, Jürgen Maibaum, Jörg Eder, Richard Sedrani, Richard A. Harrison, Muneto Mogi, Bruce D. Jaffee, <span class="NLM_string-name hlFld-ContribAuthor">Christopher M. Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5697-5722. <a href="https://doi.org/10.1021/acs.jmedchem.9b01870" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01870%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%252528%2525282S%25252C4S%252529-4-Ethoxy-1-%252528%2525285-methoxy-7-methyl-1H-indol-4-yl%252529methyl%252529piperidin-2-yl%252529benzoic%252BAcid%252B%252528LNP023%252529%25252C%252Ba%252BFactor%252BB%252BInhibitor%252BSpecifically%252BDesigned%252BTo%252BBe%252BApplicable%252Bto%252BTreating%252Ba%252BDiverse%252BArray%252Bof%252BComplement%252BMediated%252BDiseases%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D19022020%26volume%3D63%26issue%3D11%26spage%3D5697%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rajeshri G. Karki, James Powers, Nello Mainolfi, Karen Anderson, David B. Belanger, Donglei Liu, Nan Ji, Keith Jendza, Christine F. Gelin, Aengus Mac Sweeney, Catherine Solovay, Omar Delgado, Maura Crowley, Sha-Mei Liao, Upendra A. Argikar, Stefanie Flohr, Laura R. La Bonte, Edwige L. Lorthiois, Anna Vulpetti, Ann Brown, Debby Long, Melissa Prentiss, Nathalie Gradoux, Andrea de Erkenez, Frederic Cumin, Christopher Adams, Bruce Jaffee, <span class="NLM_string-name hlFld-ContribAuthor">Muneto Mogi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4656-4668. <a href="https://doi.org/10.1021/acs.jmedchem.9b00271" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00271%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPreclinical%252BCharacterization%252Bof%252BSelective%252BFactor%252BD%252BInhibitors%252BTargeting%252Bthe%252BAlternative%252BComplement%252BPathway%26aulast%3DKarki%26aufirst%3DRajeshri%2BG.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10022019%26date%3D30042019%26date%3D17042019%26volume%3D62%26issue%3D9%26spage%3D4656%26epage%3D4668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul N. Mortenson, Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3857-3872. <a href="https://doi.org/10.1021/acs.jmedchem.8b01472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2017%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D21112018%26volume%3D62%26issue%3D8%26spage%3D3857%26epage%3D3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Vulpetti, Nils Ostermann, Stefan Randl, Taeyoung Yoon, Aengus Mac Sweeney, Frederic Cumin, Edwige Lorthiois, Simon Rüdisser, Paul Erbel, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 490-495. <a href="https://doi.org/10.1021/acsmedchemlett.8b00104" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00104%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BDesign%252Bof%252BFirst%252BBenzylamine-Based%252BLigands%252BBinding%252Bto%252Ban%252BUnlocked%252BConformation%252Bof%252Bthe%252BComplement%252BFactor%252BD%26aulast%3DVulpetti%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03032018%26date%3D24042018%26date%3D30042018%26date%3D24042018%26volume%3D9%26issue%3D5%26spage%3D490%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenxi  Duan</span>, <span class="hlFld-ContribAuthor ">Zhihao  Ma</span>, <span class="hlFld-ContribAuthor ">Siwei  Wu</span>, <span class="hlFld-ContribAuthor ">Xuejuan  Ding</span>, <span class="hlFld-ContribAuthor ">Xiao  Tu</span>, <span class="hlFld-ContribAuthor ">Jianmin  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Functional characterization of complement factor D on the defense against Gyrodactylus kobayashii (Monogenea) infection in goldfish (Carassius auratus). </span><span class="cited-content_cbyCitation_journal-name">Aquaculture</span><span> <strong>2021,</strong> <em>545 </em>, 737214. <a href="https://doi.org/10.1016/j.aquaculture.2021.737214" title="DOI URL">https://doi.org/10.1016/j.aquaculture.2021.737214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aquaculture.2021.737214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aquaculture.2021.737214%26sid%3Dliteratum%253Aachs%26jtitle%3DAquaculture%26atitle%3DFunctional%252Bcharacterization%252Bof%252Bcomplement%252Bfactor%252BD%252Bon%252Bthe%252Bdefense%252Bagainst%252BGyrodactylus%252Bkobayashii%252B%252528Monogenea%252529%252Binfection%252Bin%252Bgoldfish%252B%252528Carassius%252Bauratus%252529%26aulast%3DDuan%26aufirst%3DChenxi%26date%3D2021%26volume%3D545%26spage%3D737214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Gun  Park</span>, <span class="hlFld-ContribAuthor ">Yong Soo  Park</span>, <span class="hlFld-ContribAuthor ">In-Beom  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Complement System and Potential Therapeutics in Age-Related Macular Degeneration. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (13)
                                     , 6851. <a href="https://doi.org/10.3390/ijms22136851" title="DOI URL">https://doi.org/10.3390/ijms22136851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22136851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22136851%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DComplement%252BSystem%252Band%252BPotential%252BTherapeutics%252Bin%252BAge-Related%252BMacular%252BDegeneration%26aulast%3DPark%26aufirst%3DYoung%2BGun%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D13%26spage%3D6851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuedong  He</span>, <span class="hlFld-ContribAuthor ">Lu  Zhao</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhong</span>, <span class="hlFld-ContribAuthor ">Hsin-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoting  Shan</span>, <span class="hlFld-ContribAuthor ">Ning  Tang</span>, <span class="hlFld-ContribAuthor ">Calvin Yu-Chian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>129 </em>, 110360. <a href="https://doi.org/10.1016/j.biopha.2020.110360" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110360%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DInsight%252Binto%252Bpotent%252Bleads%252Bfor%252Balzheimer%252527s%252Bdisease%252Bby%252Busing%252Bseveral%252Bartificial%252Bintelligence%252Balgorithms%26aulast%3DHe%26aufirst%3DXuedong%26date%3D2020%26volume%3D129%26spage%3D110360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason A.  Wiles</span>, <span class="hlFld-ContribAuthor ">Manuel D.  Galvan</span>, <span class="hlFld-ContribAuthor ">Steven D.  Podos</span>, <span class="hlFld-ContribAuthor ">Michael  Geffner</span>, <span class="hlFld-ContribAuthor ">Mingjun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471). </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (25)
                                     , 4165-4180. <a href="https://doi.org/10.2174/0929867326666191001130342" title="DOI URL">https://doi.org/10.2174/0929867326666191001130342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666191001130342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666191001130342%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252Bthe%252BOral%252BComplement%252BFactor%252BD%252BInhibitor%252BDanicopan%252B%252528ACH-4471%252529%26aulast%3DWiles%26aufirst%3DJason%2BA.%26date%3D2020%26volume%3D27%26issue%3D25%26spage%3D4165%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukas  Prantl</span>, <span class="hlFld-ContribAuthor ">Michael  Gerken</span>, <span class="hlFld-ContribAuthor ">Florian  Zeman</span>, <span class="hlFld-ContribAuthor ">Michael  Leitzmann</span>, <span class="hlFld-ContribAuthor ">Michael  Koller</span>, <span class="hlFld-ContribAuthor ">Monika  Klinkhammer-Schalke</span>, <span class="hlFld-ContribAuthor ">Matthias  Evert</span>, <span class="hlFld-ContribAuthor ">Britta  Kuehlmann</span>, <span class="hlFld-ContribAuthor ">Niklas  Biermann</span>. </span><span class="cited-content_cbyCitation_article-title">Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 1247. <a href="https://doi.org/10.3390/jcm9051247" title="DOI URL">https://doi.org/10.3390/jcm9051247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9051247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9051247%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DIncidence%252Bof%252BAnaplastic%252BLarge%252BCell%252BLymphoma%252Band%252BBreast-Implant-Associated%252BLymphoma%2525E2%252580%252594An%252BAnalysis%252Bof%252Ba%252BCertified%252BTumor%252BRegistry%252Bover%252B17%252BYears%26aulast%3DPrantl%26aufirst%3DLukas%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guido  Gembillo</span>, <span class="hlFld-ContribAuthor ">Rossella  Siligato</span>, <span class="hlFld-ContribAuthor ">Valeria  Cernaro</span>, <span class="hlFld-ContribAuthor ">Domenico  Santoro</span>. </span><span class="cited-content_cbyCitation_article-title">Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist’s Opinion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 1261. <a href="https://doi.org/10.3390/jcm9051261" title="DOI URL">https://doi.org/10.3390/jcm9051261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9051261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9051261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DComplement%252BInhibition%252BTherapy%252Band%252BDialytic%252BStrategies%252Bin%252BParoxysmal%252BNocturnal%252BHemoglobinuria%25253A%252BThe%252BNephrologist%2525E2%252580%252599s%252BOpinion%26aulast%3DGembillo%26aufirst%3DGuido%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient drug discovery by rational lead hybridization based on crystallographic overlay. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 805-813. <a href="https://doi.org/10.1016/j.drudis.2018.11.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DEfficient%252Bdrug%252Bdiscovery%252Bby%252Brational%252Blead%252Bhybridization%252Bbased%252Bon%252Bcrystallographic%252Boverlay%26aulast%3DZhang%26aufirst%3DShuo%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Michael J.  Waring</span>. </span><span class="cited-content_cbyCitation_article-title">Practical application of ligand efficiency metrics in lead optimisation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 3006-3015. <a href="https://doi.org/10.1016/j.bmc.2018.04.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPractical%252Bapplication%252Bof%252Bligand%252Befficiency%252Bmetrics%252Bin%252Blead%252Boptimisation%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D3006%26epage%3D3015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic drawing of the classical, the lectin, and the alternative complement pathways, highlighting the pivotal role of the S1 serine protease factor D. An inhibitor of factor D has the potential to block the initiating step of the alternative pathway (AP) and the amplification loop that augments the other two pathways and prevent the formation of the AP C3 and C5 convertases. The key effector mechanisms of innate immunity contributed by complement are opsonization by C3 fragments and lysis by deposition of the membrane attack complex (MAC) on cell surfaces.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Compounds <b>1</b>–<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Crystal structure of the complex between human FD and <b>5</b> (in pink) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT">5NAT</a>) overlaid with FD-bound <b>6</b> (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBI">5FBI</a>). Hydrogen-bond interactions of the urea carbonyl to the Gly<sub>193</sub> NH (oxyanion hole) and the amide NH of compound <b>5</b> to the backbone carbonyl of Leu<sub>41</sub> are highlighted, as well as the H-bonds of the terminal carboxamide of <b>6</b> to Thr<sub>214</sub> of the self-inhibitory loop and to Arg<sub>218</sub> at the bottom of the S1 pocket, and the H-bond of the indole-NH with the Arg<sub>218</sub> backbone carbonyl. Note that the benzoic acid portion of <b>6</b> is positioned in solvent space and hence is not resolved in the crystal structure. (B) Crystal structure of the complex between human FD and <b>7</b> (in orange) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR">5NAR</a>). The imidazole side chain of the catalytic His<sub>57</sub> is in an “out” conformation. The network of H-bonds between the <i>N</i>-carbamoyl residue of <b>7</b> and Thr<sub>214</sub>, Arg<sub>218</sub>, and a water molecule bound deeply in the S1 pocket is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Superpositions of compounds <b>7</b> (in orange color), <b>13</b> (magenta) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW">5NAW</a>), <b>14</b> (cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA">5NBA</a>), and <b>18</b> (yellow) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6">5NB6</a>) observed in their X-ray crystal structures in complex to human FD. The conformational flexibility of the His<sub>57</sub> and Ser<sub>215</sub> side chains are highlighted, while the Cys<sub>42</sub>–Cys<sub>58</sub> disulfide bridge conformation is largely conserved. (B) Close-up view highlighting the antiparallel dipole–dipole interaction observed between the C–F dipole in <b>14</b> and the FD His<sub>57</sub> carbonyl dipole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structures of human FD in complex with <b>2</b> (the protein is shown in gray color and the ligand in cyan color; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7">5NB7</a>) overlaid with the crystal structure of the complex with compound <b>13</b> (only the ligand is shown, magenta color). The network of H-bonds (black dashed lines) in the S1 pocket, to the backbone of Gly<sub>193</sub> and the H-bond between the amide spacer and Leu<sub>41</sub> backbone carbonyl are conserved. (B) Close up view of the S2′ region, the halogen bond (green dashed lines) between the bromine atom in compound <b>2</b> and the Trp<sub>141</sub> backbone carbonyl is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Inhibitors <b>2</b>, <b>5</b>, and <b>7</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> or DMF, RT or DMF, 70 °C (for X = CF and R<sup>1</sup> = OCF<sub>3</sub>); (b) 1-chloro-<i>N</i>,<i>N</i>,2-trimethylpropenylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C (for X = N and R<sup>1</sup> = CF<sub>3</sub>, Br); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) R<sup>2</sup>NCO (<b>31</b> or <b>32</b>), Et<sub>3</sub>N, THF; (e) piperidine 20% in DMF, RT for the Fmoc deprotection leading to <b>18</b>; (f) R<sup>5</sup>CO<sub>2</sub>H (<b>33</b>, <b>34</b>, <b>35</b>, or <b>36</b>), HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, RT (cf. <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for structures).</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Intermediates <b>39</b> and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, RT, 100%; (b) H<sub>2</sub>, Pd/C, MeOH, <b>39</b> (7%) and <b>40</b> (53%).</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes for Intermediates <b>31</b>–<b>33</b> and <b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions:(a) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF (83%); (b) NaH, THF, ClSO<sub>2</sub>NCO (<b>43</b>, 29%; <b>47</b>, 75%); (c) H<sub>2</sub>, Pd/C 10%, THF/DMF, (100%); (d) (i) Et<sub>3</sub>N, DPPA, CH<sub>2</sub>Cl<sub>2</sub>, −15 to 15 °C, (ii) toluene, reflux (<b>31</b>, 89%; <b>32</b>, 52%); (e) NaOH, MeOH/H<sub>2</sub>O (95%); (f) BrCH<sub>2</sub>CO<sub>2</sub><sup><i>t</i></sup>Bu, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub> (100% for 2 steps).</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma and ocular pharmacokinetics profiles of inhibitor <b>2</b> in Brown Norway rats after oral administration (10 mg/kg). The compound was formulated as a suspension in 0.5% HPMC and 0.1% Tween 80 and was administered by oral gavage to male 250 g Brown Norway rats (<i>n</i> = 2 per time point). Tissues from 2 animals were collected at 0.25, 0.5, 1, 3, 6, and 24 h, respectively, for analysis (4 eyes/time point; each eye dissected into neural retina and posterior eye cup). Two plasma samples per time point were collected. Points represent the mean, and error bars represent the standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibitor <b>2</b> tested at 30 mg/kg in the human factor D knock-in mouse pharmacodynamic model: (A) inhibition of Ba generation in plasma and (B) inhibition of iC3b and C3d generation in ocular tissues. Groups of mice (<i>n</i> = 4, female human FD knock-in) were treated either with <b>2</b> or dosing vehicle by oral gavage at 24, 16, 12, 8, 6, and 4 h, respectively, prior to the termination of the study. All animals were given intraperitoneal LPS to activate complement 7.5 h prior to study termination. Baseline complement levels were obtained from mice that received oral dosing vehicle and intraperitoneal saline (indicated by PBS line on graph). The positive control group received oral dosing vehicle and intraperitoneal LPS (LPS line on graph). Data shown represent mean ± sem for the group. Statistical analysis was by ANOVA with Tukeys multiple comparison test, where ***<i>P</i> < 0.001 and **<i>P</i> < 0.01 compared to the positive control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/medium/jm-2017-00425j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition of <i>ex vivo</i> MAC deposition after oral dosing of <b>2</b> to male cynomolgus monkeys. A single dose of <b>2</b> was administered by oral gavage at 10 (<i>n</i> = 3) and 50 mg/kg (<i>n</i> = 3), respectively. Serum samples were obtained predosing and at 4, 7, and 24 h after dosing, and complement activity was assessed with an <i>ex vivo</i> serum MAC deposition assay (A). The concentration of <b>2</b> in each sample relative to complement inhibition achieved was plotted in panel B. The dotted lines indicate the 95% confidence band for the curve.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00425/20170707/images/large/jm-2017-00425j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00425&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajishengallis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Complement: a key system for immune surveillance and homeostasis</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span><span class="refDoi"> DOI: 10.1038/ni.1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fni.1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=20720586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCmtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=785-797&author=D.+Ricklinauthor=G.+Hajishengallisauthor=K.+Yangauthor=J.+D.+Lambris&title=Complement%3A+a+key+system+for+immune+surveillance+and+homeostasis&doi=10.1038%2Fni.1923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Complement: a key system for immune surveillance and homeostasis</span></div><div class="casAuthors">Ricklin, Daniel; Hajishengallis, George; Yang, Kun; Lambris, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-797</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nearly a century after the significance of the human complement system was recognized, we have come to realize that its functions extend far beyond the elimination of microbes.  Complement acts as a rapid and efficient immune surveillance system that has distinct effects on healthy and altered host cells and foreign intruders.  By eliminating cellular debris and infectious microbes, orchestrating immune responses and sending 'danger' signals, complement contributes substantially to homeostasis, but it can also take action against healthy cells if not properly controlled.  This review describes our updated view of the function, structure and dynamics of the complement network, highlights its interconnection with immunity at large and with other endogenous pathways, and illustrates its multiple roles in homeostasis and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx5zRC2bFGqLVg90H21EOLACvtfcHk0lhE82fRGSOvUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCmtbfO&md5=9fd72883ccfb6bf77b4bdebe82197d11</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni.1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1923%26sid%3Dliteratum%253Aachs%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DHajishengallis%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DComplement%253A%2520a%2520key%2520system%2520for%2520immune%2520surveillance%2520and%2520homeostasis%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D785%26epage%3D797%26doi%3D10.1038%2Fni.1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zarkadis, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastellos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Phylogenetic aspects of the complement system</span> <span class="citation_source-journal">Dev. Comp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1016/S0145-305X(01)00034-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS0145-305X%2801%2900034-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=745-762&author=I.+K.+Zarkadisauthor=D.+Mastellosauthor=J.+D.+Lambris&title=Phylogenetic+aspects+of+the+complement+system&doi=10.1016%2FS0145-305X%2801%2900034-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0145-305X%2801%2900034-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0145-305X%252801%252900034-9%26sid%3Dliteratum%253Aachs%26aulast%3DZarkadis%26aufirst%3DI.%2BK.%26aulast%3DMastellos%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DPhylogenetic%2520aspects%2520of%2520the%2520complement%2520system%26jtitle%3DDev.%2520Comp.%2520Immunol.%26date%3D2001%26volume%3D25%26spage%3D745%26epage%3D762%26doi%3D10.1016%2FS0145-305X%2801%2900034-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Complement-targeted therapeutics</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1038/nbt1342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnbt1342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1265-1275&author=D.+Ricklinauthor=J.+D.+Lambris&title=Complement-targeted+therapeutics&doi=10.1038%2Fnbt1342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnbt1342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1342%26sid%3Dliteratum%253Aachs%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DComplement-targeted%2520therapeutics%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1265%26epage%3D1275%26doi%3D10.1038%2Fnbt1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Complement factor D, a novel serine protease</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1002/pro.5560050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fpro.5560050401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=8845746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=553-564&author=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Complement+factor+D%2C+a+novel+serine+protease&doi=10.1002%2Fpro.5560050401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D, a novel serine protease</span></div><div class="casAuthors">Volanakis, John E.; Narayana, Sthanam V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with many refs.  Factor D is unique among serine proteases in that it requires neither enzymic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control.  Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity.  These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations.  Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-WO4fTyq7LVg90H21EOLACvtfcHk0lhE82fRGSOvUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D&md5=d55e7afa5c827b02023dd94994690eaa</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560050401%26sid%3Dliteratum%253Aachs%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DComplement%2520factor%2520D%252C%2520a%2520novel%2520serine%2520protease%26jtitle%3DProtein%2520Sci.%26date%3D1996%26volume%3D5%26spage%3D553%26epage%3D564%26doi%3D10.1002%2Fpro.5560050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Structures of native and complexed complement factor D: Implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1081</span><span class="refDoi"> DOI: 10.1006/jmbi.1998.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1006%2Fjmbi.1998.2089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1061-1081&author=H.+Jingauthor=Y.+S.+Babuauthor=D.+Mooreauthor=J.+M.+Kilpatrickauthor=X.-Y.+Liuauthor=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Structures+of+native+and+complexed+complement+factor+D%3A+Implications+of+the+atypical+His57+conformation+and+self-inhibitory+loop+in+the+regulation+of+specific+serine+protease+activity&doi=10.1006%2Fjmbi.1998.2089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2089%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DH.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DKilpatrick%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DX.-Y.%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DStructures%2520of%2520native%2520and%2520complexed%2520complement%2520factor%2520D%253A%2520Implications%2520of%2520the%2520atypical%2520His57%2520conformation%2520and%2520self-inhibitory%2520loop%2520in%2520the%2520regulation%2520of%2520specific%2520serine%2520protease%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D282%26spage%3D1061%26epage%3D1081%26doi%3D10.1006%2Fjmbi.1998.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volanakis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, S. V. L.</span><span> </span><span class="NLM_article-title">Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span><span class="refDoi"> DOI: 10.1093/emboj/18.4.804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1093%2Femboj%2F18.4.804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=804-814&author=H.+Jingauthor=K.+J.+Maconauthor=D.+Mooreauthor=L.+J.+DeLucasauthor=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Structural+basis+of+profactor+D+activation%3A+from+a+highly+flexible+zymogen+to+a+novel+self-inhibited+serine+protease%2C+complement+factor+D&doi=10.1093%2Femboj%2F18.4.804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.4.804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.4.804%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DH.%26aulast%3DMacon%26aufirst%3DK.%2BJ.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DDeLucas%26aufirst%3DL.%2BJ.%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DStructural%2520basis%2520of%2520profactor%2520D%2520activation%253A%2520from%2520a%2520highly%2520flexible%2520zymogen%2520to%2520a%2520novel%2520self-inhibited%2520serine%2520protease%252C%2520complement%2520factor%2520D%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D804%26epage%3D814%26doi%3D10.1093%2Femboj%2F18.4.804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Taylor, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bixler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budman, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpusas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safari-Fard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">Induced fit activation mechanism of the exceptionally specific serine protease, Complement Factor D</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">–</span> <span class="NLM_lpage">2859</span><span class="refDoi"> DOI: 10.1021/bi982140f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi982140f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2849-2859&author=F.+R.+Taylorauthor=S.+A.+Bixlerauthor=J.+I.+Budmanauthor=D.+Wenauthor=M.+Karpusasauthor=S.+T.+Ryanauthor=G.+J.+Jaworskiauthor=A.+Safari-Fardauthor=S.+Pollardauthor=A.+Whitty&title=Induced+fit+activation+mechanism+of+the+exceptionally+specific+serine+protease%2C+Complement+Factor+D&doi=10.1021%2Fbi982140f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fbi982140f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982140f%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DF.%2BR.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DBudman%26aufirst%3DJ.%2BI.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DS.%2BT.%26aulast%3DJaworski%26aufirst%3DG.%2BJ.%26aulast%3DSafari-Fard%26aufirst%3DA.%26aulast%3DPollard%26aufirst%3DS.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DInduced%2520fit%2520activation%2520mechanism%2520of%2520the%2520exceptionally%2520specific%2520serine%2520protease%252C%2520Complement%2520Factor%2520D%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D2849%26epage%3D2859%26doi%3D10.1021%2Fbi982140f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Forneris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzekou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span> </span><span class="NLM_article-title">Structures of C3b in complex with factors B and D give insight into complement convertase formation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1816</span><span class="NLM_x">–</span> <span class="NLM_lpage">1820</span><span class="refDoi"> DOI: 10.1126/science.1195821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1126%2Fscience.1195821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21205667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2jtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1816-1820&author=F.+Fornerisauthor=D.+Ricklinauthor=J.+Wuauthor=A.+Tzekouauthor=R.+S.+Wallaceauthor=J.+D.+Lambrisauthor=P.+Gros&title=Structures+of+C3b+in+complex+with+factors+B+and+D+give+insight+into+complement+convertase+formation&doi=10.1126%2Fscience.1195821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation</span></div><div class="casAuthors">Forneris, Federico; Ricklin, Daniel; Wu, Jin; Tzekou, Apostolia; Wallace, Rachel S.; Lambris, John D.; Gros, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6012</span>),
    <span class="NLM_cas:pages">1816-1820</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of the complement cascade induces inflammatory responses and marks cells for immune clearance.  In the central complement-amplification step, a complex consisting of surface-bound C3b and factor B is cleaved by factor D to generate active convertases on targeted surfaces.  We present crystal structures of the pro-convertase C3bB at 4 angstrom resoln. and its complex with factor D at 3.5 angstrom resoln.  Our data show how factor B binding to C3b forms an open "activation" state of C3bB.  Factor D specifically binds the open conformation of factor B through a site distant from the catalytic center and is activated by the substrate, which displaces factor D's self-inhibitory loop.  This concerted proteolytic mechanism, which is cofactor-dependent and substrate-induced, restricts complement amplification to C3b-tagged target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0MfnHYjx4LLVg90H21EOLACvtfcHk0lj1MgHtAyP9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2jtbvK&md5=8b9967b841de551442fa949d7ab7bab8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1195821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1195821%26sid%3Dliteratum%253Aachs%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DTzekou%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DR.%2BS.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26aulast%3DGros%26aufirst%3DP.%26atitle%3DStructures%2520of%2520C3b%2520in%2520complex%2520with%2520factors%2520B%2520and%2520D%2520give%2520insight%2520into%2520complement%2520convertase%2520formation%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1816%26epage%3D1820%26doi%3D10.1126%2Fscience.1195821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fettis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussauge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span> </span><span class="NLM_article-title">Small-molecule factor D inhibitors targeting the alternative complement pathway</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span><span class="refDoi"> DOI: 10.1038/nchembio.2208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnchembio.2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=27775713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1105-1110&author=J.+Maibaumauthor=S.-M.+Liaoauthor=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=S.+Rudisserauthor=E.+Lorthioisauthor=P.+Erbelauthor=B.+Kinzelauthor=F.+A.+Kolbauthor=S.+Barbieriauthor=J.+Wagnerauthor=C.+Durandauthor=K.+Fettisauthor=S.+Dussaugeauthor=N.+Hughesauthor=O.+Delgadoauthor=U.+Hommelauthor=T.+Gouldauthor=A.+Mac+Sweeneyauthor=B.+Gerhartzauthor=F.+Cuminauthor=S.+Flohrauthor=A.+Schubartauthor=B.+Jaffeeauthor=R.+Harrisonauthor=A.+M.+Risitanoauthor=J.+Ederauthor=K.+Anderson&title=Small-molecule+factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1038%2Fnchembio.2208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule factor D inhibitors targeting the alternative complement pathway</span></div><div class="casAuthors">Maibaum, Jurgen; Liao, Sha-Mei; Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Kolb, Fabrice A.; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Delgado, Omar; Hommel, Ulrich; Gould, Ty; Mac Sweeney, Aengus; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Jaffee, Bruce; Harrison, Richard; Risitano, Antonio Maria; Eder, Jorg; Anderson, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1105-1110</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Complement is a key component of the innate immune system, recognizing pathogens and promoting their elimination.  Complement component 3 (C3) is the central component of the system.  Activation of C3 can be initiated by three distinct routes-the classical, the lectin and the alternative pathways-with the alternative pathway also acting as an amplification loop for the other two pathways.  The protease factor D (FD) is essential for this amplification process, which, when dysregulated, predisposes individuals to diverse disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH).  Here the authors describe the identification of potent and selective small-mol. inhibitors of FD.  These inhibitors efficiently block alternative pathway (AP) activation and prevent both C3 deposition onto, and lysis of, PNH erythrocytes.  Their oral administration inhibited lipopolysaccharide-induced AP activation in FD-humanized mice.  These data demonstrate the feasibility of inhibiting the AP with small-mol. antagonists and support the development of FD inhibitors for the treatment of complement-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28_wznUz9QLVg90H21EOLACvtfcHk0lj1MgHtAyP9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P&md5=270ea1f129b3e25c22680e74f82ffc36</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2208%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DKolb%26aufirst%3DF.%2BA.%26aulast%3DBarbieri%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26atitle%3DSmall-molecule%2520factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1105%26epage%3D1110%26doi%3D10.1038%2Fnchembio.2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüdisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Structure-based library design and fragment screening for the identification of reversible complement Factor D protease inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1958</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1946-1958&author=A.+Vulpettiauthor=S.+Randlauthor=S.+R%C3%BCdisserauthor=N.+Ostermannauthor=P.+Erbelauthor=A.+Mac+Sweeneyauthor=T.+Zollerauthor=B.+Salemauthor=B.+Gerhartzauthor=F.+Cuminauthor=U.+Hommelauthor=C.+Dalvitauthor=E.+Lorthioisauthor=J.+Maibaum&title=Structure-based+library+design+and+fragment+screening+for+the+identification+of+reversible+complement+Factor+D+protease+inhibitors&doi=10.1021%2Facs.jmedchem.6b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors</span></div><div class="casAuthors">Vulpetti, Anna; Randl, Stefan; Rudisser, Simon; Ostermann, Nils; Erbel, Paul; Mac Sweeney, Aengus; Zoller, Thomas; Salem, Bahaa; Gerhartz, Bernd; Cumin, Frederic; Hommel, Ulrich; Dalvit, Claudio; Lorthiois, Edwige; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1958</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic dysregulation of alternative complement pathway activation has been assocd. with diverse clin. disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinurea.  Factor D is a trypsin-like serine protease with a narrow specificity for arginine in the P1 position, which catalyzes the first enzymic reaction of the amplification loop of the alternative pathway.  In this paper, the authors describe two hit finding approaches leading to the discovery of new chem. matter for this pivotal protease of the complement system: in silico active site mapping for hot spots identification to guide rational structure-based design and NMR screening of focused and diverse fragment libraries.  The wealth of information gathered by these complementary approaches enabled the identification of ligands binding to different sub-pockets of the latent Factor D conformation and was instrumental for understanding the binding requirements for the generation of the first known potent noncovalent reversible Factor D inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPFgFvVDvCyrVg90H21EOLACvtfcHk0li8XGs9eZV87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D&md5=179ea6dc5fb9ccb60931da60f23e6381</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01684%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DS.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DStructure-based%2520library%2520design%2520and%2520fragment%2520screening%2520for%2520the%2520identification%2520of%2520reversible%2520complement%2520Factor%2520D%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1946%26epage%3D1958%26doi%3D10.1021%2Facs.jmedchem.6b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Morikis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Structural aspects and design of low-molecular-mass complement inhibitors</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1042/bst0301026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1042%2Fbst0301026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=12440966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=1026-1036&author=D.+Morikisauthor=J.+D.+Lambris&title=Structural+aspects+and+design+of+low-molecular-mass+complement+inhibitors&doi=10.1042%2Fbst0301026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects and design of low-molecular-mass complement inhibitors</span></div><div class="casAuthors">Morikis, D.; Lambris, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1026-1036</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  We present a mini-review on the structure-based design of three promising complement inhibitors.  Firstly, we review compstatin, a 13-residue cyclic peptide that binds to C3 and inhibits the cleavage of C3 to C3a and C3b.  Secondly, we review a six-residue cyclic peptide that binds to C5aR and antagonizes the binding of C5a to its receptor C5aR.  Finally, we review three small mols. that bind to Factor D and inhibit the enzymic action of Factor D, during which Factor D proteolytically cleaves Factor B in complex with C3 or C3b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHnN6gQihz2rVg90H21EOLACvtfcHk0li8XGs9eZV87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2isb8%253D&md5=02ac5a9db829994c0e512aaeea0d7e2c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2Fbst0301026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0301026%26sid%3Dliteratum%253Aachs%26aulast%3DMorikis%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DStructural%2520aspects%2520and%2520design%2520of%2520low-molecular-mass%2520complement%2520inhibitors%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2002%26volume%3D30%26spage%3D1026%26epage%3D1036%26doi%3D10.1042%2Fbst0301026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Katschke, K. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hass, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Lookeren Campagne, M.</span><span> </span><span class="NLM_article-title">Inhibiting alternative pathway complement activation by targeting the factor D exosite</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">12886</span><span class="NLM_x">–</span> <span class="NLM_lpage">12892</span><span class="refDoi"> DOI: 10.1074/jbc.M112.345082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1074%2Fjbc.M112.345082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=12886-12892&author=K.+J.+Katschkeauthor=P.+Wuauthor=R.+Ganesanauthor=R.+F.+Kelleyauthor=M.+A.+Mathieuauthor=P.+E.+Hassauthor=J.+Murrayauthor=D.+Kirchhoferauthor=C.+Wiesmannauthor=M.+van+Lookeren+Campagne&title=Inhibiting+alternative+pathway+complement+activation+by+targeting+the+factor+D+exosite&doi=10.1074%2Fjbc.M112.345082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.345082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.345082%26sid%3Dliteratum%253Aachs%26aulast%3DKatschke%26aufirst%3DK.%2BJ.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DR.%2BF.%26aulast%3DMathieu%26aufirst%3DM.%2BA.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3Dvan%2BLookeren%2BCampagne%26aufirst%3DM.%26atitle%3DInhibiting%2520alternative%2520pathway%2520complement%2520activation%2520by%2520targeting%2520the%2520factor%2520D%2520exosite%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D12886%26epage%3D12892%26doi%3D10.1074%2Fjbc.M112.345082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mastellos, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancopoulou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkinos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber-Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajishengallis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biglarnia, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambris, J. D.</span><span> </span><span class="NLM_article-title">Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1111/eci.12419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1111%2Feci.12419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25678219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=423-440&author=D.+C.+Mastellosauthor=D.+Yancopoulouauthor=P.+Kokkinosauthor=M.+Huber-Langauthor=G.+Hajishengallisauthor=A.+R.+Biglarniaauthor=F.+Lupuauthor=B.+Nilssonauthor=A.+M.+Risitanoauthor=D.+Ricklinauthor=J.+D.+Lambris&title=Compstatin%3A+a+C3-targeted+complement+inhibitor+reaching+its+prime+for+bedside+intervention&doi=10.1111%2Feci.12419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention</span></div><div class="casAuthors">Mastellos, Dimitrios C.; Yancopoulou, Despina; Kokkinos, Petros; Huber-Lang, Markus; Hajishengallis, George; Biglarnia, Ali R.; Lupu, Florea; Nilsson, Bo; Risitano, Antonio M.; Ricklin, Daniel; Lambris, John D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-440</span>CODEN:
                <span class="NLM_cas:coden">EJCIB8</span>;
        ISSN:<span class="NLM_cas:issn">0014-2972</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There is a growing awareness that complement plays an integral role in human physiol. and disease, transcending its traditional perception as an accessory system for pathogen clearance and opsonic cell killing.  As the list of pathologies linked to dysregulated complement activation grows longer, it has become clear that targeted modulation of this innate immune system opens new windows of therapeutic opportunity for anti-inflammatory drug design.  Indeed, the introduction of the first complement-targeting drugs has reignited a vibrant interest in the clin. translation of complement-based inhibitors.  Compstatin was discovered as a cyclic peptide that inhibits complement activation by binding C3 and interfering with convertase formation and C3 cleavage.  As the convergence point of all activation pathways and a mol. hub for crosstalk with multiple pathogenic pathways, C3 represents an attractive target for therapeutic modulation of the complement cascade.  A multidisciplinary drug optimization effort encompassing rational 'wet' and in silico synthetic approaches and an array of biophys., structural and anal. tools has culminated in an impressive structure-function refinement of compstatin, yielding a series of analogs that show promise for a wide spectrum of clin. applications.  These new derivs. have improved inhibitory potency and pharmacokinetic profiles and show efficacy in clin. relevant primate models of disease.  This review provides an up-to-date survey of the drug design effort placed on the compstatin family of C3 inhibitors, highlighting the most promising drug candidates.  It also discusses translational challenges in complement drug discovery and peptide drug development and reviews concerns related to systemic C3 interception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXFg7iERaJbVg90H21EOLACvtfcHk0lgaTMqm05lUWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKjt74%253D&md5=81d73c3a2f7b39c9ae7415d466c7b294</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Feci.12419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Feci.12419%26sid%3Dliteratum%253Aachs%26aulast%3DMastellos%26aufirst%3DD.%2BC.%26aulast%3DYancopoulou%26aufirst%3DD.%26aulast%3DKokkinos%26aufirst%3DP.%26aulast%3DHuber-Lang%26aufirst%3DM.%26aulast%3DHajishengallis%26aufirst%3DG.%26aulast%3DBiglarnia%26aufirst%3DA.%2BR.%26aulast%3DLupu%26aufirst%3DF.%26aulast%3DNilsson%26aufirst%3DB.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DRicklin%26aufirst%3DD.%26aulast%3DLambris%26aufirst%3DJ.%2BD.%26atitle%3DCompstatin%253A%2520a%2520C3-targeted%2520complement%2520inhibitor%2520reaching%2520its%2520prime%2520for%2520bedside%2520intervention%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D45%26spage%3D423%26epage%3D440%26doi%3D10.1111%2Feci.12419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yuan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavriilaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanassi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podos, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, R. A.</span><span> </span><span class="NLM_article-title">Small-molecule Factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span><span class="refDoi"> DOI: 10.3324/haematol.2016.153312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.3324%2Fhaematol.2016.153312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2017&pages=466-475&author=X.+Yuanauthor=E.+Gavriilakiauthor=A.+C.+Bainesauthor=J.+A.+Thanassiauthor=G.+Yangauthor=S.+D.+Podosauthor=Y.+Huangauthor=M.+Huangauthor=R.+A.+Brodsky&title=Small-molecule+Factor+D+inhibitors+selectively+block+the+alternative+pathway+of+complement+in+paroxysmal+nocturnal+hemoglobinuria+and+atypical+hemolytic+uremic+syndrome&doi=10.3324%2Fhaematol.2016.153312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2016.153312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2016.153312%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DGavriilaki%26aufirst%3DE.%26aulast%3DBaines%26aufirst%3DA.%2BC.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DBrodsky%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520Factor%2520D%2520inhibitors%2520selectively%2520block%2520the%2520alternative%2520pathway%2520of%2520complement%2520in%2520paroxysmal%2520nocturnal%2520hemoglobinuria%2520and%2520atypical%2520hemolytic%2520uremic%2520syndrome%26jtitle%3DHaematologica%26date%3D2017%26volume%3D102%26spage%3D466%26epage%3D475%26doi%3D10.3324%2Fhaematol.2016.153312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.9997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands&doi=10.1073%2Fpnas.96.18.9997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lgaTMqm05lUWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002%26doi%3D10.1073%2Fpnas.96.18.9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZtcPSa3Dw6obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J. T.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1016/S1359-6446(05)03386-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery&doi=10.1016%2FS1359-6446%2805%2903386-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eZtcPSa3Dw6obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469%26doi%3D10.1016%2FS1359-6446%2805%2903386-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The role of molecular size in ligand efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+role+of+molecular+size+in+ligand+efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0ljHwe8Ma7_Rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520role%2520of%2520molecular%2520size%2520in%2520ligand%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug+like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljHwe8Ma7_Rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug%2520like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of binding efficiencies of drugs and their leads in successful drug discovery programs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Analysis of the Binding Efficiencies of Drugs and their Leads in Successful Drug Discovery Programs</span></div><div class="casAuthors">Perola, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2986-2997</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to investigate the evolution of binding efficiency in successful drug discovery programs, a data set of 60 lead/drug pairs with known binding affinities has been compiled and analyzed.  Low-end thresholds for the binding efficiencies of viable leads and drugs have been derived.  On av., the drugs in the set are significantly larger and more potent but have similar lipophilicity relative to their originating leads, suggesting that the ability to maintain low levels of lipophilicity while increasing mol. wt. is one of the keys to a successful drug discovery program.  A no. of examples demonstrate that large increases in binding efficiency from leads to more elaborate drugs sharing the same scaffold can be achieved.  The importance of dissecting a lead structure to identify the most efficient fragments and the option of sacrificing binding efficiency to optimize other properties are discussed, and relevant examples are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRqzYFBuX2Q7Vg90H21EOLACvtfcHk0liOQcW0Jp1EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlWqu7o%253D&md5=a7eaad792f1518d093588951df64d22f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0liOQcW0Jp1EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shultz, M. D.</span><span> </span><span class="NLM_article-title">The thermodynamic basis for the use of lipophilic efficiency in enthalpic optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5992</span><span class="NLM_x">–</span> <span class="NLM_lpage">6000</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.bmcl.2013.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=24054120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5992-6000&author=M.+D.+Shultz&title=The+thermodynamic+basis+for+the+use+of+lipophilic+efficiency+in+enthalpic+optimization&doi=10.1016%2Fj.bmcl.2013.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5992-6000</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Approaches to improve the efficiency of mol. optimizations have received great attention and numerous efficiency metrics have been introduced to assist in this effort.  Optimization of properties is equally important to optimization of potency and therefore these metrics contain potency vs. property calcns.  Widespread use of a metric does not guarantee its accuracy and a further understanding of which, if any, metric increases the probability of success was sought.  An anal. of LE, LELP and LipE based on theor. and exptl. data was performed demonstrating that LipE most strongly correlates with compd. quality as defined by enthalpy-driven binding.  The basis for the prioritization of LipE over other metrics in enthalpic optimizations is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuMO74LdKnbVg90H21EOLACvtfcHk0liOQcW0Jp1EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P&md5=23d948d1135eeefdfebc60846f28ec2b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DThe%2520thermodynamic%2520basis%2520for%2520the%2520use%2520of%2520lipophilic%2520efficiency%2520in%2520enthalpic%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5992%26epage%3D6000%26doi%3D10.1016%2Fj.bmcl.2013.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Escobar, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowienke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galloway, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, B.</span><span> </span><span class="NLM_article-title">Bacterial mutagenicity screening in the pharmaceutical industry</span> <span class="citation_source-journal">Mutat. Res., Rev. Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">752</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.mrrev.2012.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.mrrev.2012.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvV2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=752&publication_year=2013&pages=99-118&author=P.+A.+Escobarauthor=R.+A.+Kemperauthor=J.+Tarcaauthor=J.+Nicoletteauthor=M.+Kenyonauthor=S.+Glowienkeauthor=S.+G.+Sawantauthor=J.+Christensenauthor=T.+E.+Johnsonauthor=C.+McKnightauthor=G.+Wardauthor=S.+M.+Gallowayauthor=L.+Custerauthor=E.+Gockeauthor=M.+R.+O%E2%80%99Donovanauthor=K.+Braunauthor=R.+D.+Snyderauthor=B.+Mahadevan&title=Bacterial+mutagenicity+screening+in+the+pharmaceutical+industry&doi=10.1016%2Fj.mrrev.2012.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial mutagenicity screening in the pharmaceutical industry</span></div><div class="casAuthors">Escobar, P. A.; Kemper, R. A.; Tarca, J.; Nicolette, J.; Kenyon, M.; Glowienke, S.; Sawant, S. G.; Christensen, J.; Johnson, T. E.; McKnight, C.; Ward, G.; Galloway, S. M.; Custer, L.; Gocke, E.; O'Donovan, M. R.; Braun, K.; Snyder, R. D.; Mahadevan, B.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">752</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-118</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Genetic toxicity testing is used as an early surrogate for carcinogenicity testing.  Genetic toxicity testing is also required by regulatory agencies to be conducted prior to initiation of first in human clin. trials and subsequent marketing for most small mol. pharmaceutical compds.  To reduce the chances of advancing mutagenic pharmaceutical candidates through the drug discovery and development processes, companies have focused on developing testing strategies to maximize hazard identification while minimizing resource expenditure due to late stage attrition.  With a large no. of testing options, consensus has not been reached on the best mutagenicity platform to use or on the best time to use a specific test to aid in the selection of drug candidates for development.  Most companies use a process in which compds. are initially screened for mutagenicity early in drug development using tests that require only a few milligrams of compd. and then follow those studies up with a more robust mutagenicity test prior to selecting a compd. for full development.This review summarizes the current applications of bacterial mutagenicity assays utilized by pharmaceutical companies in early and late discovery programs.  The initial impetus for this review was derived from a workshop on bacterial mutagenicity screening in the pharmaceutical industry presented at the 40th Annual Environmental Mutagen Society Meeting held in St. Louis, MO in Oct., 2009.  However, included in this review are succinct summaries of use and interpretation of genetic toxicity assays, several mutagenicity assays that were not presented at the meeting, and updates to testing strategies resulting in current state-of the art description of best practices.  In addn., here we discuss the advantages and liabilities of many broadly used mutagenicity screening platforms and strategies used by pharmaceutical companies.  The sensitivity and specificity of these early mutagenicity screening assays using proprietary compds. and their concordance (predictivity) with the regulatory bacterial mutation test are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUdQuOZSGkLVg90H21EOLACvtfcHk0lh9eQtLxFuNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvV2ksg%253D%253D&md5=9fd2eeed7c14cfeb833491c751854623</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.mrrev.2012.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrrev.2012.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DEscobar%26aufirst%3DP.%2BA.%26aulast%3DKemper%26aufirst%3DR.%2BA.%26aulast%3DTarca%26aufirst%3DJ.%26aulast%3DNicolette%26aufirst%3DJ.%26aulast%3DKenyon%26aufirst%3DM.%26aulast%3DGlowienke%26aufirst%3DS.%26aulast%3DSawant%26aufirst%3DS.%2BG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DG.%26aulast%3DGalloway%26aufirst%3DS.%2BM.%26aulast%3DCuster%26aufirst%3DL.%26aulast%3DGocke%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BR.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DSnyder%26aufirst%3DR.%2BD.%26aulast%3DMahadevan%26aufirst%3DB.%26atitle%3DBacterial%2520mutagenicity%2520screening%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DMutat.%2520Res.%252C%2520Rev.%2520Mutat.%2520Res.%26date%3D2013%26volume%3D752%26spage%3D99%26epage%3D118%26doi%3D10.1016%2Fj.mrrev.2012.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Frieauff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martus, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhajouji, A.</span><span> </span><span class="NLM_article-title">Automatic analysis of the micronucleus test in primary human lymphocytes using image analysis</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1093/mutage/ges047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1093%2Fmutage%2Fges047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=15-23&author=W.+Frieauffauthor=H.+J.+Martusauthor=W.+Suterauthor=A.+Elhajouji&title=Automatic+analysis+of+the+micronucleus+test+in+primary+human+lymphocytes+using+image+analysis&doi=10.1093%2Fmutage%2Fges047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fges047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fges047%26sid%3Dliteratum%253Aachs%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DMartus%26aufirst%3DH.%2BJ.%26aulast%3DSuter%26aufirst%3DW.%26aulast%3DElhajouji%26aufirst%3DA.%26atitle%3DAutomatic%2520analysis%2520of%2520the%2520micronucleus%2520test%2520in%2520primary%2520human%2520lymphocytes%2520using%2520image%2520analysis%26jtitle%3DMutagenesis%26date%3D2013%26volume%3D28%26spage%3D15%26epage%3D23%26doi%3D10.1093%2Fmutage%2Fges047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8359</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0ljnY37sfrRAlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Böhm, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.-J.+B%C3%B6hmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+M%C3%BCllerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2ebGF3DYouadxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.-J.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+M%C3%BCllerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceuticals: Looking Beyond Intuition</span></div><div class="casAuthors">Mueller, Klaus; Faeh, Christoph; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-1886</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all phys. and adsorption, distribution, metab., and excretion properties of a lead compd.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on mol. conformation of the drug, has only recently begun.  Here, we review exptl. progress in this vein and add complementary anal. based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwX-YnONRc3LVg90H21EOLACvtfcHk0ljnY37sfrRAlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN&md5=f804876c801518e48d0bdb7d87b7fb1c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span> </span><span class="NLM_article-title">Fluorine in drug design: A case study with fluoroanisoles</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1002/cmdc.201402555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcmdc.201402555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25755132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=715-726&author=L.+Xingauthor=D.+C.+Blakemoreauthor=A.+Narayananauthor=R.+Unwallaauthor=F.+Loveringauthor=R.+A.+Dennyauthor=H.+Zhouauthor=M.+E.+Bunnage&title=Fluorine+in+drug+design%3A+A+case+study+with+fluoroanisoles&doi=10.1002%2Fcmdc.201402555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Drug Design: A Case Study with Fluoroanisoles</span></div><div class="casAuthors">Xing, Li; Blakemore, David C.; Narayanan, Arjun; Unwalla, Ray; Lovering, Frank; Denny, R. Aldrin; Zhou, Huanyu; Bunnage, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Anisole and fluoroanisoles display distinct conformational preferences, as evident from a survey of their crystal structures.  In addn. to altering the free ligand conformation, various degrees of fluorination have a strong impact on physicochem. and pharmacokinetic properties.  Anal. of anisole and fluoroanisole matched mol. pairs in the Pfizer corporate database reveals interesting trends: (1) PhOCF3 increases log D by ∼1 log unit over PhOCH3 compds.; (2) PhOCF3 shows lower passive permeability despite its higher lipophilicity; and (3) PhOCF3 does not appreciably improve metabolic stability over PhOCH3.  Emerging from the investigation, difluoroanisole (PhOCF2H) strikes a better balance of properties with noticeable advantages of log D and transcellular permeability over PhOCF3.  Synthetic assessment illustrates that the routes to access difluoroanisoles are often more straightforward than those for trifluoroanisoles.  Whereas replacing PhOCH3 with PhOCF3 is a common tactic to optimize ADME properties, the anal. suggests PhOCF2H may be a more attractive alternative, and greater exploitation of this motif is recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4j7y_ly3TGrVg90H21EOLACvtfcHk0lhc580Zlzg7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWku7Y%253D&md5=45dbead703594c31581cc6c7e62d1b81</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402555%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DFluorine%2520in%2520drug%2520design%253A%2520A%2520case%2520study%2520with%2520fluoroanisoles%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D715%26epage%3D726%26doi%3D10.1002%2Fcmdc.201402555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">–</span> <span class="NLM_lpage">16794</span><span class="refDoi"> DOI: 10.1073/pnas.0407607101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules&doi=10.1073%2Fpnas.0407607101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-X···O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the X···O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Å for Cl···O, 3.37 Å for Br···O, and 3.50 Å for I···O) and can conform to the geometry seen in small mols., with the C-X···O angle ≈165° (consistent with a strong directional polarization of the halogen) and the X···O-Y angle ≈120°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized π-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0lhc580Zlzg7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794%26doi%3D10.1073%2Fpnas.0407607101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Voth, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds as orthogonal molecular interactions to hydrogen bonds</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1038/nchem.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1038%2Fnchem.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21378804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlSlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=74-79&author=A.+R.+Vothauthor=P.+Khuuauthor=K.+Oishiauthor=P.+S.+Ho&title=Halogen+bonds+as+orthogonal+molecular+interactions+to+hydrogen+bonds&doi=10.1038%2Fnchem.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds as orthogonal molecular interactions to hydrogen bonds</span></div><div class="casAuthors">Voth, Andrea Regier; Khuu, Patricia; Oishi, Keita; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Halogen bonds (X-bonds) are shown to be geometrically perpendicular to and energetically independent of hydrogen bonds (H-bonds) that share a common carbonyl oxygen acceptor.  This orthogonal relationship is accommodated by the in-plane and out-of-plane electroneg. potentials of the oxygen, which are differentially populated by H- and X-bonds.  Furthermore, the local conformation of a peptide helps to define the geometry of the H-bond and thus the oxygen surface that is accessible for X-bonding.  These electrostatic and steric forces conspire to impose a strong preference for the orthogonal geometry of X- and H-bonds.  Thus, the optimum geometry of an X-bond can be predicted from the pattern of H-bonds in a folded protein, enabling X-bonds to be introduced to improve ligand affinities without disrupting these structurally important interactions.  This concept of orthogonal mol. interactions can be exploited for the rational design of halogenated ligands as inhibitors and drugs, and in biomol. engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBR3qQ1-IvprVg90H21EOLACvtfcHk0lhc580Zlzg7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlSlsb4%253D&md5=fd9ef235df86c00261b9bd0a782f88c2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchem.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.112%26sid%3Dliteratum%253Aachs%26aulast%3DVoth%26aufirst%3DA.%2BR.%26aulast%3DKhuu%26aufirst%3DP.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520as%2520orthogonal%2520molecular%2520interactions%2520to%2520hydrogen%2520bonds%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D74%26epage%3D79%26doi%3D10.1038%2Fnchem.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0liqUUH5bAWy7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Parisini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metrangolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terraneo, G.</span><span> </span><span class="NLM_article-title">Halogen bonding in halocarbon–protein complexes: a structural survey</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span><span class="refDoi"> DOI: 10.1039/c0cs00177e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1039%2Fc0cs00177e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21365086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVWju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=2267-2278&author=E.+Parisiniauthor=P.+Metrangoloauthor=T.+Pilatiauthor=G.+Resnatiauthor=G.+Terraneo&title=Halogen+bonding+in+halocarbon%E2%80%93protein+complexes%3A+a+structural+survey&doi=10.1039%2Fc0cs00177e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonding in halocarbon-protein complexes: a structural survey</span></div><div class="casAuthors">Parisini, Emilio; Metrangolo, Pierangelo; Pilati, Tullio; Resnati, Giuseppe; Terraneo, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2267-2278</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Halogen bonding was extensively described in the context of a variety of self-assembled supramol. systems and efficiently used in the rational design of materials with specific structural properties.  However, it has so far received only little recognition for its possible role in the stabilization of small mol.-protein complexes.  In this tutorial review, the authors provide a few examples of halogen bonds occurring between small halogen-substituted ligands and their biol. substrates.  Examples were drawn from a diverse set of compds., ranging from chem. additives and possible environmental agents such as triclosan to pharmacol. active principles such as the volatile anesthetic halothane or HIV-1 reverse transcriptase inhibitors or a subset of nonsteroidal antiinflammatory drugs (NSAIDs) that are halogen-substituted.  The crystal structures presented here, where iodine, bromine, or chlorine atoms function as halogen bonding donors and a variety of electron rich sites, such as oxygen, nitrogen and sulfur atoms, as well as arom. π-electron systems, function as halogen bonding acceptors, prove how halogen bonds can occur in biol. systems and provide a class of highly directional stabilizing contacts that can be exploited in the process of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7H2tafSt7bVg90H21EOLACvtfcHk0liqUUH5bAWy7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVWju7g%253D&md5=a5834e03eecc4d8b32acf6149f3a1b81</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0cs00177e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cs00177e%26sid%3Dliteratum%253Aachs%26aulast%3DParisini%26aufirst%3DE.%26aulast%3DMetrangolo%26aufirst%3DP.%26aulast%3DPilati%26aufirst%3DT.%26aulast%3DResnati%26aufirst%3DG.%26aulast%3DTerraneo%26aufirst%3DG.%26atitle%3DHalogen%2520bonding%2520in%2520halocarbon%25E2%2580%2593protein%2520complexes%253A%2520a%2520structural%2520survey%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D2267%26epage%3D2278%26doi%3D10.1039%2Fc0cs00177e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span> </span><span class="NLM_article-title">Intermolecular and intramolecular hydrogen bonds involving fluorine atoms: Implications for recognition, selectivity, and chemical properties</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1002/cmdc.201100483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1002%2Fcmdc.201100483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=22262517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=262-272&author=C.+Dalvitauthor=A.+Vulpetti&title=Intermolecular+and+intramolecular+hydrogen+bonds+involving+fluorine+atoms%3A+Implications+for+recognition%2C+selectivity%2C+and+chemical+properties&doi=10.1002%2Fcmdc.201100483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties</span></div><div class="casAuthors">Dalvit, Claudio; Vulpetti, Anna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A correlation between 19F NMR isotropic chem. shift and close intermol. F···H-X contacts (with X = N or O) has been identified upon anal. of the X-ray crystal structures of fluorinated mols. listed in the Cambridge Structural Database (CSD).  An optimal F···X distance involving primary and shielded secondary fluorine atoms in hydrogen-bond formation along with a correlation between F···H distance and F···H-X angle were also derived from the anal.  The hydrogen bonds involving fluorine are relevant, not only for the recognition mechanism and stabilization of a preferred conformation, but also for improvement in the permeability of the mols., as shown with examples taken from a proprietary database.  Results of an anal. of the small no. of fluorine-contg. natural products listed in the Protein Data Bank (PDB) appear to strengthen the derived correlation between 19F NMR isotropic chem. shift and interactions involving fluorine (also known as the "rule of shielding") and provides a hypothesis for the recognition mechanism and catalytic activity of specific enzymes.  Novel chem. scaffolds, based on the rule of shielding, have been designed for recognizing distinct structural motifs present in proteins.  It is envisaged that this approach could find useful applications in drug design for the efficient optimization of chem. fragments or promising compds. by increasing potency and selectivity against the desired biomol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtfxYsmG4NrVg90H21EOLACvtfcHk0liqUUH5bAWy7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D&md5=21efccc023f44ed600725e2a834222ae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100483%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DIntermolecular%2520and%2520intramolecular%2520hydrogen%2520bonds%2520involving%2520fluorine%2520atoms%253A%2520Implications%2520for%2520recognition%252C%2520selectivity%252C%2520and%2520chemical%2520properties%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D262%26epage%3D272%26doi%3D10.1002%2Fcmdc.201100483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span><span class="refDoi"> DOI: 10.1007/s00894-011-1015-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1007%2Fs00894-011-1015-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=21369930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKgsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3309-3318&author=K.+E.+Rileyauthor=J.+S.+Murrayauthor=J.+Fanfrlikauthor=J.+Rezacauthor=R.+J.+Solaauthor=M.+C.+Conchaauthor=F.+M.+Ramosauthor=P.+Politzer&title=Halogen+bond+tunability+I%3A+the+effects+of+aromatic+fluorine+substitution+on+the+strengths+of+halogen-bonding+interactions+involving+chlorine%2C+bromine%2C+and+iodine&doi=10.1007%2Fs00894-011-1015-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine</span></div><div class="casAuthors">Riley, Kevin E.; Murray, Jane S.; Fanfrlik, Jindrich; Rezac, Jan; Sola, Ricardo J.; Concha, Monica C.; Ramos, Felix M.; Politzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the past several years, halogen bonds are relevant in crystal engineering and biomedical applications.  One of the reasons for the utility of these types of noncovalent interactions in the development of, for example, pharmaceutical ligands is that their strengths and geometric properties are very tunable.  That is, substitution of atoms or chem. groups in the vicinity of a halogen can have a very strong effect on the strength of the halogen bond.  The authors study halogen-bonding interactions involving aromatically-bound halogens (Cl, Br, and I) and a carbonyl oxygen.  The properties of these halogen bonds are modulated by substitution of arom. hydrogens with fluorines, which are very electroneg.  These types of substitutions have dramatic effects on the strengths of the halogen bonds, leading to interactions that can be up to 100% stronger.  Very good correlations are obtained between the interaction energies and the magnitudes of the pos. electrostatic potentials (σ-holes) on the halogens.  The substitution of fluorines in systems contg. smaller halogens results in electrostatic potentials resembling those of systems with larger halogens, with correspondingly stronger interaction energies.  Also arom. fluorine substitutions affect the optimal geometries of the halogen-bonded complexes, often as the result of secondary interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZIKmPNfePKbVg90H21EOLACvtfcHk0lj2C9NKeZMRPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKgsrrF&md5=4992c9015ff429af1c2d83be574411e6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1015-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1015-6%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DRezac%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DR.%2BJ.%26aulast%3DConcha%26aufirst%3DM.%2BC.%26aulast%3DRamos%26aufirst%3DF.%2BM.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DHalogen%2520bond%2520tunability%2520I%253A%2520the%2520effects%2520of%2520aromatic%2520fluorine%2520substitution%2520on%2520the%2520strengths%2520of%2520halogen-bonding%2520interactions%2520involving%2520chlorine%252C%2520bromine%252C%2520and%2520iodine%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2011%26volume%3D17%26spage%3D3309%26epage%3D3318%26doi%3D10.1007%2Fs00894-011-1015-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politzer, P.</span><span> </span><span class="NLM_article-title">Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4651</span><span class="NLM_x">–</span> <span class="NLM_lpage">4659</span><span class="refDoi"> DOI: 10.1007/s00894-012-1428-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1007%2Fs00894-012-1428-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=22643966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4651-4659&author=K.+E.+Rileyauthor=J.+S.+Murrayauthor=J.+Fanfrlikauthor=J.+Rezacauthor=R.+J.+Solaauthor=M.+C.+Conchaauthor=F.+M.+Ramosauthor=P.+Politzer&title=Halogen+bond+tunability+II%3A+the+varying+roles+of+electrostatic+and+dispersion+contributions+to+attraction+in+halogen+bonds&doi=10.1007%2Fs00894-012-1428-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds</span></div><div class="casAuthors">Riley, Kevin E.; Murray, Jane S.; Fanfrlik, Jindrich; Rezac, Jan; Sola, Ricardo J.; Concha, Monica C.; Ramos, Felix M.; Politzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4651-4659</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In a previous study we investigated the effects of arom. fluorine substitution on the strengths of the halogen bonds in halobenzene...acetone complexes (halo = chloro, bromo, and iodo).  In this work, we have examd. the origins of these halogen bonds (excluding the iodo systems), more specifically, the relative contributions of electrostatic and dispersion forces in these interactions and how these contributions change when halogen σ-holes are modified.  These studies have been carried out using d. functional symmetry adapted perturbation theory (DFT-SAPT) and through analyses of intermol. correlation energies and mol. electrostatic potentials.  It is found that electrostatic and dispersion contributions to attraction in halogen bonds vary from complex to complex, but are generally quite similar in magnitude.  Not surprisingly, increasing the size and pos. nature of a halogen's σ-hole dramatically enhances the strength of the electrostatic component of the halogen bonding interaction.  Not so obviously, halogens with larger, more pos. σ-holes tend to exhibit weaker dispersion interactions, which is attributable to the lower local polarizabilities of the larger σ-holes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_e4IgsyVCbVg90H21EOLACvtfcHk0lj2C9NKeZMRPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlt7nM&md5=57e1f70c9c039a0d8f491b119e125b2d</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1428-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1428-x%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DMurray%26aufirst%3DJ.%2BS.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DRezac%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DR.%2BJ.%26aulast%3DConcha%26aufirst%3DM.%2BC.%26aulast%3DRamos%26aufirst%3DF.%2BM.%26aulast%3DPolitzer%26aufirst%3DP.%26atitle%3DHalogen%2520bond%2520tunability%2520II%253A%2520the%2520varying%2520roles%2520of%2520electrostatic%2520and%2520dispersion%2520contributions%2520to%2520attraction%2520in%2520halogen%2520bonds%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D4651%26epage%3D4659%26doi%3D10.1007%2Fs00894-012-1428-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Riley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobza, P.</span><span> </span><span class="NLM_article-title">Strength and character of halogen bonds in protein–ligand complexes</span> <span class="citation_source-journal">Cryst. Growth Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4272</span><span class="NLM_x">–</span> <span class="NLM_lpage">4278</span><span class="refDoi"> DOI: 10.1021/cg200882f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg200882f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Sltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=4272-4278&author=K.+E.+Rileyauthor=P.+Hobza&title=Strength+and+character+of+halogen+bonds+in+protein%E2%80%93ligand+complexes&doi=10.1021%2Fcg200882f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32cR"><div class="casContent"><span class="casTitleNuber">32c</span><div class="casTitle"><span class="NLM_cas:atitle">Strength and Character of Halogen Bonds in Protein-Ligand Complexes</span></div><div class="casAuthors">Riley, Kevin E.; Hobza, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4272-4278</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study we investigate the strength and character of eight halogen bonding interactions from six protein-ligand complexes.  The halogen bonding complexes investigated here were selected because of their favorable halogen bond characteristics.  Interaction energies of model systems derived from protein-ligand complexes are computed at the MP2/aug-cc-pVDZ level of theory, and the relative contributions of electrostatics and dispersion are estd. by computing ΔE(HF)/ΔE(MP2) ratios.  The relationship between these ratios and DFT-SAPT Eelec/Edisp results is calibrated using smaller model systems in order to gain a qual. understanding of the relative roles that electrostatics and dispersion play in these halogen bonds.  Electrostatic potentials for the halogen bonding ligands are also generated in order to study the relationship between halogen bond strengths and halogen σ-hole size (and charge).  It is found that the strength and character of the protein-ligand halogen bonds investigated here are strongly dependent on geometric factors and σ-hole characteristics.  Many of the halogen bonds studied here, esp. those with favorable geometric and electrostatic properties, are found to be of sufficient magnitude to make significant contributions to protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtt8FGL0esPbVg90H21EOLACvtfcHk0lj2C9NKeZMRPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Sltr3E&md5=d4412eba0b06264bb17c3842f319096a</span></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=10.1021%2Fcg200882f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg200882f%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DK.%2BE.%26aulast%3DHobza%26aufirst%3DP.%26atitle%3DStrength%2520and%2520character%2520of%2520halogen%2520bonds%2520in%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2011%26volume%3D11%26spage%3D4272%26epage%3D4278%26doi%3D10.1021%2Fcg200882f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delproposto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span> </span><span class="NLM_article-title">Buried hydrogen bond interactions contribute to the high potency of complement factor D inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1092-1096&author=C.-Y.+Yangauthor=J.+G.+Phillipsauthor=J.+A.+Stuckeyauthor=L.+Baiauthor=H.+Sunauthor=J.+Delpropostoauthor=W.+C.+Brownauthor=K.+Chinnaswamy&title=Buried+hydrogen+bond+interactions+contribute+to+the+high+potency+of+complement+factor+D+inhibitors&doi=10.1021%2Facsmedchemlett.6b00299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00299%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DPhillips%26aufirst%3DJ.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DDelproposto%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DChinnaswamy%26aufirst%3DK.%26atitle%3DBuried%2520hydrogen%2520bond%2520interactions%2520contribute%2520to%2520the%2520high%2520potency%2520of%2520complement%2520factor%2520D%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1092%26epage%3D1096%26doi%3D10.1021%2Facsmedchemlett.6b00299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">The crystal complex structure of a structurally related compound, the preparation of which had been directly inspired by our work (WO2012093101), bound to recombinant human FD at very low 3.15 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TCA">5TCA</a>) has been reported recently (see ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0ljmBD7MN2waQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Conrow, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, W. D.</span><span> </span><span class="NLM_article-title">Diazidomethane explosion</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1021/op8000977</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8000977" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVeitLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1285-1286&author=R.+E.+Conrowauthor=W.+D.+Dean&title=Diazidomethane+explosion&doi=10.1021%2Fop8000977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Diazidomethane Explosion</span></div><div class="casAuthors">Conrow, Raymond E.; Dean, W. Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1285-1286</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An explosion which caused extensive damage to a 20-L rotary evaporator and nearby equipment in a kilo lab. was detd. to have been caused by diazidomethane accumulated in the condenser.  Factors contributing to this incident are discussed and safer alternative procedures are recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKi7tHWrmyLVg90H21EOLACvtfcHk0ljmBD7MN2waQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVeitLnJ&md5=6011ed28a24fd01dc1bfdd20726e3fa7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fop8000977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8000977%26sid%3Dliteratum%253Aachs%26aulast%3DConrow%26aufirst%3DR.%2BE.%26aulast%3DDean%26aufirst%3DW.%2BD.%26atitle%3DDiazidomethane%2520explosion%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1285%26epage%3D1286%26doi%3D10.1021%2Fop8000977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">Warning! The acyl azide intermediate has a relatively low onset temperature of decomposition with a large energy release (dynamic DSC, onset <i>T</i> = 139.6 °C, 963 J/g).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Schramm, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triebwasser, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seddon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, J. P.</span><span> </span><span class="NLM_article-title">Genetic variants in the complement system predisposing to age-related macular degeneration: a review</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1016/j.molimm.2014.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=10.1016%2Fj.molimm.2014.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=25034031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=118-125&author=E.+C.+Schrammauthor=S.+J.+Clarkauthor=M.+P.+Triebwasserauthor=S.+Raychaudhuriauthor=J.+M.+Seddonauthor=J.+P.+Atkinson&title=Genetic+variants+in+the+complement+system+predisposing+to+age-related+macular+degeneration%3A+a+review&doi=10.1016%2Fj.molimm.2014.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in the complement system predisposing to age-related macular degeneration</span></div><div class="casAuthors">Schramm, Elizabeth C.; Clark, Simon J.; Triebwasser, Michael P.; Raychaudhuri, Soumya; Seddon, Johanna M.; Atkinson, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Age-related macular degeneration (AMD) is a major cause of visual impairment in the western world.  It is characterized by the presence of lipoproteinaceous deposits (drusen) in the inner layers of the retina.  Immunohistochem. studies identified deposition of complement proteins in the drusen as well as in the choroid.  In the last decade, genetic studies have linked both common and rare variants in genes of the complement system to increased risk of development of AMD.  Here, we review the variants described to date and discuss the functional implications of dysregulation of the alternative pathway of complement in AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5ZQzYfD307Vg90H21EOLACvtfcHk0ljmBD7MN2waQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK&md5=8b8ec6496b04e1a7748b2817045d2eb1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2014.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2014.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DE.%2BC.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26aulast%3DTriebwasser%26aufirst%3DM.%2BP.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DAtkinson%26aufirst%3DJ.%2BP.%26atitle%3DGenetic%2520variants%2520in%2520the%2520complement%2520system%2520predisposing%2520to%2520age-related%2520macular%2520degeneration%253A%2520a%2520review%26jtitle%3DMol.%2520Immunol.%26date%3D2014%26volume%3D61%26spage%3D118%26epage%3D125%26doi%3D10.1016%2Fj.molimm.2014.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE','PDB','5FBE'); return false;">PDB: 5FBE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT','PDB','5NAT'); return false;">PDB: 5NAT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBI','PDB','5FBI'); return false;">PDB: 5FBI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR','PDB','5NAR'); return false;">PDB: 5NAR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW','PDB','5NAW'); return false;">PDB: 5NAW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA','PDB','5NBA'); return false;">PDB: 5NBA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6','PDB','5NB6'); return false;">PDB: 5NB6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7','PDB','5NB7'); return false;">PDB: 5NB7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TCA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TCA','PDB','5TCA'); return false;">PDB: 5TCA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00425">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22708"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00425">10.1021/acs.jmedchem.7b00425</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystallographic structure determination of FD in complex with compounds <b>5</b>, <b>7</b>, <b>13</b>, <b>14</b>, <b>18</b>, and <b>2</b>, complement FD thioesterolysis assay, membrane attack complex formation assay in 50% human whole blood or in 50% human or cynomolgus monkey serum, <i>in vivo</i> studies in LPS-induced AP activation in mice expressing human FD, and pharmacokinetic studies for <b>7</b>, Sprague–Dawley rat pharmacokinetic study and ocular PK in Brown Norway rats (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_001.pdf">jm7b00425_si_001.pdf (235.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00425/suppl_file/jm7b00425_si_002.csv">jm7b00425_si_002.csv (2.97 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of complement Factor D with compounds <b>5</b>, <b>7</b>, <b>13</b>, <b>14</b>, <b>18</b>, and <b>2</b> can be accessed using PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAT">5NAT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAR">5NAR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NAW">5NAW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBA">5NBA</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB6">5NB6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NB7">5NB7</a>, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00425" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00425" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991e83cc9c3c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
